Prism AI
  • 30,000 reports
  • 1.2 million data points
  • One conversation
Explore with AI
Epilepsy And Seizure Drug-Level Market Intelligence, Commercial Forecasting, Estimations & Portfolio Report

Epilepsy And Seizure Drug-Level Market Intelligence, Commercial Forecasting, Estimations & Portfolio Analysis, 2021 - 2033

Table of Contents

Chapter 1. Levetiracetam (Keppra) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 1.1. Drug Information
  • 1.1.1. Drug Information
  • 1.1.2. Drug Patent Analysis
  • 1.2. Drug Estimates By Region
  • 1.2.1. North America
  • 1.2.1.1. Drug Insights
  • 1.2.1.2. Drug Estimates By Route of Administration
  • 1.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.3. Drug Estimates By Type
  • 1.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4. Drug Estimates By Country
  • 1.2.1.4.1. U.S.
  • 1.2.1.4.1.1. Drug Insight
  • 1.2.1.4.1.2. Drug Estimates By Route of Administration
  • 1.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.1.3. Drug Estimates By Type
  • 1.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.2. Canada
  • 1.2.1.4.2.1. Drug Insights
  • 1.2.1.4.2.2. Drug Estimates By Route of Administration
  • 1.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.2.3. Drug Estimates By Type
  • 1.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.3. Mexico
  • 1.2.1.4.3.1. Drug Insights
  • 1.2.1.4.3.2. Drug Estimates By Route of Administration
  • 1.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.3.3. Drug Estimates By Type
  • 1.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2. Europe
  • 1.2.2.1. UK
  • 1.2.2.1.1. Drug Insights
  • 1.2.2.1.2. Drug Estimates By Route of Administration
  • 1.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.1.3. Drug Estimates By Type
  • 1.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.2. Germany
  • 1.2.2.2.1. Drug Insights
  • 1.2.2.2.2. Drug Estimates By Route of Administration
  • 1.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.2.3. Drug Estimates By Type
  • 1.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.3. France
  • 1.2.2.3.1. Drug Insights
  • 1.2.2.3.2. Drug Estimates By Route of Administration
  • 1.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.3.3. Drug Estimates By Type
  • 1.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.4. Italy
  • 1.2.2.4.1. Drug Insights
  • 1.2.2.4.2. Drug Estimates By Route of Administration
  • 1.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.4.3. Drug Estimates By Type
  • 1.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.5. Spain
  • 1.2.2.5.1. Drug Insights
  • 1.2.2.5.2. Drug Estimates By Route of Administration
  • 1.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.5.3. Drug Estimates By Type
  • 1.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.6. Denmark
  • 1.2.2.6.1. Drug Insights
  • 1.2.2.6.2. Drug Estimates By Route of Administration
  • 1.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.6.3. Drug Estimates By Type
  • 1.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.7. Sweden
  • 1.2.2.7.1. Drug Insights
  • 1.2.2.7.2. Drug Estimates By Route of Administration
  • 1.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.7.3. Drug Estimates By Type
  • 1.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.8. Norway
  • 1.2.2.8.1. Drug Insights
  • 1.2.2.8.2. Drug Estimates By Route of Administration
  • 1.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.8.3. Drug Estimates By Type
  • 1.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.9. Rest of Europe
  • 1.2.2.9.1. Drug Insights
  • 1.2.2.9.2. Drug Estimates By Route of Administration
  • 1.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.9.3. Drug Estimates By Type
  • 1.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3. Asia Pacific
  • 1.2.3.1. Japan
  • 1.2.3.1.1. Drug Insights
  • 1.2.3.1.2. Drug Estimates By Route of Administration
  • 1.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.1.3. Drug Estimates By Type
  • 1.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.2. China
  • 1.2.3.2.1. Drug Insights
  • 1.2.3.2.2. Drug Estimates By Route of Administration
  • 1.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.2.3. Drug Estimates By Type
  • 1.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.3. India
  • 1.2.3.3.1. Drug Insights
  • 1.2.3.3.2. Drug Estimates By Route of Administration
  • 1.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.3.3. Drug Estimates By Type
  • 1.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.4. South Korea
  • 1.2.3.4.1. Drug Insights
  • 1.2.3.4.2. Drug Estimates By Route of Administration
  • 1.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.4.3. Drug Estimates By Type
  • 1.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.5. Australia
  • 1.2.3.5.1. Drug Insights
  • 1.2.3.5.2. Drug Estimates By Route of Administration
  • 1.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.5.3. Drug Estimates By Type
  • 1.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.6. Thailand
  • 1.2.3.6.1. Drug Insights
  • 1.2.3.6.2. Drug Estimates By Route of Administration
  • 1.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.6.3. Drug Estimates By Type
  • 1.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.7. Rest of APAC
  • 1.2.3.7.1. Drug Insights
  • 1.2.3.7.2. Drug Estimates By Route of Administration
  • 1.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.7.3. Drug Estimates By Type
  • 1.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4. Latin America
  • 1.2.4.1. Brazil
  • 1.2.4.1.1. Drug Insights
  • 1.2.4.1.2. Drug Estimates By Route of Administration
  • 1.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.1.3. Drug Estimates By Type
  • 1.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.2. Argentina
  • 1.2.4.2.1. Drug Insights
  • 1.2.4.2.2. Drug Estimates By Route of Administration
  • 1.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.2.3. Drug Estimates By Type
  • 1.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.3. Rest of Latin America
  • 1.2.4.3.1. Drug Insights
  • 1.2.4.3.2. Drug Estimates By Route of Administration
  • 1.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.3.3. Drug Estimates By Type
  • 1.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5. Middle East & Africa
  • 1.2.5.1. Saudi Arabia
  • 1.2.5.1.1. Drug Insights
  • 1.2.5.1.2. Drug Estimates By Route of Administration
  • 1.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.1.3. Drug Estimates By Type
  • 1.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.2. UAE
  • 1.2.5.2.1. Drug Insights
  • 1.2.5.2.2. Drug Estimates By Route of Administration
  • 1.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.2.3. Drug Estimates By Type
  • 1.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.3. Kuwait
  • 1.2.5.3.1. Drug Insights
  • 1.2.5.3.2. Drug Estimates By Route of Administration
  • 1.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.3.3. Drug Estimates By Type
  • 1.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.4. Rest of Middle East & Africa
  • 1.2.5.4.1. Drug Insights
  • 1.2.5.4.2. Drug Estimates By Route of Administration
  • 1.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.4.3. Drug Estimates By Type
  • 1.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 1.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 2. Lacosamide (Vimpat) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 2.1. Drug Information
  • 2.1.1. Drug Information
  • 2.1.2. Drug Patent Analysis
  • 2.2. Drug Estimates By Region
  • 2.2.1. North America
  • 2.2.1.1. Drug Insights
  • 2.2.1.2. Drug Estimates By Route of Administration
  • 2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.3. Drug Estimates By Type
  • 2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4. Drug Estimates By Country
  • 2.2.1.4.1. U.S.
  • 2.2.1.4.1.1. Drug Insight
  • 2.2.1.4.1.2. Drug Estimates By Route of Administration
  • 2.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.1.3. Drug Estimates By Type
  • 2.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.2. Canada
  • 2.2.1.4.2.1. Drug Insights
  • 2.2.1.4.2.2. Drug Estimates By Route of Administration
  • 2.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.2.3. Drug Estimates By Type
  • 2.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.3. Mexico
  • 2.2.1.4.3.1. Drug Insights
  • 2.2.1.4.3.2. Drug Estimates By Route of Administration
  • 2.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.3.3. Drug Estimates By Type
  • 2.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2. Europe
  • 2.2.2.1. UK
  • 2.2.2.1.1. Drug Insights
  • 2.2.2.1.2. Drug Estimates By Route of Administration
  • 2.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.1.3. Drug Estimates By Type
  • 2.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.2. Germany
  • 2.2.2.2.1. Drug Insights
  • 2.2.2.2.2. Drug Estimates By Route of Administration
  • 2.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.2.3. Drug Estimates By Type
  • 2.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.3. France
  • 2.2.2.3.1. Drug Insights
  • 2.2.2.3.2. Drug Estimates By Route of Administration
  • 2.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.3.3. Drug Estimates By Type
  • 2.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.4. Italy
  • 2.2.2.4.1. Drug Insights
  • 2.2.2.4.2. Drug Estimates By Route of Administration
  • 2.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.4.3. Drug Estimates By Type
  • 2.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.5. Spain
  • 2.2.2.5.1. Drug Insights
  • 2.2.2.5.2. Drug Estimates By Route of Administration
  • 2.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.5.3. Drug Estimates By Type
  • 2.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.6. Denmark
  • 2.2.2.6.1. Drug Insights
  • 2.2.2.6.2. Drug Estimates By Route of Administration
  • 2.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.6.3. Drug Estimates By Type
  • 2.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.7. Sweden
  • 2.2.2.7.1. Drug Insights
  • 2.2.2.7.2. Drug Estimates By Route of Administration
  • 2.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.7.3. Drug Estimates By Type
  • 2.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.8. Norway
  • 2.2.2.8.1. Drug Insights
  • 2.2.2.8.2. Drug Estimates By Route of Administration
  • 2.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.8.3. Drug Estimates By Type
  • 2.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.9. Rest of Europe
  • 2.2.2.9.1. Drug Insights
  • 2.2.2.9.2. Drug Estimates By Route of Administration
  • 2.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.9.3. Drug Estimates By Type
  • 2.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3. Asia Pacific
  • 2.2.3.1. Japan
  • 2.2.3.1.1. Drug Insights
  • 2.2.3.1.2. Drug Estimates By Route of Administration
  • 2.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.1.3. Drug Estimates By Type
  • 2.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.2. China
  • 2.2.3.2.1. Drug Insights
  • 2.2.3.2.2. Drug Estimates By Route of Administration
  • 2.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.2.3. Drug Estimates By Type
  • 2.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.3. India
  • 2.2.3.3.1. Drug Insights
  • 2.2.3.3.2. Drug Estimates By Route of Administration
  • 2.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.3.3. Drug Estimates By Type
  • 2.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.4. South Korea
  • 2.2.3.4.1. Drug Insights
  • 2.2.3.4.2. Drug Estimates By Route of Administration
  • 2.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.4.3. Drug Estimates By Type
  • 2.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.5. Australia
  • 2.2.3.5.1. Drug Insights
  • 2.2.3.5.2. Drug Estimates By Route of Administration
  • 2.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.5.3. Drug Estimates By Type
  • 2.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.6. Thailand
  • 2.2.3.6.1. Drug Insights
  • 2.2.3.6.2. Drug Estimates By Route of Administration
  • 2.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.6.3. Drug Estimates By Type
  • 2.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.7. Rest of APAC
  • 2.2.3.7.1. Drug Insights
  • 2.2.3.7.2. Drug Estimates By Route of Administration
  • 2.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.7.3. Drug Estimates By Type
  • 2.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4. Latin America
  • 2.2.4.1. Brazil
  • 2.2.4.1.1. Drug Insights
  • 2.2.4.1.2. Drug Estimates By Route of Administration
  • 2.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.1.3. Drug Estimates By Type
  • 2.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.2. Argentina
  • 2.2.4.2.1. Drug Insights
  • 2.2.4.2.2. Drug Estimates By Route of Administration
  • 2.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.2.3. Drug Estimates By Type
  • 2.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.3. Rest of Latin America
  • 2.2.4.3.1. Drug Insights
  • 2.2.4.3.2. Drug Estimates By Route of Administration
  • 2.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.3.3. Drug Estimates By Type
  • 2.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5. Middle East & Africa
  • 2.2.5.1. Saudi Arabia
  • 2.2.5.1.1. Drug Insights
  • 2.2.5.1.2. Drug Estimates By Route of Administration
  • 2.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.1.3. Drug Estimates By Type
  • 2.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.2. UAE
  • 2.2.5.2.1. Drug Insights
  • 2.2.5.2.2. Drug Estimates By Route of Administration
  • 2.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.2.3. Drug Estimates By Type
  • 2.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.3. Kuwait
  • 2.2.5.3.1. Drug Insights
  • 2.2.5.3.2. Drug Estimates By Route of Administration
  • 2.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.3.3. Drug Estimates By Type
  • 2.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.4. Rest of Middle East & Africa
  • 2.2.5.4.1. Drug Insights
  • 2.2.5.4.2. Drug Estimates By Route of Administration
  • 2.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.4.3. Drug Estimates By Type
  • 2.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 2.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 3. Brivaracetam (Briviact) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 3.1. Drug Information
  • 3.1.1. Drug Information
  • 3.1.2. Drug Patent Analysis
  • 3.2. Drug Estimates By Region
  • 3.2.1. North America
  • 3.2.1.1. Drug Insights
  • 3.2.1.2. Drug Estimates By Route of Administration
  • 3.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.3. Drug Estimates By Type
  • 3.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4. Drug Estimates By Country
  • 3.2.1.4.1. U.S.
  • 3.2.1.4.1.1. Drug Insight
  • 3.2.1.4.1.2. Drug Estimates By Route of Administration
  • 3.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.1.3. Drug Estimates By Type
  • 3.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.2. Canada
  • 3.2.1.4.2.1. Drug Insights
  • 3.2.1.4.2.2. Drug Estimates By Route of Administration
  • 3.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.2.3. Drug Estimates By Type
  • 3.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.3. Mexico
  • 3.2.1.4.3.1. Drug Insights
  • 3.2.1.4.3.2. Drug Estimates By Route of Administration
  • 3.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.3.3. Drug Estimates By Type
  • 3.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2. Europe
  • 3.2.2.1. UK
  • 3.2.2.1.1. Drug Insights
  • 3.2.2.1.2. Drug Estimates By Route of Administration
  • 3.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.1.3. Drug Estimates By Type
  • 3.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.2. Germany
  • 3.2.2.2.1. Drug Insights
  • 3.2.2.2.2. Drug Estimates By Route of Administration
  • 3.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.2.3. Drug Estimates By Type
  • 3.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.3. France
  • 3.2.2.3.1. Drug Insights
  • 3.2.2.3.2. Drug Estimates By Route of Administration
  • 3.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.3.3. Drug Estimates By Type
  • 3.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.4. Italy
  • 3.2.2.4.1. Drug Insights
  • 3.2.2.4.2. Drug Estimates By Route of Administration
  • 3.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.4.3. Drug Estimates By Type
  • 3.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.5. Spain
  • 3.2.2.5.1. Drug Insights
  • 3.2.2.5.2. Drug Estimates By Route of Administration
  • 3.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.5.3. Drug Estimates By Type
  • 3.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.6. Denmark
  • 3.2.2.6.1. Drug Insights
  • 3.2.2.6.2. Drug Estimates By Route of Administration
  • 3.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.6.3. Drug Estimates By Type
  • 3.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.7. Sweden
  • 3.2.2.7.1. Drug Insights
  • 3.2.2.7.2. Drug Estimates By Route of Administration
  • 3.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.7.3. Drug Estimates By Type
  • 3.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.8. Norway
  • 3.2.2.8.1. Drug Insights
  • 3.2.2.8.2. Drug Estimates By Route of Administration
  • 3.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.8.3. Drug Estimates By Type
  • 3.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.9. Rest of Europe
  • 3.2.2.9.1. Drug Insights
  • 3.2.2.9.2. Drug Estimates By Route of Administration
  • 3.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.9.3. Drug Estimates By Type
  • 3.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3. Asia Pacific
  • 3.2.3.1. Japan
  • 3.2.3.1.1. Drug Insights
  • 3.2.3.1.2. Drug Estimates By Route of Administration
  • 3.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.1.3. Drug Estimates By Type
  • 3.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.2. China
  • 3.2.3.2.1. Drug Insights
  • 3.2.3.2.2. Drug Estimates By Route of Administration
  • 3.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.2.3. Drug Estimates By Type
  • 3.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.3. India
  • 3.2.3.3.1. Drug Insights
  • 3.2.3.3.2. Drug Estimates By Route of Administration
  • 3.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.3.3. Drug Estimates By Type
  • 3.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.4. South Korea
  • 3.2.3.4.1. Drug Insights
  • 3.2.3.4.2. Drug Estimates By Route of Administration
  • 3.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.4.3. Drug Estimates By Type
  • 3.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.5. Australia
  • 3.2.3.5.1. Drug Insights
  • 3.2.3.5.2. Drug Estimates By Route of Administration
  • 3.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.5.3. Drug Estimates By Type
  • 3.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.6. Thailand
  • 3.2.3.6.1. Drug Insights
  • 3.2.3.6.2. Drug Estimates By Route of Administration
  • 3.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.6.3. Drug Estimates By Type
  • 3.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.7. Rest of APAC
  • 3.2.3.7.1. Drug Insights
  • 3.2.3.7.2. Drug Estimates By Route of Administration
  • 3.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.7.3. Drug Estimates By Type
  • 3.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4. Latin America
  • 3.2.4.1. Brazil
  • 3.2.4.1.1. Drug Insights
  • 3.2.4.1.2. Drug Estimates By Route of Administration
  • 3.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.1.3. Drug Estimates By Type
  • 3.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.2. Argentina
  • 3.2.4.2.1. Drug Insights
  • 3.2.4.2.2. Drug Estimates By Route of Administration
  • 3.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.2.3. Drug Estimates By Type
  • 3.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.3. Rest of Latin America
  • 3.2.4.3.1. Drug Insights
  • 3.2.4.3.2. Drug Estimates By Route of Administration
  • 3.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.3.3. Drug Estimates By Type
  • 3.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5. Middle East & Africa
  • 3.2.5.1. Saudi Arabia
  • 3.2.5.1.1. Drug Insights
  • 3.2.5.1.2. Drug Estimates By Route of Administration
  • 3.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.1.3. Drug Estimates By Type
  • 3.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.2. UAE
  • 3.2.5.2.1. Drug Insights
  • 3.2.5.2.2. Drug Estimates By Route of Administration
  • 3.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.2.3. Drug Estimates By Type
  • 3.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.3. Kuwait
  • 3.2.5.3.1. Drug Insights
  • 3.2.5.3.2. Drug Estimates By Route of Administration
  • 3.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.3.3. Drug Estimates By Type
  • 3.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.4. Rest of Middle East & Africa
  • 3.2.5.4.1. Drug Insights
  • 3.2.5.4.2. Drug Estimates By Route of Administration
  • 3.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.4.3. Drug Estimates By Type
  • 3.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 3.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 4. Fnflura (Fintepla) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 4.1. Drug Information
  • 4.1.1. Drug Information
  • 4.1.2. Drug Patent Analysis
  • 4.2. Drug Estimates By Region
  • 4.2.1. North America
  • 4.2.1.1. Drug Insights
  • 4.2.1.2. Drug Estimates By Route of Administration
  • 4.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.3. Drug Estimates By Type
  • 4.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4. Drug Estimates By Country
  • 4.2.1.4.1. U.S.
  • 4.2.1.4.1.1. Drug Insight
  • 4.2.1.4.1.2. Drug Estimates By Route of Administration
  • 4.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.1.3. Drug Estimates By Type
  • 4.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.2. Canada
  • 4.2.1.4.2.1. Drug Insights
  • 4.2.1.4.2.2. Drug Estimates By Route of Administration
  • 4.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.2.3. Drug Estimates By Type
  • 4.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.3. Mexico
  • 4.2.1.4.3.1. Drug Insights
  • 4.2.1.4.3.2. Drug Estimates By Route of Administration
  • 4.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.3.3. Drug Estimates By Type
  • 4.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2. Europe
  • 4.2.2.1. UK
  • 4.2.2.1.1. Drug Insights
  • 4.2.2.1.2. Drug Estimates By Route of Administration
  • 4.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.1.3. Drug Estimates By Type
  • 4.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.2. Germany
  • 4.2.2.2.1. Drug Insights
  • 4.2.2.2.2. Drug Estimates By Route of Administration
  • 4.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.2.3. Drug Estimates By Type
  • 4.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.3. France
  • 4.2.2.3.1. Drug Insights
  • 4.2.2.3.2. Drug Estimates By Route of Administration
  • 4.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.3.3. Drug Estimates By Type
  • 4.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.4. Italy
  • 4.2.2.4.1. Drug Insights
  • 4.2.2.4.2. Drug Estimates By Route of Administration
  • 4.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.4.3. Drug Estimates By Type
  • 4.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.5. Spain
  • 4.2.2.5.1. Drug Insights
  • 4.2.2.5.2. Drug Estimates By Route of Administration
  • 4.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.5.3. Drug Estimates By Type
  • 4.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.6. Denmark
  • 4.2.2.6.1. Drug Insights
  • 4.2.2.6.2. Drug Estimates By Route of Administration
  • 4.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.6.3. Drug Estimates By Type
  • 4.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.7. Sweden
  • 4.2.2.7.1. Drug Insights
  • 4.2.2.7.2. Drug Estimates By Route of Administration
  • 4.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.7.3. Drug Estimates By Type
  • 4.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.8. Norway
  • 4.2.2.8.1. Drug Insights
  • 4.2.2.8.2. Drug Estimates By Route of Administration
  • 4.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.8.3. Drug Estimates By Type
  • 4.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.9. Rest of Europe
  • 4.2.2.9.1. Drug Insights
  • 4.2.2.9.2. Drug Estimates By Route of Administration
  • 4.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.9.3. Drug Estimates By Type
  • 4.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3. Asia Pacific
  • 4.2.3.1. Japan
  • 4.2.3.1.1. Drug Insights
  • 4.2.3.1.2. Drug Estimates By Route of Administration
  • 4.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.1.3. Drug Estimates By Type
  • 4.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.2. China
  • 4.2.3.2.1. Drug Insights
  • 4.2.3.2.2. Drug Estimates By Route of Administration
  • 4.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.2.3. Drug Estimates By Type
  • 4.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.3. India
  • 4.2.3.3.1. Drug Insights
  • 4.2.3.3.2. Drug Estimates By Route of Administration
  • 4.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.3.3. Drug Estimates By Type
  • 4.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.4. South Korea
  • 4.2.3.4.1. Drug Insights
  • 4.2.3.4.2. Drug Estimates By Route of Administration
  • 4.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.4.3. Drug Estimates By Type
  • 4.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.5. Australia
  • 4.2.3.5.1. Drug Insights
  • 4.2.3.5.2. Drug Estimates By Route of Administration
  • 4.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.5.3. Drug Estimates By Type
  • 4.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.6. Thailand
  • 4.2.3.6.1. Drug Insights
  • 4.2.3.6.2. Drug Estimates By Route of Administration
  • 4.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.6.3. Drug Estimates By Type
  • 4.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.7. Rest of APAC
  • 4.2.3.7.1. Drug Insights
  • 4.2.3.7.2. Drug Estimates By Route of Administration
  • 4.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.7.3. Drug Estimates By Type
  • 4.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4. Latin America
  • 4.2.4.1. Brazil
  • 4.2.4.1.1. Drug Insights
  • 4.2.4.1.2. Drug Estimates By Route of Administration
  • 4.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.1.3. Drug Estimates By Type
  • 4.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.2. Argentina
  • 4.2.4.2.1. Drug Insights
  • 4.2.4.2.2. Drug Estimates By Route of Administration
  • 4.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.2.3. Drug Estimates By Type
  • 4.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.3. Rest of Latin America
  • 4.2.4.3.1. Drug Insights
  • 4.2.4.3.2. Drug Estimates By Route of Administration
  • 4.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.3.3. Drug Estimates By Type
  • 4.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5. Middle East & Africa
  • 4.2.5.1. Saudi Arabia
  • 4.2.5.1.1. Drug Insights
  • 4.2.5.1.2. Drug Estimates By Route of Administration
  • 4.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.1.3. Drug Estimates By Type
  • 4.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.2. UAE
  • 4.2.5.2.1. Drug Insights
  • 4.2.5.2.2. Drug Estimates By Route of Administration
  • 4.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.2.3. Drug Estimates By Type
  • 4.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.3. Kuwait
  • 4.2.5.3.1. Drug Insights
  • 4.2.5.3.2. Drug Estimates By Route of Administration
  • 4.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.3.3. Drug Estimates By Type
  • 4.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.4. Rest of Middle East & Africa
  • 4.2.5.4.1. Drug Insights
  • 4.2.5.4.2. Drug Estimates By Route of Administration
  • 4.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.4.3. Drug Estimates By Type
  • 4.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 4.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 5. Midazolam (Nayzilam) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 5.1. Drug Information
  • 5.1.1. Drug Information
  • 5.1.2. Drug Patent Analysis
  • 5.2. Drug Estimates By Region
  • 5.2.1. North America
  • 5.2.1.1. Drug Insights
  • 5.2.1.2. Drug Estimates By Route of Administration
  • 5.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.3. Drug Estimates By Type
  • 5.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4. Drug Estimates By Country
  • 5.2.1.4.1. U.S.
  • 5.2.1.4.1.1. Drug Insight
  • 5.2.1.4.1.2. Drug Estimates By Route of Administration
  • 5.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.1.3. Drug Estimates By Type
  • 5.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.2. Canada
  • 5.2.1.4.2.1. Drug Insights
  • 5.2.1.4.2.2. Drug Estimates By Route of Administration
  • 5.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.2.3. Drug Estimates By Type
  • 5.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.3. Mexico
  • 5.2.1.4.3.1. Drug Insights
  • 5.2.1.4.3.2. Drug Estimates By Route of Administration
  • 5.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.3.3. Drug Estimates By Type
  • 5.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2. Europe
  • 5.2.2.1. UK
  • 5.2.2.1.1. Drug Insights
  • 5.2.2.1.2. Drug Estimates By Route of Administration
  • 5.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.1.3. Drug Estimates By Type
  • 5.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.2. Germany
  • 5.2.2.2.1. Drug Insights
  • 5.2.2.2.2. Drug Estimates By Route of Administration
  • 5.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.2.3. Drug Estimates By Type
  • 5.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.3. France
  • 5.2.2.3.1. Drug Insights
  • 5.2.2.3.2. Drug Estimates By Route of Administration
  • 5.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.3.3. Drug Estimates By Type
  • 5.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.4. Italy
  • 5.2.2.4.1. Drug Insights
  • 5.2.2.4.2. Drug Estimates By Route of Administration
  • 5.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.4.3. Drug Estimates By Type
  • 5.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.5. Spain
  • 5.2.2.5.1. Drug Insights
  • 5.2.2.5.2. Drug Estimates By Route of Administration
  • 5.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.5.3. Drug Estimates By Type
  • 5.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.6. Denmark
  • 5.2.2.6.1. Drug Insights
  • 5.2.2.6.2. Drug Estimates By Route of Administration
  • 5.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.6.3. Drug Estimates By Type
  • 5.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.7. Sweden
  • 5.2.2.7.1. Drug Insights
  • 5.2.2.7.2. Drug Estimates By Route of Administration
  • 5.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.7.3. Drug Estimates By Type
  • 5.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.8. Norway
  • 5.2.2.8.1. Drug Insights
  • 5.2.2.8.2. Drug Estimates By Route of Administration
  • 5.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.8.3. Drug Estimates By Type
  • 5.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.9. Rest of Europe
  • 5.2.2.9.1. Drug Insights
  • 5.2.2.9.2. Drug Estimates By Route of Administration
  • 5.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.9.3. Drug Estimates By Type
  • 5.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3. Asia Pacific
  • 5.2.3.1. Japan
  • 5.2.3.1.1. Drug Insights
  • 5.2.3.1.2. Drug Estimates By Route of Administration
  • 5.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.1.3. Drug Estimates By Type
  • 5.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.2. China
  • 5.2.3.2.1. Drug Insights
  • 5.2.3.2.2. Drug Estimates By Route of Administration
  • 5.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.2.3. Drug Estimates By Type
  • 5.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.3. India
  • 5.2.3.3.1. Drug Insights
  • 5.2.3.3.2. Drug Estimates By Route of Administration
  • 5.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.3.3. Drug Estimates By Type
  • 5.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.4. South Korea
  • 5.2.3.4.1. Drug Insights
  • 5.2.3.4.2. Drug Estimates By Route of Administration
  • 5.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.4.3. Drug Estimates By Type
  • 5.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.5. Australia
  • 5.2.3.5.1. Drug Insights
  • 5.2.3.5.2. Drug Estimates By Route of Administration
  • 5.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.5.3. Drug Estimates By Type
  • 5.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.6. Thailand
  • 5.2.3.6.1. Drug Insights
  • 5.2.3.6.2. Drug Estimates By Route of Administration
  • 5.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.6.3. Drug Estimates By Type
  • 5.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.7. Rest of APAC
  • 5.2.3.7.1. Drug Insights
  • 5.2.3.7.2. Drug Estimates By Route of Administration
  • 5.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.7.3. Drug Estimates By Type
  • 5.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4. Latin America
  • 5.2.4.1. Brazil
  • 5.2.4.1.1. Drug Insights
  • 5.2.4.1.2. Drug Estimates By Route of Administration
  • 5.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.1.3. Drug Estimates By Type
  • 5.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.2. Argentina
  • 5.2.4.2.1. Drug Insights
  • 5.2.4.2.2. Drug Estimates By Route of Administration
  • 5.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.2.3. Drug Estimates By Type
  • 5.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.3. Rest of Latin America
  • 5.2.4.3.1. Drug Insights
  • 5.2.4.3.2. Drug Estimates By Route of Administration
  • 5.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.3.3. Drug Estimates By Type
  • 5.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5. Middle East & Africa
  • 5.2.5.1. Saudi Arabia
  • 5.2.5.1.1. Drug Insights
  • 5.2.5.1.2. Drug Estimates By Route of Administration
  • 5.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.1.3. Drug Estimates By Type
  • 5.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.2. UAE
  • 5.2.5.2.1. Drug Insights
  • 5.2.5.2.2. Drug Estimates By Route of Administration
  • 5.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.2.3. Drug Estimates By Type
  • 5.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.3. Kuwait
  • 5.2.5.3.1. Drug Insights
  • 5.2.5.3.2. Drug Estimates By Route of Administration
  • 5.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.3.3. Drug Estimates By Type
  • 5.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.4. Rest of Middle East & Africa
  • 5.2.5.4.1. Drug Insights
  • 5.2.5.4.2. Drug Estimates By Route of Administration
  • 5.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.4.3. Drug Estimates By Type
  • 5.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 5.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 6. Eslicarbazepine Acetate (Aptiom / Zebinix) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 6.1. Drug Information
  • 6.1.1. Drug Information
  • 6.1.2. Drug Patent Analysis
  • 6.2. Drug Estimates By Region
  • 6.2.1. North America
  • 6.2.1.1. Drug Insights
  • 6.2.1.2. Drug Estimates By Route of Administration
  • 6.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.3. Drug Estimates By Type
  • 6.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4. Drug Estimates By Country
  • 6.2.1.4.1. U.S.
  • 6.2.1.4.1.1. Drug Insight
  • 6.2.1.4.1.2. Drug Estimates By Route of Administration
  • 6.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.1.3. Drug Estimates By Type
  • 6.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.2. Canada
  • 6.2.1.4.2.1. Drug Insights
  • 6.2.1.4.2.2. Drug Estimates By Route of Administration
  • 6.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.2.3. Drug Estimates By Type
  • 6.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.3. Mexico
  • 6.2.1.4.3.1. Drug Insights
  • 6.2.1.4.3.2. Drug Estimates By Route of Administration
  • 6.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.3.3. Drug Estimates By Type
  • 6.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2. Europe
  • 6.2.2.1. UK
  • 6.2.2.1.1. Drug Insights
  • 6.2.2.1.2. Drug Estimates By Route of Administration
  • 6.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.1.3. Drug Estimates By Type
  • 6.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.2. Germany
  • 6.2.2.2.1. Drug Insights
  • 6.2.2.2.2. Drug Estimates By Route of Administration
  • 6.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.2.3. Drug Estimates By Type
  • 6.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.3. France
  • 6.2.2.3.1. Drug Insights
  • 6.2.2.3.2. Drug Estimates By Route of Administration
  • 6.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.3.3. Drug Estimates By Type
  • 6.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.4. Italy
  • 6.2.2.4.1. Drug Insights
  • 6.2.2.4.2. Drug Estimates By Route of Administration
  • 6.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.4.3. Drug Estimates By Type
  • 6.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.5. Spain
  • 6.2.2.5.1. Drug Insights
  • 6.2.2.5.2. Drug Estimates By Route of Administration
  • 6.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.5.3. Drug Estimates By Type
  • 6.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.6. Denmark
  • 6.2.2.6.1. Drug Insights
  • 6.2.2.6.2. Drug Estimates By Route of Administration
  • 6.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.6.3. Drug Estimates By Type
  • 6.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.7. Sweden
  • 6.2.2.7.1. Drug Insights
  • 6.2.2.7.2. Drug Estimates By Route of Administration
  • 6.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.7.3. Drug Estimates By Type
  • 6.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.8. Norway
  • 6.2.2.8.1. Drug Insights
  • 6.2.2.8.2. Drug Estimates By Route of Administration
  • 6.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.8.3. Drug Estimates By Type
  • 6.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.9. Rest of Europe
  • 6.2.2.9.1. Drug Insights
  • 6.2.2.9.2. Drug Estimates By Route of Administration
  • 6.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.9.3. Drug Estimates By Type
  • 6.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3. Asia Pacific
  • 6.2.3.1. Japan
  • 6.2.3.1.1. Drug Insights
  • 6.2.3.1.2. Drug Estimates By Route of Administration
  • 6.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.1.3. Drug Estimates By Type
  • 6.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.2. China
  • 6.2.3.2.1. Drug Insights
  • 6.2.3.2.2. Drug Estimates By Route of Administration
  • 6.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.2.3. Drug Estimates By Type
  • 6.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.3. India
  • 6.2.3.3.1. Drug Insights
  • 6.2.3.3.2. Drug Estimates By Route of Administration
  • 6.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.3.3. Drug Estimates By Type
  • 6.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.4. South Korea
  • 6.2.3.4.1. Drug Insights
  • 6.2.3.4.2. Drug Estimates By Route of Administration
  • 6.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.4.3. Drug Estimates By Type
  • 6.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.5. Australia
  • 6.2.3.5.1. Drug Insights
  • 6.2.3.5.2. Drug Estimates By Route of Administration
  • 6.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.5.3. Drug Estimates By Type
  • 6.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.6. Thailand
  • 6.2.3.6.1. Drug Insights
  • 6.2.3.6.2. Drug Estimates By Route of Administration
  • 6.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.6.3. Drug Estimates By Type
  • 6.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.7. Rest of APAC
  • 6.2.3.7.1. Drug Insights
  • 6.2.3.7.2. Drug Estimates By Route of Administration
  • 6.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.7.3. Drug Estimates By Type
  • 6.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4. Latin America
  • 6.2.4.1. Brazil
  • 6.2.4.1.1. Drug Insights
  • 6.2.4.1.2. Drug Estimates By Route of Administration
  • 6.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.1.3. Drug Estimates By Type
  • 6.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.2. Argentina
  • 6.2.4.2.1. Drug Insights
  • 6.2.4.2.2. Drug Estimates By Route of Administration
  • 6.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.2.3. Drug Estimates By Type
  • 6.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.3. Rest of Latin America
  • 6.2.4.3.1. Drug Insights
  • 6.2.4.3.2. Drug Estimates By Route of Administration
  • 6.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.3.3. Drug Estimates By Type
  • 6.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5. Middle East & Africa
  • 6.2.5.1. Saudi Arabia
  • 6.2.5.1.1. Drug Insights
  • 6.2.5.1.2. Drug Estimates By Route of Administration
  • 6.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.1.3. Drug Estimates By Type
  • 6.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.2. UAE
  • 6.2.5.2.1. Drug Insights
  • 6.2.5.2.2. Drug Estimates By Route of Administration
  • 6.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.2.3. Drug Estimates By Type
  • 6.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.3. Kuwait
  • 6.2.5.3.1. Drug Insights
  • 6.2.5.3.2. Drug Estimates By Route of Administration
  • 6.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.3.3. Drug Estimates By Type
  • 6.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.4. Rest of Middle East & Africa
  • 6.2.5.4.1. Drug Insights
  • 6.2.5.4.2. Drug Estimates By Route of Administration
  • 6.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.4.3. Drug Estimates By Type
  • 6.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 6.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 7. Cenobamate (Ontozry) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 7.1. Drug Information
  • 7.1.1. Drug Information
  • 7.1.2. Drug Patent Analysis
  • 7.2. Drug Estimates By Region
  • 7.2.1. North America
  • 7.2.1.1. Drug Insights
  • 7.2.1.2. Drug Estimates By Route of Administration
  • 7.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.3. Drug Estimates By Type
  • 7.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4. Drug Estimates By Country
  • 7.2.1.4.1. U.S.
  • 7.2.1.4.1.1. Drug Insight
  • 7.2.1.4.1.2. Drug Estimates By Route of Administration
  • 7.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.1.3. Drug Estimates By Type
  • 7.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.2. Canada
  • 7.2.1.4.2.1. Drug Insights
  • 7.2.1.4.2.2. Drug Estimates By Route of Administration
  • 7.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.2.3. Drug Estimates By Type
  • 7.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.3. Mexico
  • 7.2.1.4.3.1. Drug Insights
  • 7.2.1.4.3.2. Drug Estimates By Route of Administration
  • 7.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.3.3. Drug Estimates By Type
  • 7.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2. Europe
  • 7.2.2.1. UK
  • 7.2.2.1.1. Drug Insights
  • 7.2.2.1.2. Drug Estimates By Route of Administration
  • 7.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.1.3. Drug Estimates By Type
  • 7.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.2. Germany
  • 7.2.2.2.1. Drug Insights
  • 7.2.2.2.2. Drug Estimates By Route of Administration
  • 7.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.2.3. Drug Estimates By Type
  • 7.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.3. France
  • 7.2.2.3.1. Drug Insights
  • 7.2.2.3.2. Drug Estimates By Route of Administration
  • 7.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.3.3. Drug Estimates By Type
  • 7.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.4. Italy
  • 7.2.2.4.1. Drug Insights
  • 7.2.2.4.2. Drug Estimates By Route of Administration
  • 7.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.4.3. Drug Estimates By Type
  • 7.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.5. Spain
  • 7.2.2.5.1. Drug Insights
  • 7.2.2.5.2. Drug Estimates By Route of Administration
  • 7.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.5.3. Drug Estimates By Type
  • 7.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.6. Denmark
  • 7.2.2.6.1. Drug Insights
  • 7.2.2.6.2. Drug Estimates By Route of Administration
  • 7.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.6.3. Drug Estimates By Type
  • 7.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.7. Sweden
  • 7.2.2.7.1. Drug Insights
  • 7.2.2.7.2. Drug Estimates By Route of Administration
  • 7.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.7.3. Drug Estimates By Type
  • 7.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.8. Norway
  • 7.2.2.8.1. Drug Insights
  • 7.2.2.8.2. Drug Estimates By Route of Administration
  • 7.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.8.3. Drug Estimates By Type
  • 7.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.9. Rest of Europe
  • 7.2.2.9.1. Drug Insights
  • 7.2.2.9.2. Drug Estimates By Route of Administration
  • 7.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.9.3. Drug Estimates By Type
  • 7.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3. Asia Pacific
  • 7.2.3.1. Japan
  • 7.2.3.1.1. Drug Insights
  • 7.2.3.1.2. Drug Estimates By Route of Administration
  • 7.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.1.3. Drug Estimates By Type
  • 7.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.2. China
  • 7.2.3.2.1. Drug Insights
  • 7.2.3.2.2. Drug Estimates By Route of Administration
  • 7.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.2.3. Drug Estimates By Type
  • 7.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.3. India
  • 7.2.3.3.1. Drug Insights
  • 7.2.3.3.2. Drug Estimates By Route of Administration
  • 7.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.3.3. Drug Estimates By Type
  • 7.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.4. South Korea
  • 7.2.3.4.1. Drug Insights
  • 7.2.3.4.2. Drug Estimates By Route of Administration
  • 7.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.4.3. Drug Estimates By Type
  • 7.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.5. Australia
  • 7.2.3.5.1. Drug Insights
  • 7.2.3.5.2. Drug Estimates By Route of Administration
  • 7.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.5.3. Drug Estimates By Type
  • 7.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.6. Thailand
  • 7.2.3.6.1. Drug Insights
  • 7.2.3.6.2. Drug Estimates By Route of Administration
  • 7.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.6.3. Drug Estimates By Type
  • 7.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.7. Rest of APAC
  • 7.2.3.7.1. Drug Insights
  • 7.2.3.7.2. Drug Estimates By Route of Administration
  • 7.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.7.3. Drug Estimates By Type
  • 7.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4. Latin America
  • 7.2.4.1. Brazil
  • 7.2.4.1.1. Drug Insights
  • 7.2.4.1.2. Drug Estimates By Route of Administration
  • 7.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.1.3. Drug Estimates By Type
  • 7.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.2. Argentina
  • 7.2.4.2.1. Drug Insights
  • 7.2.4.2.2. Drug Estimates By Route of Administration
  • 7.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.2.3. Drug Estimates By Type
  • 7.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.3. Rest of Latin America
  • 7.2.4.3.1. Drug Insights
  • 7.2.4.3.2. Drug Estimates By Route of Administration
  • 7.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.3.3. Drug Estimates By Type
  • 7.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5. Middle East & Africa
  • 7.2.5.1. Saudi Arabia
  • 7.2.5.1.1. Drug Insights
  • 7.2.5.1.2. Drug Estimates By Route of Administration
  • 7.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.1.3. Drug Estimates By Type
  • 7.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.2. UAE
  • 7.2.5.2.1. Drug Insights
  • 7.2.5.2.2. Drug Estimates By Route of Administration
  • 7.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.2.3. Drug Estimates By Type
  • 7.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.3. Kuwait
  • 7.2.5.3.1. Drug Insights
  • 7.2.5.3.2. Drug Estimates By Route of Administration
  • 7.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.3.3. Drug Estimates By Type
  • 7.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.4. Rest of Middle East & Africa
  • 7.2.5.4.1. Drug Insights
  • 7.2.5.4.2. Drug Estimates By Route of Administration
  • 7.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.4.3. Drug Estimates By Type
  • 7.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 7.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 8. Cenobamate (Xcopri) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 8.1. Drug Information
  • 8.1.1. Drug Information
  • 8.1.2. Drug Patent Analysis
  • 8.2. Drug Estimates By Region
  • 8.2.1. North America
  • 8.2.1.1. Drug Insights
  • 8.2.1.2. Drug Estimates By Route of Administration
  • 8.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.3. Drug Estimates By Type
  • 8.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4. Drug Estimates By Country
  • 8.2.1.4.1. U.S.
  • 8.2.1.4.1.1. Drug Insight
  • 8.2.1.4.1.2. Drug Estimates By Route of Administration
  • 8.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.1.3. Drug Estimates By Type
  • 8.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.2. Canada
  • 8.2.1.4.2.1. Drug Insights
  • 8.2.1.4.2.2. Drug Estimates By Route of Administration
  • 8.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.2.3. Drug Estimates By Type
  • 8.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.3. Mexico
  • 8.2.1.4.3.1. Drug Insights
  • 8.2.1.4.3.2. Drug Estimates By Route of Administration
  • 8.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.3.3. Drug Estimates By Type
  • 8.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2. Europe
  • 8.2.2.1. UK
  • 8.2.2.1.1. Drug Insights
  • 8.2.2.1.2. Drug Estimates By Route of Administration
  • 8.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.1.3. Drug Estimates By Type
  • 8.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.2. Germany
  • 8.2.2.2.1. Drug Insights
  • 8.2.2.2.2. Drug Estimates By Route of Administration
  • 8.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.2.3. Drug Estimates By Type
  • 8.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.3. France
  • 8.2.2.3.1. Drug Insights
  • 8.2.2.3.2. Drug Estimates By Route of Administration
  • 8.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.3.3. Drug Estimates By Type
  • 8.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.4. Italy
  • 8.2.2.4.1. Drug Insights
  • 8.2.2.4.2. Drug Estimates By Route of Administration
  • 8.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.4.3. Drug Estimates By Type
  • 8.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.5. Spain
  • 8.2.2.5.1. Drug Insights
  • 8.2.2.5.2. Drug Estimates By Route of Administration
  • 8.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.5.3. Drug Estimates By Type
  • 8.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.6. Denmark
  • 8.2.2.6.1. Drug Insights
  • 8.2.2.6.2. Drug Estimates By Route of Administration
  • 8.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.6.3. Drug Estimates By Type
  • 8.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.7. Sweden
  • 8.2.2.7.1. Drug Insights
  • 8.2.2.7.2. Drug Estimates By Route of Administration
  • 8.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.7.3. Drug Estimates By Type
  • 8.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.8. Norway
  • 8.2.2.8.1. Drug Insights
  • 8.2.2.8.2. Drug Estimates By Route of Administration
  • 8.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.8.3. Drug Estimates By Type
  • 8.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.9. Rest of Europe
  • 8.2.2.9.1. Drug Insights
  • 8.2.2.9.2. Drug Estimates By Route of Administration
  • 8.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.9.3. Drug Estimates By Type
  • 8.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3. Asia Pacific
  • 8.2.3.1. Japan
  • 8.2.3.1.1. Drug Insights
  • 8.2.3.1.2. Drug Estimates By Route of Administration
  • 8.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.1.3. Drug Estimates By Type
  • 8.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.2. China
  • 8.2.3.2.1. Drug Insights
  • 8.2.3.2.2. Drug Estimates By Route of Administration
  • 8.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.2.3. Drug Estimates By Type
  • 8.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.3. India
  • 8.2.3.3.1. Drug Insights
  • 8.2.3.3.2. Drug Estimates By Route of Administration
  • 8.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.3.3. Drug Estimates By Type
  • 8.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.4. South Korea
  • 8.2.3.4.1. Drug Insights
  • 8.2.3.4.2. Drug Estimates By Route of Administration
  • 8.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.4.3. Drug Estimates By Type
  • 8.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.5. Australia
  • 8.2.3.5.1. Drug Insights
  • 8.2.3.5.2. Drug Estimates By Route of Administration
  • 8.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.5.3. Drug Estimates By Type
  • 8.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.6. Thailand
  • 8.2.3.6.1. Drug Insights
  • 8.2.3.6.2. Drug Estimates By Route of Administration
  • 8.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.6.3. Drug Estimates By Type
  • 8.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.7. Rest of APAC
  • 8.2.3.7.1. Drug Insights
  • 8.2.3.7.2. Drug Estimates By Route of Administration
  • 8.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.7.3. Drug Estimates By Type
  • 8.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4. Latin America
  • 8.2.4.1. Brazil
  • 8.2.4.1.1. Drug Insights
  • 8.2.4.1.2. Drug Estimates By Route of Administration
  • 8.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.1.3. Drug Estimates By Type
  • 8.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.2. Argentina
  • 8.2.4.2.1. Drug Insights
  • 8.2.4.2.2. Drug Estimates By Route of Administration
  • 8.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.2.3. Drug Estimates By Type
  • 8.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.3. Rest of Latin America
  • 8.2.4.3.1. Drug Insights
  • 8.2.4.3.2. Drug Estimates By Route of Administration
  • 8.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.3.3. Drug Estimates By Type
  • 8.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5. Middle East & Africa
  • 8.2.5.1. Saudi Arabia
  • 8.2.5.1.1. Drug Insights
  • 8.2.5.1.2. Drug Estimates By Route of Administration
  • 8.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.1.3. Drug Estimates By Type
  • 8.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.2. UAE
  • 8.2.5.2.1. Drug Insights
  • 8.2.5.2.2. Drug Estimates By Route of Administration
  • 8.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.2.3. Drug Estimates By Type
  • 8.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.3. Kuwait
  • 8.2.5.3.1. Drug Insights
  • 8.2.5.3.2. Drug Estimates By Route of Administration
  • 8.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.3.3. Drug Estimates By Type
  • 8.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.4. Rest of Middle East & Africa
  • 8.2.5.4.1. Drug Insights
  • 8.2.5.4.2. Drug Estimates By Route of Administration
  • 8.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.4.3. Drug Estimates By Type
  • 8.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 8.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 9. Perampanel (Fycompa) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 9.1. Drug Information
  • 9.1.1. Drug Information
  • 9.1.2. Drug Patent Analysis
  • 9.2. Drug Estimates By Region
  • 9.2.1. North America
  • 9.2.1.1. Drug Insights
  • 9.2.1.2. Drug Estimates By Route of Administration
  • 9.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.3. Drug Estimates By Type
  • 9.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4. Drug Estimates By Country
  • 9.2.1.4.1. U.S.
  • 9.2.1.4.1.1. Drug Insight
  • 9.2.1.4.1.2. Drug Estimates By Route of Administration
  • 9.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.1.3. Drug Estimates By Type
  • 9.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.2. Canada
  • 9.2.1.4.2.1. Drug Insights
  • 9.2.1.4.2.2. Drug Estimates By Route of Administration
  • 9.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.2.3. Drug Estimates By Type
  • 9.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.3. Mexico
  • 9.2.1.4.3.1. Drug Insights
  • 9.2.1.4.3.2. Drug Estimates By Route of Administration
  • 9.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.3.3. Drug Estimates By Type
  • 9.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2. Europe
  • 9.2.2.1. UK
  • 9.2.2.1.1. Drug Insights
  • 9.2.2.1.2. Drug Estimates By Route of Administration
  • 9.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.1.3. Drug Estimates By Type
  • 9.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.2. Germany
  • 9.2.2.2.1. Drug Insights
  • 9.2.2.2.2. Drug Estimates By Route of Administration
  • 9.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.2.3. Drug Estimates By Type
  • 9.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.3. France
  • 9.2.2.3.1. Drug Insights
  • 9.2.2.3.2. Drug Estimates By Route of Administration
  • 9.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.3.3. Drug Estimates By Type
  • 9.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.4. Italy
  • 9.2.2.4.1. Drug Insights
  • 9.2.2.4.2. Drug Estimates By Route of Administration
  • 9.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.4.3. Drug Estimates By Type
  • 9.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.5. Spain
  • 9.2.2.5.1. Drug Insights
  • 9.2.2.5.2. Drug Estimates By Route of Administration
  • 9.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.5.3. Drug Estimates By Type
  • 9.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.6. Denmark
  • 9.2.2.6.1. Drug Insights
  • 9.2.2.6.2. Drug Estimates By Route of Administration
  • 9.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.6.3. Drug Estimates By Type
  • 9.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.7. Sweden
  • 9.2.2.7.1. Drug Insights
  • 9.2.2.7.2. Drug Estimates By Route of Administration
  • 9.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.7.3. Drug Estimates By Type
  • 9.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.8. Norway
  • 9.2.2.8.1. Drug Insights
  • 9.2.2.8.2. Drug Estimates By Route of Administration
  • 9.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.8.3. Drug Estimates By Type
  • 9.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.9. Rest of Europe
  • 9.2.2.9.1. Drug Insights
  • 9.2.2.9.2. Drug Estimates By Route of Administration
  • 9.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.9.3. Drug Estimates By Type
  • 9.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3. Asia Pacific
  • 9.2.3.1. Japan
  • 9.2.3.1.1. Drug Insights
  • 9.2.3.1.2. Drug Estimates By Route of Administration
  • 9.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.1.3. Drug Estimates By Type
  • 9.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.2. China
  • 9.2.3.2.1. Drug Insights
  • 9.2.3.2.2. Drug Estimates By Route of Administration
  • 9.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.2.3. Drug Estimates By Type
  • 9.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.3. India
  • 9.2.3.3.1. Drug Insights
  • 9.2.3.3.2. Drug Estimates By Route of Administration
  • 9.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.3.3. Drug Estimates By Type
  • 9.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.4. South Korea
  • 9.2.3.4.1. Drug Insights
  • 9.2.3.4.2. Drug Estimates By Route of Administration
  • 9.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.4.3. Drug Estimates By Type
  • 9.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.5. Australia
  • 9.2.3.5.1. Drug Insights
  • 9.2.3.5.2. Drug Estimates By Route of Administration
  • 9.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.5.3. Drug Estimates By Type
  • 9.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.6. Thailand
  • 9.2.3.6.1. Drug Insights
  • 9.2.3.6.2. Drug Estimates By Route of Administration
  • 9.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.6.3. Drug Estimates By Type
  • 9.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.7. Rest of APAC
  • 9.2.3.7.1. Drug Insights
  • 9.2.3.7.2. Drug Estimates By Route of Administration
  • 9.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.7.3. Drug Estimates By Type
  • 9.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4. Latin America
  • 9.2.4.1. Brazil
  • 9.2.4.1.1. Drug Insights
  • 9.2.4.1.2. Drug Estimates By Route of Administration
  • 9.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.1.3. Drug Estimates By Type
  • 9.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.2. Argentina
  • 9.2.4.2.1. Drug Insights
  • 9.2.4.2.2. Drug Estimates By Route of Administration
  • 9.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.2.3. Drug Estimates By Type
  • 9.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.3. Rest of Latin America
  • 9.2.4.3.1. Drug Insights
  • 9.2.4.3.2. Drug Estimates By Route of Administration
  • 9.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.3.3. Drug Estimates By Type
  • 9.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5. Middle East & Africa
  • 9.2.5.1. Saudi Arabia
  • 9.2.5.1.1. Drug Insights
  • 9.2.5.1.2. Drug Estimates By Route of Administration
  • 9.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.1.3. Drug Estimates By Type
  • 9.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.2. UAE
  • 9.2.5.2.1. Drug Insights
  • 9.2.5.2.2. Drug Estimates By Route of Administration
  • 9.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.2.3. Drug Estimates By Type
  • 9.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.3. Kuwait
  • 9.2.5.3.1. Drug Insights
  • 9.2.5.3.2. Drug Estimates By Route of Administration
  • 9.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.3.3. Drug Estimates By Type
  • 9.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.4. Rest of Middle East & Africa
  • 9.2.5.4.1. Drug Insights
  • 9.2.5.4.2. Drug Estimates By Route of Administration
  • 9.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.4.3. Drug Estimates By Type
  • 9.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 9.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 10. Rufinamide (Banzel) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 10.1. Drug Information
  • 10.1.1. Drug Information
  • 10.1.2. Drug Patent Analysis
  • 10.2. Drug Estimates By Region
  • 10.2.1. North America
  • 10.2.1.1. Drug Insights
  • 10.2.1.2. Drug Estimates By Route of Administration
  • 10.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.3. Drug Estimates By Type
  • 10.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4. Drug Estimates By Country
  • 10.2.1.4.1. U.S.
  • 10.2.1.4.1.1. Drug Insight
  • 10.2.1.4.1.2. Drug Estimates By Route of Administration
  • 10.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.1.3. Drug Estimates By Type
  • 10.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.2. Canada
  • 10.2.1.4.2.1. Drug Insights
  • 10.2.1.4.2.2. Drug Estimates By Route of Administration
  • 10.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.2.3. Drug Estimates By Type
  • 10.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.3. Mexico
  • 10.2.1.4.3.1. Drug Insights
  • 10.2.1.4.3.2. Drug Estimates By Route of Administration
  • 10.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.3.3. Drug Estimates By Type
  • 10.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2. Europe
  • 10.2.2.1. UK
  • 10.2.2.1.1. Drug Insights
  • 10.2.2.1.2. Drug Estimates By Route of Administration
  • 10.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.1.3. Drug Estimates By Type
  • 10.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.2. Germany
  • 10.2.2.2.1. Drug Insights
  • 10.2.2.2.2. Drug Estimates By Route of Administration
  • 10.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.2.3. Drug Estimates By Type
  • 10.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.3. France
  • 10.2.2.3.1. Drug Insights
  • 10.2.2.3.2. Drug Estimates By Route of Administration
  • 10.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.3.3. Drug Estimates By Type
  • 10.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.4. Italy
  • 10.2.2.4.1. Drug Insights
  • 10.2.2.4.2. Drug Estimates By Route of Administration
  • 10.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.4.3. Drug Estimates By Type
  • 10.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.5. Spain
  • 10.2.2.5.1. Drug Insights
  • 10.2.2.5.2. Drug Estimates By Route of Administration
  • 10.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.5.3. Drug Estimates By Type
  • 10.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.6. Denmark
  • 10.2.2.6.1. Drug Insights
  • 10.2.2.6.2. Drug Estimates By Route of Administration
  • 10.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.6.3. Drug Estimates By Type
  • 10.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.7. Sweden
  • 10.2.2.7.1. Drug Insights
  • 10.2.2.7.2. Drug Estimates By Route of Administration
  • 10.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.7.3. Drug Estimates By Type
  • 10.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.8. Norway
  • 10.2.2.8.1. Drug Insights
  • 10.2.2.8.2. Drug Estimates By Route of Administration
  • 10.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.8.3. Drug Estimates By Type
  • 10.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.9. Rest of Europe
  • 10.2.2.9.1. Drug Insights
  • 10.2.2.9.2. Drug Estimates By Route of Administration
  • 10.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.9.3. Drug Estimates By Type
  • 10.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3. Asia Pacific
  • 10.2.3.1. Japan
  • 10.2.3.1.1. Drug Insights
  • 10.2.3.1.2. Drug Estimates By Route of Administration
  • 10.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.1.3. Drug Estimates By Type
  • 10.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.2. China
  • 10.2.3.2.1. Drug Insights
  • 10.2.3.2.2. Drug Estimates By Route of Administration
  • 10.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.2.3. Drug Estimates By Type
  • 10.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.3. India
  • 10.2.3.3.1. Drug Insights
  • 10.2.3.3.2. Drug Estimates By Route of Administration
  • 10.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.3.3. Drug Estimates By Type
  • 10.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.4. South Korea
  • 10.2.3.4.1. Drug Insights
  • 10.2.3.4.2. Drug Estimates By Route of Administration
  • 10.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.4.3. Drug Estimates By Type
  • 10.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.5. Australia
  • 10.2.3.5.1. Drug Insights
  • 10.2.3.5.2. Drug Estimates By Route of Administration
  • 10.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.5.3. Drug Estimates By Type
  • 10.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.6. Thailand
  • 10.2.3.6.1. Drug Insights
  • 10.2.3.6.2. Drug Estimates By Route of Administration
  • 10.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.6.3. Drug Estimates By Type
  • 10.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.7. Rest of APAC
  • 10.2.3.7.1. Drug Insights
  • 10.2.3.7.2. Drug Estimates By Route of Administration
  • 10.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.7.3. Drug Estimates By Type
  • 10.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4. Latin America
  • 10.2.4.1. Brazil
  • 10.2.4.1.1. Drug Insights
  • 10.2.4.1.2. Drug Estimates By Route of Administration
  • 10.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.1.3. Drug Estimates By Type
  • 10.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.2. Argentina
  • 10.2.4.2.1. Drug Insights
  • 10.2.4.2.2. Drug Estimates By Route of Administration
  • 10.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.2.3. Drug Estimates By Type
  • 10.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.3. Rest of Latin America
  • 10.2.4.3.1. Drug Insights
  • 10.2.4.3.2. Drug Estimates By Route of Administration
  • 10.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.3.3. Drug Estimates By Type
  • 10.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5. Middle East & Africa
  • 10.2.5.1. Saudi Arabia
  • 10.2.5.1.1. Drug Insights
  • 10.2.5.1.2. Drug Estimates By Route of Administration
  • 10.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.1.3. Drug Estimates By Type
  • 10.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.2. UAE
  • 10.2.5.2.1. Drug Insights
  • 10.2.5.2.2. Drug Estimates By Route of Administration
  • 10.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.2.3. Drug Estimates By Type
  • 10.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.3. Kuwait
  • 10.2.5.3.1. Drug Insights
  • 10.2.5.3.2. Drug Estimates By Route of Administration
  • 10.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.3.3. Drug Estimates By Type
  • 10.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.4. Rest of Middle East & Africa
  • 10.2.5.4.1. Drug Insights
  • 10.2.5.4.2. Drug Estimates By Route of Administration
  • 10.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.4.3. Drug Estimates By Type
  • 10.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 10.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 11. Rufinamide (Inovelon) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 11.1. Drug Information
  • 11.1.1. Drug Information
  • 11.1.2. Drug Patent Analysis
  • 11.2. Drug Estimates By Region
  • 11.2.1. North America
  • 11.2.1.1. Drug Insights
  • 11.2.1.2. Drug Estimates By Route of Administration
  • 11.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.3. Drug Estimates By Type
  • 11.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4. Drug Estimates By Country
  • 11.2.1.4.1. U.S.
  • 11.2.1.4.1.1. Drug Insight
  • 11.2.1.4.1.2. Drug Estimates By Route of Administration
  • 11.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.1.3. Drug Estimates By Type
  • 11.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.2. Canada
  • 11.2.1.4.2.1. Drug Insights
  • 11.2.1.4.2.2. Drug Estimates By Route of Administration
  • 11.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.2.3. Drug Estimates By Type
  • 11.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.3. Mexico
  • 11.2.1.4.3.1. Drug Insights
  • 11.2.1.4.3.2. Drug Estimates By Route of Administration
  • 11.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.3.3. Drug Estimates By Type
  • 11.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2. Europe
  • 11.2.2.1. UK
  • 11.2.2.1.1. Drug Insights
  • 11.2.2.1.2. Drug Estimates By Route of Administration
  • 11.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.1.3. Drug Estimates By Type
  • 11.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.2. Germany
  • 11.2.2.2.1. Drug Insights
  • 11.2.2.2.2. Drug Estimates By Route of Administration
  • 11.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.2.3. Drug Estimates By Type
  • 11.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.3. France
  • 11.2.2.3.1. Drug Insights
  • 11.2.2.3.2. Drug Estimates By Route of Administration
  • 11.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.3.3. Drug Estimates By Type
  • 11.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.4. Italy
  • 11.2.2.4.1. Drug Insights
  • 11.2.2.4.2. Drug Estimates By Route of Administration
  • 11.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.4.3. Drug Estimates By Type
  • 11.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.5. Spain
  • 11.2.2.5.1. Drug Insights
  • 11.2.2.5.2. Drug Estimates By Route of Administration
  • 11.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.5.3. Drug Estimates By Type
  • 11.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.6. Denmark
  • 11.2.2.6.1. Drug Insights
  • 11.2.2.6.2. Drug Estimates By Route of Administration
  • 11.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.6.3. Drug Estimates By Type
  • 11.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.7. Sweden
  • 11.2.2.7.1. Drug Insights
  • 11.2.2.7.2. Drug Estimates By Route of Administration
  • 11.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.7.3. Drug Estimates By Type
  • 11.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.8. Norway
  • 11.2.2.8.1. Drug Insights
  • 11.2.2.8.2. Drug Estimates By Route of Administration
  • 11.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.8.3. Drug Estimates By Type
  • 11.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.9. Rest of Europe
  • 11.2.2.9.1. Drug Insights
  • 11.2.2.9.2. Drug Estimates By Route of Administration
  • 11.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.9.3. Drug Estimates By Type
  • 11.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3. Asia Pacific
  • 11.2.3.1. Japan
  • 11.2.3.1.1. Drug Insights
  • 11.2.3.1.2. Drug Estimates By Route of Administration
  • 11.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.1.3. Drug Estimates By Type
  • 11.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.2. China
  • 11.2.3.2.1. Drug Insights
  • 11.2.3.2.2. Drug Estimates By Route of Administration
  • 11.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.2.3. Drug Estimates By Type
  • 11.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.3. India
  • 11.2.3.3.1. Drug Insights
  • 11.2.3.3.2. Drug Estimates By Route of Administration
  • 11.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.3.3. Drug Estimates By Type
  • 11.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.4. South Korea
  • 11.2.3.4.1. Drug Insights
  • 11.2.3.4.2. Drug Estimates By Route of Administration
  • 11.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.4.3. Drug Estimates By Type
  • 11.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.5. Australia
  • 11.2.3.5.1. Drug Insights
  • 11.2.3.5.2. Drug Estimates By Route of Administration
  • 11.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.5.3. Drug Estimates By Type
  • 11.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.6. Thailand
  • 11.2.3.6.1. Drug Insights
  • 11.2.3.6.2. Drug Estimates By Route of Administration
  • 11.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.6.3. Drug Estimates By Type
  • 11.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.7. Rest of APAC
  • 11.2.3.7.1. Drug Insights
  • 11.2.3.7.2. Drug Estimates By Route of Administration
  • 11.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.7.3. Drug Estimates By Type
  • 11.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4. Latin America
  • 11.2.4.1. Brazil
  • 11.2.4.1.1. Drug Insights
  • 11.2.4.1.2. Drug Estimates By Route of Administration
  • 11.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.1.3. Drug Estimates By Type
  • 11.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.2. Argentina
  • 11.2.4.2.1. Drug Insights
  • 11.2.4.2.2. Drug Estimates By Route of Administration
  • 11.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.2.3. Drug Estimates By Type
  • 11.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.3. Rest of Latin America
  • 11.2.4.3.1. Drug Insights
  • 11.2.4.3.2. Drug Estimates By Route of Administration
  • 11.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.3.3. Drug Estimates By Type
  • 11.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5. Middle East & Africa
  • 11.2.5.1. Saudi Arabia
  • 11.2.5.1.1. Drug Insights
  • 11.2.5.1.2. Drug Estimates By Route of Administration
  • 11.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.1.3. Drug Estimates By Type
  • 11.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.2. UAE
  • 11.2.5.2.1. Drug Insights
  • 11.2.5.2.2. Drug Estimates By Route of Administration
  • 11.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.2.3. Drug Estimates By Type
  • 11.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.3. Kuwait
  • 11.2.5.3.1. Drug Insights
  • 11.2.5.3.2. Drug Estimates By Route of Administration
  • 11.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.3.3. Drug Estimates By Type
  • 11.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.4. Rest of Middle East & Africa
  • 11.2.5.4.1. Drug Insights
  • 11.2.5.4.2. Drug Estimates By Route of Administration
  • 11.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.4.3. Drug Estimates By Type
  • 11.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 11.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 12. Ganaxolone (Ztalmy) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 12.1. Drug Information
  • 12.1.1. Drug Information
  • 12.1.2. Drug Patent Analysis
  • 12.2. Drug Estimates By Region
  • 12.2.1. North America
  • 12.2.1.1. Drug Insights
  • 12.2.1.2. Drug Estimates By Route of Administration
  • 12.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.3. Drug Estimates By Type
  • 12.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4. Drug Estimates By Country
  • 12.2.1.4.1. U.S.
  • 12.2.1.4.1.1. Drug Insight
  • 12.2.1.4.1.2. Drug Estimates By Route of Administration
  • 12.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.1.3. Drug Estimates By Type
  • 12.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.2. Canada
  • 12.2.1.4.2.1. Drug Insights
  • 12.2.1.4.2.2. Drug Estimates By Route of Administration
  • 12.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.2.3. Drug Estimates By Type
  • 12.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.3. Mexico
  • 12.2.1.4.3.1. Drug Insights
  • 12.2.1.4.3.2. Drug Estimates By Route of Administration
  • 12.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.3.3. Drug Estimates By Type
  • 12.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2. Europe
  • 12.2.2.1. UK
  • 12.2.2.1.1. Drug Insights
  • 12.2.2.1.2. Drug Estimates By Route of Administration
  • 12.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.1.3. Drug Estimates By Type
  • 12.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.2. Germany
  • 12.2.2.2.1. Drug Insights
  • 12.2.2.2.2. Drug Estimates By Route of Administration
  • 12.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.2.3. Drug Estimates By Type
  • 12.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.3. France
  • 12.2.2.3.1. Drug Insights
  • 12.2.2.3.2. Drug Estimates By Route of Administration
  • 12.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.3.3. Drug Estimates By Type
  • 12.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.4. Italy
  • 12.2.2.4.1. Drug Insights
  • 12.2.2.4.2. Drug Estimates By Route of Administration
  • 12.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.4.3. Drug Estimates By Type
  • 12.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.5. Spain
  • 12.2.2.5.1. Drug Insights
  • 12.2.2.5.2. Drug Estimates By Route of Administration
  • 12.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.5.3. Drug Estimates By Type
  • 12.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.6. Denmark
  • 12.2.2.6.1. Drug Insights
  • 12.2.2.6.2. Drug Estimates By Route of Administration
  • 12.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.6.3. Drug Estimates By Type
  • 12.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.7. Sweden
  • 12.2.2.7.1. Drug Insights
  • 12.2.2.7.2. Drug Estimates By Route of Administration
  • 12.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.7.3. Drug Estimates By Type
  • 12.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.8. Norway
  • 12.2.2.8.1. Drug Insights
  • 12.2.2.8.2. Drug Estimates By Route of Administration
  • 12.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.8.3. Drug Estimates By Type
  • 12.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.9. Rest of Europe
  • 12.2.2.9.1. Drug Insights
  • 12.2.2.9.2. Drug Estimates By Route of Administration
  • 12.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.9.3. Drug Estimates By Type
  • 12.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3. Asia Pacific
  • 12.2.3.1. Japan
  • 12.2.3.1.1. Drug Insights
  • 12.2.3.1.2. Drug Estimates By Route of Administration
  • 12.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.1.3. Drug Estimates By Type
  • 12.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.2. China
  • 12.2.3.2.1. Drug Insights
  • 12.2.3.2.2. Drug Estimates By Route of Administration
  • 12.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.2.3. Drug Estimates By Type
  • 12.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.3. India
  • 12.2.3.3.1. Drug Insights
  • 12.2.3.3.2. Drug Estimates By Route of Administration
  • 12.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.3.3. Drug Estimates By Type
  • 12.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.4. South Korea
  • 12.2.3.4.1. Drug Insights
  • 12.2.3.4.2. Drug Estimates By Route of Administration
  • 12.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.4.3. Drug Estimates By Type
  • 12.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.5. Australia
  • 12.2.3.5.1. Drug Insights
  • 12.2.3.5.2. Drug Estimates By Route of Administration
  • 12.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.5.3. Drug Estimates By Type
  • 12.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.6. Thailand
  • 12.2.3.6.1. Drug Insights
  • 12.2.3.6.2. Drug Estimates By Route of Administration
  • 12.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.6.3. Drug Estimates By Type
  • 12.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.7. Rest of APAC
  • 12.2.3.7.1. Drug Insights
  • 12.2.3.7.2. Drug Estimates By Route of Administration
  • 12.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.7.3. Drug Estimates By Type
  • 12.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4. Latin America
  • 12.2.4.1. Brazil
  • 12.2.4.1.1. Drug Insights
  • 12.2.4.1.2. Drug Estimates By Route of Administration
  • 12.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.1.3. Drug Estimates By Type
  • 12.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.2. Argentina
  • 12.2.4.2.1. Drug Insights
  • 12.2.4.2.2. Drug Estimates By Route of Administration
  • 12.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.2.3. Drug Estimates By Type
  • 12.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.3. Rest of Latin America
  • 12.2.4.3.1. Drug Insights
  • 12.2.4.3.2. Drug Estimates By Route of Administration
  • 12.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.3.3. Drug Estimates By Type
  • 12.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5. Middle East & Africa
  • 12.2.5.1. Saudi Arabia
  • 12.2.5.1.1. Drug Insights
  • 12.2.5.1.2. Drug Estimates By Route of Administration
  • 12.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.1.3. Drug Estimates By Type
  • 12.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.2. UAE
  • 12.2.5.2.1. Drug Insights
  • 12.2.5.2.2. Drug Estimates By Route of Administration
  • 12.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.2.3. Drug Estimates By Type
  • 12.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.3. Kuwait
  • 12.2.5.3.1. Drug Insights
  • 12.2.5.3.2. Drug Estimates By Route of Administration
  • 12.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.3.3. Drug Estimates By Type
  • 12.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.4. Rest of Middle East & Africa
  • 12.2.5.4.1. Drug Insights
  • 12.2.5.4.2. Drug Estimates By Route of Administration
  • 12.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.4.3. Drug Estimates By Type
  • 12.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 12.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 13. Diazepam (Valtoco) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 13.1. Drug Information
  • 13.1.1. Drug Information
  • 13.1.2. Drug Patent Analysis
  • 13.2. Drug Estimates By Region
  • 13.2.1. North America
  • 13.2.1.1. Drug Insights
  • 13.2.1.2. Drug Estimates By Route of Administration
  • 13.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.3. Drug Estimates By Type
  • 13.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4. Drug Estimates By Country
  • 13.2.1.4.1. U.S.
  • 13.2.1.4.1.1. Drug Insight
  • 13.2.1.4.1.2. Drug Estimates By Route of Administration
  • 13.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.1.3. Drug Estimates By Type
  • 13.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.2. Canada
  • 13.2.1.4.2.1. Drug Insights
  • 13.2.1.4.2.2. Drug Estimates By Route of Administration
  • 13.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.2.3. Drug Estimates By Type
  • 13.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.3. Mexico
  • 13.2.1.4.3.1. Drug Insights
  • 13.2.1.4.3.2. Drug Estimates By Route of Administration
  • 13.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.3.3. Drug Estimates By Type
  • 13.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2. Europe
  • 13.2.2.1. UK
  • 13.2.2.1.1. Drug Insights
  • 13.2.2.1.2. Drug Estimates By Route of Administration
  • 13.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.1.3. Drug Estimates By Type
  • 13.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.2. Germany
  • 13.2.2.2.1. Drug Insights
  • 13.2.2.2.2. Drug Estimates By Route of Administration
  • 13.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.2.3. Drug Estimates By Type
  • 13.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.3. France
  • 13.2.2.3.1. Drug Insights
  • 13.2.2.3.2. Drug Estimates By Route of Administration
  • 13.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.3.3. Drug Estimates By Type
  • 13.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.4. Italy
  • 13.2.2.4.1. Drug Insights
  • 13.2.2.4.2. Drug Estimates By Route of Administration
  • 13.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.4.3. Drug Estimates By Type
  • 13.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.5. Spain
  • 13.2.2.5.1. Drug Insights
  • 13.2.2.5.2. Drug Estimates By Route of Administration
  • 13.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.5.3. Drug Estimates By Type
  • 13.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.6. Denmark
  • 13.2.2.6.1. Drug Insights
  • 13.2.2.6.2. Drug Estimates By Route of Administration
  • 13.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.6.3. Drug Estimates By Type
  • 13.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.7. Sweden
  • 13.2.2.7.1. Drug Insights
  • 13.2.2.7.2. Drug Estimates By Route of Administration
  • 13.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.7.3. Drug Estimates By Type
  • 13.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.8. Norway
  • 13.2.2.8.1. Drug Insights
  • 13.2.2.8.2. Drug Estimates By Route of Administration
  • 13.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.8.3. Drug Estimates By Type
  • 13.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.9. Rest of Europe
  • 13.2.2.9.1. Drug Insights
  • 13.2.2.9.2. Drug Estimates By Route of Administration
  • 13.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.9.3. Drug Estimates By Type
  • 13.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3. Asia Pacific
  • 13.2.3.1. Japan
  • 13.2.3.1.1. Drug Insights
  • 13.2.3.1.2. Drug Estimates By Route of Administration
  • 13.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.1.3. Drug Estimates By Type
  • 13.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.2. China
  • 13.2.3.2.1. Drug Insights
  • 13.2.3.2.2. Drug Estimates By Route of Administration
  • 13.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.2.3. Drug Estimates By Type
  • 13.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.3. India
  • 13.2.3.3.1. Drug Insights
  • 13.2.3.3.2. Drug Estimates By Route of Administration
  • 13.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.3.3. Drug Estimates By Type
  • 13.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.4. South Korea
  • 13.2.3.4.1. Drug Insights
  • 13.2.3.4.2. Drug Estimates By Route of Administration
  • 13.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.4.3. Drug Estimates By Type
  • 13.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.5. Australia
  • 13.2.3.5.1. Drug Insights
  • 13.2.3.5.2. Drug Estimates By Route of Administration
  • 13.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.5.3. Drug Estimates By Type
  • 13.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.6. Thailand
  • 13.2.3.6.1. Drug Insights
  • 13.2.3.6.2. Drug Estimates By Route of Administration
  • 13.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.6.3. Drug Estimates By Type
  • 13.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.7. Rest of APAC
  • 13.2.3.7.1. Drug Insights
  • 13.2.3.7.2. Drug Estimates By Route of Administration
  • 13.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.7.3. Drug Estimates By Type
  • 13.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4. Latin America
  • 13.2.4.1. Brazil
  • 13.2.4.1.1. Drug Insights
  • 13.2.4.1.2. Drug Estimates By Route of Administration
  • 13.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.1.3. Drug Estimates By Type
  • 13.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.2. Argentina
  • 13.2.4.2.1. Drug Insights
  • 13.2.4.2.2. Drug Estimates By Route of Administration
  • 13.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.2.3. Drug Estimates By Type
  • 13.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.3. Rest of Latin America
  • 13.2.4.3.1. Drug Insights
  • 13.2.4.3.2. Drug Estimates By Route of Administration
  • 13.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.3.3. Drug Estimates By Type
  • 13.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5. Middle East & Africa
  • 13.2.5.1. Saudi Arabia
  • 13.2.5.1.1. Drug Insights
  • 13.2.5.1.2. Drug Estimates By Route of Administration
  • 13.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.1.3. Drug Estimates By Type
  • 13.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.2. UAE
  • 13.2.5.2.1. Drug Insights
  • 13.2.5.2.2. Drug Estimates By Route of Administration
  • 13.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.2.3. Drug Estimates By Type
  • 13.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.3. Kuwait
  • 13.2.5.3.1. Drug Insights
  • 13.2.5.3.2. Drug Estimates By Route of Administration
  • 13.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.3.3. Drug Estimates By Type
  • 13.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.4. Rest of Middle East & Africa
  • 13.2.5.4.1. Drug Insights
  • 13.2.5.4.2. Drug Estimates By Route of Administration
  • 13.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.4.3. Drug Estimates By Type
  • 13.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 13.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 14. Diazepam (Spydia) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 14.1. Drug Information
  • 14.1.1. Drug Information
  • 14.1.2. Drug Patent Analysis
  • 14.2. Drug Estimates By Region
  • 14.2.1. North America
  • 14.2.1.1. Drug Insights
  • 14.2.1.2. Drug Estimates By Route of Administration
  • 14.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.3. Drug Estimates By Type
  • 14.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4. Drug Estimates By Country
  • 14.2.1.4.1. U.S.
  • 14.2.1.4.1.1. Drug Insight
  • 14.2.1.4.1.2. Drug Estimates By Route of Administration
  • 14.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.1.3. Drug Estimates By Type
  • 14.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.2. Canada
  • 14.2.1.4.2.1. Drug Insights
  • 14.2.1.4.2.2. Drug Estimates By Route of Administration
  • 14.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.2.3. Drug Estimates By Type
  • 14.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.3. Mexico
  • 14.2.1.4.3.1. Drug Insights
  • 14.2.1.4.3.2. Drug Estimates By Route of Administration
  • 14.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.3.3. Drug Estimates By Type
  • 14.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2. Europe
  • 14.2.2.1. UK
  • 14.2.2.1.1. Drug Insights
  • 14.2.2.1.2. Drug Estimates By Route of Administration
  • 14.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.1.3. Drug Estimates By Type
  • 14.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.2. Germany
  • 14.2.2.2.1. Drug Insights
  • 14.2.2.2.2. Drug Estimates By Route of Administration
  • 14.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.2.3. Drug Estimates By Type
  • 14.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.3. France
  • 14.2.2.3.1. Drug Insights
  • 14.2.2.3.2. Drug Estimates By Route of Administration
  • 14.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.3.3. Drug Estimates By Type
  • 14.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.4. Italy
  • 14.2.2.4.1. Drug Insights
  • 14.2.2.4.2. Drug Estimates By Route of Administration
  • 14.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.4.3. Drug Estimates By Type
  • 14.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.5. Spain
  • 14.2.2.5.1. Drug Insights
  • 14.2.2.5.2. Drug Estimates By Route of Administration
  • 14.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.5.3. Drug Estimates By Type
  • 14.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.6. Denmark
  • 14.2.2.6.1. Drug Insights
  • 14.2.2.6.2. Drug Estimates By Route of Administration
  • 14.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.6.3. Drug Estimates By Type
  • 14.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.7. Sweden
  • 14.2.2.7.1. Drug Insights
  • 14.2.2.7.2. Drug Estimates By Route of Administration
  • 14.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.7.3. Drug Estimates By Type
  • 14.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.8. Norway
  • 14.2.2.8.1. Drug Insights
  • 14.2.2.8.2. Drug Estimates By Route of Administration
  • 14.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.8.3. Drug Estimates By Type
  • 14.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.9. Rest of Europe
  • 14.2.2.9.1. Drug Insights
  • 14.2.2.9.2. Drug Estimates By Route of Administration
  • 14.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.9.3. Drug Estimates By Type
  • 14.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3. Asia Pacific
  • 14.2.3.1. Japan
  • 14.2.3.1.1. Drug Insights
  • 14.2.3.1.2. Drug Estimates By Route of Administration
  • 14.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.1.3. Drug Estimates By Type
  • 14.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.2. China
  • 14.2.3.2.1. Drug Insights
  • 14.2.3.2.2. Drug Estimates By Route of Administration
  • 14.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.2.3. Drug Estimates By Type
  • 14.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.3. India
  • 14.2.3.3.1. Drug Insights
  • 14.2.3.3.2. Drug Estimates By Route of Administration
  • 14.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.3.3. Drug Estimates By Type
  • 14.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.4. South Korea
  • 14.2.3.4.1. Drug Insights
  • 14.2.3.4.2. Drug Estimates By Route of Administration
  • 14.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.4.3. Drug Estimates By Type
  • 14.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.5. Australia
  • 14.2.3.5.1. Drug Insights
  • 14.2.3.5.2. Drug Estimates By Route of Administration
  • 14.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.5.3. Drug Estimates By Type
  • 14.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.6. Thailand
  • 14.2.3.6.1. Drug Insights
  • 14.2.3.6.2. Drug Estimates By Route of Administration
  • 14.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.6.3. Drug Estimates By Type
  • 14.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.7. Rest of APAC
  • 14.2.3.7.1. Drug Insights
  • 14.2.3.7.2. Drug Estimates By Route of Administration
  • 14.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.7.3. Drug Estimates By Type
  • 14.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4. Latin America
  • 14.2.4.1. Brazil
  • 14.2.4.1.1. Drug Insights
  • 14.2.4.1.2. Drug Estimates By Route of Administration
  • 14.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.1.3. Drug Estimates By Type
  • 14.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.2. Argentina
  • 14.2.4.2.1. Drug Insights
  • 14.2.4.2.2. Drug Estimates By Route of Administration
  • 14.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.2.3. Drug Estimates By Type
  • 14.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.3. Rest of Latin America
  • 14.2.4.3.1. Drug Insights
  • 14.2.4.3.2. Drug Estimates By Route of Administration
  • 14.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.3.3. Drug Estimates By Type
  • 14.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5. Middle East & Africa
  • 14.2.5.1. Saudi Arabia
  • 14.2.5.1.1. Drug Insights
  • 14.2.5.1.2. Drug Estimates By Route of Administration
  • 14.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.1.3. Drug Estimates By Type
  • 14.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.2. UAE
  • 14.2.5.2.1. Drug Insights
  • 14.2.5.2.2. Drug Estimates By Route of Administration
  • 14.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.2.3. Drug Estimates By Type
  • 14.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.3. Kuwait
  • 14.2.5.3.1. Drug Insights
  • 14.2.5.3.2. Drug Estimates By Route of Administration
  • 14.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.3.3. Drug Estimates By Type
  • 14.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.4. Rest of Middle East & Africa
  • 14.2.5.4.1. Drug Insights
  • 14.2.5.4.2. Drug Estimates By Route of Administration
  • 14.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.4.3. Drug Estimates By Type
  • 14.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 14.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 15. Lamotrigine (Lamictal) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 15.1. Drug Information
  • 15.1.1. Drug Information
  • 15.1.2. Drug Patent Analysis
  • 15.2. Drug Estimates By Region
  • 15.2.1. North America
  • 15.2.1.1. Drug Insights
  • 15.2.1.2. Drug Estimates By Route of Administration
  • 15.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.3. Drug Estimates By Type
  • 15.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4. Drug Estimates By Country
  • 15.2.1.4.1. U.S.
  • 15.2.1.4.1.1. Drug Insight
  • 15.2.1.4.1.2. Drug Estimates By Route of Administration
  • 15.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.1.3. Drug Estimates By Type
  • 15.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.2. Canada
  • 15.2.1.4.2.1. Drug Insights
  • 15.2.1.4.2.2. Drug Estimates By Route of Administration
  • 15.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.2.3. Drug Estimates By Type
  • 15.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.3. Mexico
  • 15.2.1.4.3.1. Drug Insights
  • 15.2.1.4.3.2. Drug Estimates By Route of Administration
  • 15.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.3.3. Drug Estimates By Type
  • 15.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2. Europe
  • 15.2.2.1. UK
  • 15.2.2.1.1. Drug Insights
  • 15.2.2.1.2. Drug Estimates By Route of Administration
  • 15.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.1.3. Drug Estimates By Type
  • 15.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.2. Germany
  • 15.2.2.2.1. Drug Insights
  • 15.2.2.2.2. Drug Estimates By Route of Administration
  • 15.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.2.3. Drug Estimates By Type
  • 15.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.3. France
  • 15.2.2.3.1. Drug Insights
  • 15.2.2.3.2. Drug Estimates By Route of Administration
  • 15.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.3.3. Drug Estimates By Type
  • 15.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.4. Italy
  • 15.2.2.4.1. Drug Insights
  • 15.2.2.4.2. Drug Estimates By Route of Administration
  • 15.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.4.3. Drug Estimates By Type
  • 15.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.5. Spain
  • 15.2.2.5.1. Drug Insights
  • 15.2.2.5.2. Drug Estimates By Route of Administration
  • 15.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.5.3. Drug Estimates By Type
  • 15.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.6. Denmark
  • 15.2.2.6.1. Drug Insights
  • 15.2.2.6.2. Drug Estimates By Route of Administration
  • 15.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.6.3. Drug Estimates By Type
  • 15.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.7. Sweden
  • 15.2.2.7.1. Drug Insights
  • 15.2.2.7.2. Drug Estimates By Route of Administration
  • 15.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.7.3. Drug Estimates By Type
  • 15.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.8. Norway
  • 15.2.2.8.1. Drug Insights
  • 15.2.2.8.2. Drug Estimates By Route of Administration
  • 15.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.8.3. Drug Estimates By Type
  • 15.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.9. Rest of Europe
  • 15.2.2.9.1. Drug Insights
  • 15.2.2.9.2. Drug Estimates By Route of Administration
  • 15.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.9.3. Drug Estimates By Type
  • 15.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3. Asia Pacific
  • 15.2.3.1. Japan
  • 15.2.3.1.1. Drug Insights
  • 15.2.3.1.2. Drug Estimates By Route of Administration
  • 15.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.1.3. Drug Estimates By Type
  • 15.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.2. China
  • 15.2.3.2.1. Drug Insights
  • 15.2.3.2.2. Drug Estimates By Route of Administration
  • 15.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.2.3. Drug Estimates By Type
  • 15.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.3. India
  • 15.2.3.3.1. Drug Insights
  • 15.2.3.3.2. Drug Estimates By Route of Administration
  • 15.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.3.3. Drug Estimates By Type
  • 15.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.4. South Korea
  • 15.2.3.4.1. Drug Insights
  • 15.2.3.4.2. Drug Estimates By Route of Administration
  • 15.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.4.3. Drug Estimates By Type
  • 15.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.5. Australia
  • 15.2.3.5.1. Drug Insights
  • 15.2.3.5.2. Drug Estimates By Route of Administration
  • 15.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.5.3. Drug Estimates By Type
  • 15.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.6. Thailand
  • 15.2.3.6.1. Drug Insights
  • 15.2.3.6.2. Drug Estimates By Route of Administration
  • 15.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.6.3. Drug Estimates By Type
  • 15.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.7. Rest of APAC
  • 15.2.3.7.1. Drug Insights
  • 15.2.3.7.2. Drug Estimates By Route of Administration
  • 15.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.7.3. Drug Estimates By Type
  • 15.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4. Latin America
  • 15.2.4.1. Brazil
  • 15.2.4.1.1. Drug Insights
  • 15.2.4.1.2. Drug Estimates By Route of Administration
  • 15.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.1.3. Drug Estimates By Type
  • 15.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.2. Argentina
  • 15.2.4.2.1. Drug Insights
  • 15.2.4.2.2. Drug Estimates By Route of Administration
  • 15.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.2.3. Drug Estimates By Type
  • 15.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.3. Rest of Latin America
  • 15.2.4.3.1. Drug Insights
  • 15.2.4.3.2. Drug Estimates By Route of Administration
  • 15.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.3.3. Drug Estimates By Type
  • 15.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5. Middle East & Africa
  • 15.2.5.1. Saudi Arabia
  • 15.2.5.1.1. Drug Insights
  • 15.2.5.1.2. Drug Estimates By Route of Administration
  • 15.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.1.3. Drug Estimates By Type
  • 15.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.2. UAE
  • 15.2.5.2.1. Drug Insights
  • 15.2.5.2.2. Drug Estimates By Route of Administration
  • 15.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.2.3. Drug Estimates By Type
  • 15.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.3. Kuwait
  • 15.2.5.3.1. Drug Insights
  • 15.2.5.3.2. Drug Estimates By Route of Administration
  • 15.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.3.3. Drug Estimates By Type
  • 15.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.4. Rest of Middle East & Africa
  • 15.2.5.4.1. Drug Insights
  • 15.2.5.4.2. Drug Estimates By Route of Administration
  • 15.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.4.3. Drug Estimates By Type
  • 15.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 15.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 16. Valproic Acid/ Sodium Valproate (Depakote/ Depakene/ Stavzor) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 16.1. Drug Information
  • 16.1.1. Drug Information
  • 16.1.2. Drug Patent Analysis
  • 16.2. Drug Estimates By Region
  • 16.2.1. North America
  • 16.2.1.1. Drug Insights
  • 16.2.1.2. Drug Estimates By Route of Administration
  • 16.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.3. Drug Estimates By Type
  • 16.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4. Drug Estimates By Country
  • 16.2.1.4.1. U.S.
  • 16.2.1.4.1.1. Drug Insight
  • 16.2.1.4.1.2. Drug Estimates By Route of Administration
  • 16.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.1.3. Drug Estimates By Type
  • 16.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.2. Canada
  • 16.2.1.4.2.1. Drug Insights
  • 16.2.1.4.2.2. Drug Estimates By Route of Administration
  • 16.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.2.3. Drug Estimates By Type
  • 16.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.3. Mexico
  • 16.2.1.4.3.1. Drug Insights
  • 16.2.1.4.3.2. Drug Estimates By Route of Administration
  • 16.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.3.3. Drug Estimates By Type
  • 16.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2. Europe
  • 16.2.2.1. UK
  • 16.2.2.1.1. Drug Insights
  • 16.2.2.1.2. Drug Estimates By Route of Administration
  • 16.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.1.3. Drug Estimates By Type
  • 16.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.2. Germany
  • 16.2.2.2.1. Drug Insights
  • 16.2.2.2.2. Drug Estimates By Route of Administration
  • 16.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.2.3. Drug Estimates By Type
  • 16.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.3. France
  • 16.2.2.3.1. Drug Insights
  • 16.2.2.3.2. Drug Estimates By Route of Administration
  • 16.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.3.3. Drug Estimates By Type
  • 16.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.4. Italy
  • 16.2.2.4.1. Drug Insights
  • 16.2.2.4.2. Drug Estimates By Route of Administration
  • 16.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.4.3. Drug Estimates By Type
  • 16.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.5. Spain
  • 16.2.2.5.1. Drug Insights
  • 16.2.2.5.2. Drug Estimates By Route of Administration
  • 16.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.5.3. Drug Estimates By Type
  • 16.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.6. Denmark
  • 16.2.2.6.1. Drug Insights
  • 16.2.2.6.2. Drug Estimates By Route of Administration
  • 16.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.6.3. Drug Estimates By Type
  • 16.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.7. Sweden
  • 16.2.2.7.1. Drug Insights
  • 16.2.2.7.2. Drug Estimates By Route of Administration
  • 16.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.7.3. Drug Estimates By Type
  • 16.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.8. Norway
  • 16.2.2.8.1. Drug Insights
  • 16.2.2.8.2. Drug Estimates By Route of Administration
  • 16.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.8.3. Drug Estimates By Type
  • 16.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.9. Rest of Europe
  • 16.2.2.9.1. Drug Insights
  • 16.2.2.9.2. Drug Estimates By Route of Administration
  • 16.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.9.3. Drug Estimates By Type
  • 16.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3. Asia Pacific
  • 16.2.3.1. Japan
  • 16.2.3.1.1. Drug Insights
  • 16.2.3.1.2. Drug Estimates By Route of Administration
  • 16.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.1.3. Drug Estimates By Type
  • 16.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.2. China
  • 16.2.3.2.1. Drug Insights
  • 16.2.3.2.2. Drug Estimates By Route of Administration
  • 16.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.2.3. Drug Estimates By Type
  • 16.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.3. India
  • 16.2.3.3.1. Drug Insights
  • 16.2.3.3.2. Drug Estimates By Route of Administration
  • 16.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.3.3. Drug Estimates By Type
  • 16.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.4. South Korea
  • 16.2.3.4.1. Drug Insights
  • 16.2.3.4.2. Drug Estimates By Route of Administration
  • 16.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.4.3. Drug Estimates By Type
  • 16.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.5. Australia
  • 16.2.3.5.1. Drug Insights
  • 16.2.3.5.2. Drug Estimates By Route of Administration
  • 16.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.5.3. Drug Estimates By Type
  • 16.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.6. Thailand
  • 16.2.3.6.1. Drug Insights
  • 16.2.3.6.2. Drug Estimates By Route of Administration
  • 16.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.6.3. Drug Estimates By Type
  • 16.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.7. Rest of APAC
  • 16.2.3.7.1. Drug Insights
  • 16.2.3.7.2. Drug Estimates By Route of Administration
  • 16.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.7.3. Drug Estimates By Type
  • 16.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4. Latin America
  • 16.2.4.1. Brazil
  • 16.2.4.1.1. Drug Insights
  • 16.2.4.1.2. Drug Estimates By Route of Administration
  • 16.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.1.3. Drug Estimates By Type
  • 16.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.2. Argentina
  • 16.2.4.2.1. Drug Insights
  • 16.2.4.2.2. Drug Estimates By Route of Administration
  • 16.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.2.3. Drug Estimates By Type
  • 16.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.3. Rest of Latin America
  • 16.2.4.3.1. Drug Insights
  • 16.2.4.3.2. Drug Estimates By Route of Administration
  • 16.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.3.3. Drug Estimates By Type
  • 16.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5. Middle East & Africa
  • 16.2.5.1. Saudi Arabia
  • 16.2.5.1.1. Drug Insights
  • 16.2.5.1.2. Drug Estimates By Route of Administration
  • 16.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.1.3. Drug Estimates By Type
  • 16.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.2. UAE
  • 16.2.5.2.1. Drug Insights
  • 16.2.5.2.2. Drug Estimates By Route of Administration
  • 16.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.2.3. Drug Estimates By Type
  • 16.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.3. Kuwait
  • 16.2.5.3.1. Drug Insights
  • 16.2.5.3.2. Drug Estimates By Route of Administration
  • 16.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.3.3. Drug Estimates By Type
  • 16.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.4. Rest of Middle East & Africa
  • 16.2.5.4.1. Drug Insights
  • 16.2.5.4.2. Drug Estimates By Route of Administration
  • 16.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.4.3. Drug Estimates By Type
  • 16.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 16.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 17. Topiramate (Topamax, Trokendi XR) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 17.1. Drug Information
  • 17.1.1. Drug Information
  • 17.1.2. Drug Patent Analysis
  • 17.2. Drug Estimates By Region
  • 17.2.1. North America
  • 17.2.1.1. Drug Insights
  • 17.2.1.2. Drug Estimates By Route of Administration
  • 17.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.3. Drug Estimates By Type
  • 17.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4. Drug Estimates By Country
  • 17.2.1.4.1. U.S.
  • 17.2.1.4.1.1. Drug Insight
  • 17.2.1.4.1.2. Drug Estimates By Route of Administration
  • 17.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.1.3. Drug Estimates By Type
  • 17.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.2. Canada
  • 17.2.1.4.2.1. Drug Insights
  • 17.2.1.4.2.2. Drug Estimates By Route of Administration
  • 17.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.2.3. Drug Estimates By Type
  • 17.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.3. Mexico
  • 17.2.1.4.3.1. Drug Insights
  • 17.2.1.4.3.2. Drug Estimates By Route of Administration
  • 17.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.3.3. Drug Estimates By Type
  • 17.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2. Europe
  • 17.2.2.1. UK
  • 17.2.2.1.1. Drug Insights
  • 17.2.2.1.2. Drug Estimates By Route of Administration
  • 17.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.1.3. Drug Estimates By Type
  • 17.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.2. Germany
  • 17.2.2.2.1. Drug Insights
  • 17.2.2.2.2. Drug Estimates By Route of Administration
  • 17.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.2.3. Drug Estimates By Type
  • 17.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.3. France
  • 17.2.2.3.1. Drug Insights
  • 17.2.2.3.2. Drug Estimates By Route of Administration
  • 17.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.3.3. Drug Estimates By Type
  • 17.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.4. Italy
  • 17.2.2.4.1. Drug Insights
  • 17.2.2.4.2. Drug Estimates By Route of Administration
  • 17.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.4.3. Drug Estimates By Type
  • 17.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.5. Spain
  • 17.2.2.5.1. Drug Insights
  • 17.2.2.5.2. Drug Estimates By Route of Administration
  • 17.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.5.3. Drug Estimates By Type
  • 17.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.6. Denmark
  • 17.2.2.6.1. Drug Insights
  • 17.2.2.6.2. Drug Estimates By Route of Administration
  • 17.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.6.3. Drug Estimates By Type
  • 17.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.7. Sweden
  • 17.2.2.7.1. Drug Insights
  • 17.2.2.7.2. Drug Estimates By Route of Administration
  • 17.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.7.3. Drug Estimates By Type
  • 17.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.8. Norway
  • 17.2.2.8.1. Drug Insights
  • 17.2.2.8.2. Drug Estimates By Route of Administration
  • 17.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.8.3. Drug Estimates By Type
  • 17.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.9. Rest of Europe
  • 17.2.2.9.1. Drug Insights
  • 17.2.2.9.2. Drug Estimates By Route of Administration
  • 17.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.9.3. Drug Estimates By Type
  • 17.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3. Asia Pacific
  • 17.2.3.1. Japan
  • 17.2.3.1.1. Drug Insights
  • 17.2.3.1.2. Drug Estimates By Route of Administration
  • 17.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.1.3. Drug Estimates By Type
  • 17.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.2. China
  • 17.2.3.2.1. Drug Insights
  • 17.2.3.2.2. Drug Estimates By Route of Administration
  • 17.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.2.3. Drug Estimates By Type
  • 17.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.3. India
  • 17.2.3.3.1. Drug Insights
  • 17.2.3.3.2. Drug Estimates By Route of Administration
  • 17.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.3.3. Drug Estimates By Type
  • 17.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.4. South Korea
  • 17.2.3.4.1. Drug Insights
  • 17.2.3.4.2. Drug Estimates By Route of Administration
  • 17.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.4.3. Drug Estimates By Type
  • 17.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.5. Australia
  • 17.2.3.5.1. Drug Insights
  • 17.2.3.5.2. Drug Estimates By Route of Administration
  • 17.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.5.3. Drug Estimates By Type
  • 17.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.6. Thailand
  • 17.2.3.6.1. Drug Insights
  • 17.2.3.6.2. Drug Estimates By Route of Administration
  • 17.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.6.3. Drug Estimates By Type
  • 17.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.7. Rest of APAC
  • 17.2.3.7.1. Drug Insights
  • 17.2.3.7.2. Drug Estimates By Route of Administration
  • 17.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.7.3. Drug Estimates By Type
  • 17.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4. Latin America
  • 17.2.4.1. Brazil
  • 17.2.4.1.1. Drug Insights
  • 17.2.4.1.2. Drug Estimates By Route of Administration
  • 17.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.1.3. Drug Estimates By Type
  • 17.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.2. Argentina
  • 17.2.4.2.1. Drug Insights
  • 17.2.4.2.2. Drug Estimates By Route of Administration
  • 17.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.2.3. Drug Estimates By Type
  • 17.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.3. Rest of Latin America
  • 17.2.4.3.1. Drug Insights
  • 17.2.4.3.2. Drug Estimates By Route of Administration
  • 17.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.3.3. Drug Estimates By Type
  • 17.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5. Middle East & Africa
  • 17.2.5.1. Saudi Arabia
  • 17.2.5.1.1. Drug Insights
  • 17.2.5.1.2. Drug Estimates By Route of Administration
  • 17.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.1.3. Drug Estimates By Type
  • 17.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.2. UAE
  • 17.2.5.2.1. Drug Insights
  • 17.2.5.2.2. Drug Estimates By Route of Administration
  • 17.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.2.3. Drug Estimates By Type
  • 17.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.3. Kuwait
  • 17.2.5.3.1. Drug Insights
  • 17.2.5.3.2. Drug Estimates By Route of Administration
  • 17.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.3.3. Drug Estimates By Type
  • 17.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.4. Rest of Middle East & Africa
  • 17.2.5.4.1. Drug Insights
  • 17.2.5.4.2. Drug Estimates By Route of Administration
  • 17.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.4.3. Drug Estimates By Type
  • 17.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 17.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 18. Divalproex Sodium (Depakote, Depakote ER) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 18.1. Drug Information
  • 18.1.1. Drug Information
  • 18.1.2. Drug Patent Analysis
  • 18.2. Drug Estimates By Region
  • 18.2.1. North America
  • 18.2.1.1. Drug Insights
  • 18.2.1.2. Drug Estimates By Route of Administration
  • 18.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.3. Drug Estimates By Type
  • 18.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4. Drug Estimates By Country
  • 18.2.1.4.1. U.S.
  • 18.2.1.4.1.1. Drug Insight
  • 18.2.1.4.1.2. Drug Estimates By Route of Administration
  • 18.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.1.3. Drug Estimates By Type
  • 18.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.2. Canada
  • 18.2.1.4.2.1. Drug Insights
  • 18.2.1.4.2.2. Drug Estimates By Route of Administration
  • 18.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.2.3. Drug Estimates By Type
  • 18.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.3. Mexico
  • 18.2.1.4.3.1. Drug Insights
  • 18.2.1.4.3.2. Drug Estimates By Route of Administration
  • 18.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.3.3. Drug Estimates By Type
  • 18.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2. Europe
  • 18.2.2.1. UK
  • 18.2.2.1.1. Drug Insights
  • 18.2.2.1.2. Drug Estimates By Route of Administration
  • 18.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.1.3. Drug Estimates By Type
  • 18.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.2. Germany
  • 18.2.2.2.1. Drug Insights
  • 18.2.2.2.2. Drug Estimates By Route of Administration
  • 18.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.2.3. Drug Estimates By Type
  • 18.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.3. France
  • 18.2.2.3.1. Drug Insights
  • 18.2.2.3.2. Drug Estimates By Route of Administration
  • 18.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.3.3. Drug Estimates By Type
  • 18.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.4. Italy
  • 18.2.2.4.1. Drug Insights
  • 18.2.2.4.2. Drug Estimates By Route of Administration
  • 18.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.4.3. Drug Estimates By Type
  • 18.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.5. Spain
  • 18.2.2.5.1. Drug Insights
  • 18.2.2.5.2. Drug Estimates By Route of Administration
  • 18.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.5.3. Drug Estimates By Type
  • 18.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.6. Denmark
  • 18.2.2.6.1. Drug Insights
  • 18.2.2.6.2. Drug Estimates By Route of Administration
  • 18.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.6.3. Drug Estimates By Type
  • 18.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.7. Sweden
  • 18.2.2.7.1. Drug Insights
  • 18.2.2.7.2. Drug Estimates By Route of Administration
  • 18.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.7.3. Drug Estimates By Type
  • 18.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.8. Norway
  • 18.2.2.8.1. Drug Insights
  • 18.2.2.8.2. Drug Estimates By Route of Administration
  • 18.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.8.3. Drug Estimates By Type
  • 18.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.9. Rest of Europe
  • 18.2.2.9.1. Drug Insights
  • 18.2.2.9.2. Drug Estimates By Route of Administration
  • 18.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.9.3. Drug Estimates By Type
  • 18.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3. Asia Pacific
  • 18.2.3.1. Japan
  • 18.2.3.1.1. Drug Insights
  • 18.2.3.1.2. Drug Estimates By Route of Administration
  • 18.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.1.3. Drug Estimates By Type
  • 18.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.2. China
  • 18.2.3.2.1. Drug Insights
  • 18.2.3.2.2. Drug Estimates By Route of Administration
  • 18.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.2.3. Drug Estimates By Type
  • 18.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.3. India
  • 18.2.3.3.1. Drug Insights
  • 18.2.3.3.2. Drug Estimates By Route of Administration
  • 18.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.3.3. Drug Estimates By Type
  • 18.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.4. South Korea
  • 18.2.3.4.1. Drug Insights
  • 18.2.3.4.2. Drug Estimates By Route of Administration
  • 18.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.4.3. Drug Estimates By Type
  • 18.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.5. Australia
  • 18.2.3.5.1. Drug Insights
  • 18.2.3.5.2. Drug Estimates By Route of Administration
  • 18.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.5.3. Drug Estimates By Type
  • 18.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.6. Thailand
  • 18.2.3.6.1. Drug Insights
  • 18.2.3.6.2. Drug Estimates By Route of Administration
  • 18.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.6.3. Drug Estimates By Type
  • 18.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.7. Rest of APAC
  • 18.2.3.7.1. Drug Insights
  • 18.2.3.7.2. Drug Estimates By Route of Administration
  • 18.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.7.3. Drug Estimates By Type
  • 18.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4. Latin America
  • 18.2.4.1. Brazil
  • 18.2.4.1.1. Drug Insights
  • 18.2.4.1.2. Drug Estimates By Route of Administration
  • 18.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.1.3. Drug Estimates By Type
  • 18.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.2. Argentina
  • 18.2.4.2.1. Drug Insights
  • 18.2.4.2.2. Drug Estimates By Route of Administration
  • 18.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.2.3. Drug Estimates By Type
  • 18.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.3. Rest of Latin America
  • 18.2.4.3.1. Drug Insights
  • 18.2.4.3.2. Drug Estimates By Route of Administration
  • 18.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.3.3. Drug Estimates By Type
  • 18.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5. Middle East & Africa
  • 18.2.5.1. Saudi Arabia
  • 18.2.5.1.1. Drug Insights
  • 18.2.5.1.2. Drug Estimates By Route of Administration
  • 18.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.1.3. Drug Estimates By Type
  • 18.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.2. UAE
  • 18.2.5.2.1. Drug Insights
  • 18.2.5.2.2. Drug Estimates By Route of Administration
  • 18.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.2.3. Drug Estimates By Type
  • 18.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.3. Kuwait
  • 18.2.5.3.1. Drug Insights
  • 18.2.5.3.2. Drug Estimates By Route of Administration
  • 18.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.3.3. Drug Estimates By Type
  • 18.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.4. Rest of Middle East & Africa
  • 18.2.5.4.1. Drug Insights
  • 18.2.5.4.2. Drug Estimates By Route of Administration
  • 18.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.4.3. Drug Estimates By Type
  • 18.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 18.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 19. Carbamazepine (Tegretol, Carbatrol, Tegretol XR) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 19.1. Drug Information
  • 19.1.1. Drug Information
  • 19.1.2. Drug Patent Analysis
  • 19.2. Drug Estimates By Region
  • 19.2.1. North America
  • 19.2.1.1. Drug Insights
  • 19.2.1.2. Drug Estimates By Route of Administration
  • 19.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.3. Drug Estimates By Type
  • 19.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4. Drug Estimates By Country
  • 19.2.1.4.1. U.S.
  • 19.2.1.4.1.1. Drug Insight
  • 19.2.1.4.1.2. Drug Estimates By Route of Administration
  • 19.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.1.3. Drug Estimates By Type
  • 19.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.2. Canada
  • 19.2.1.4.2.1. Drug Insights
  • 19.2.1.4.2.2. Drug Estimates By Route of Administration
  • 19.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.2.3. Drug Estimates By Type
  • 19.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.3. Mexico
  • 19.2.1.4.3.1. Drug Insights
  • 19.2.1.4.3.2. Drug Estimates By Route of Administration
  • 19.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.3.3. Drug Estimates By Type
  • 19.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2. Europe
  • 19.2.2.1. UK
  • 19.2.2.1.1. Drug Insights
  • 19.2.2.1.2. Drug Estimates By Route of Administration
  • 19.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.1.3. Drug Estimates By Type
  • 19.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.2. Germany
  • 19.2.2.2.1. Drug Insights
  • 19.2.2.2.2. Drug Estimates By Route of Administration
  • 19.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.2.3. Drug Estimates By Type
  • 19.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.3. France
  • 19.2.2.3.1. Drug Insights
  • 19.2.2.3.2. Drug Estimates By Route of Administration
  • 19.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.3.3. Drug Estimates By Type
  • 19.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.4. Italy
  • 19.2.2.4.1. Drug Insights
  • 19.2.2.4.2. Drug Estimates By Route of Administration
  • 19.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.4.3. Drug Estimates By Type
  • 19.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.5. Spain
  • 19.2.2.5.1. Drug Insights
  • 19.2.2.5.2. Drug Estimates By Route of Administration
  • 19.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.5.3. Drug Estimates By Type
  • 19.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.6. Denmark
  • 19.2.2.6.1. Drug Insights
  • 19.2.2.6.2. Drug Estimates By Route of Administration
  • 19.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.6.3. Drug Estimates By Type
  • 19.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.7. Sweden
  • 19.2.2.7.1. Drug Insights
  • 19.2.2.7.2. Drug Estimates By Route of Administration
  • 19.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.7.3. Drug Estimates By Type
  • 19.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.8. Norway
  • 19.2.2.8.1. Drug Insights
  • 19.2.2.8.2. Drug Estimates By Route of Administration
  • 19.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.8.3. Drug Estimates By Type
  • 19.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.9. Rest of Europe
  • 19.2.2.9.1. Drug Insights
  • 19.2.2.9.2. Drug Estimates By Route of Administration
  • 19.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.9.3. Drug Estimates By Type
  • 19.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3. Asia Pacific
  • 19.2.3.1. Japan
  • 19.2.3.1.1. Drug Insights
  • 19.2.3.1.2. Drug Estimates By Route of Administration
  • 19.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.1.3. Drug Estimates By Type
  • 19.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.2. China
  • 19.2.3.2.1. Drug Insights
  • 19.2.3.2.2. Drug Estimates By Route of Administration
  • 19.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.2.3. Drug Estimates By Type
  • 19.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.3. India
  • 19.2.3.3.1. Drug Insights
  • 19.2.3.3.2. Drug Estimates By Route of Administration
  • 19.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.3.3. Drug Estimates By Type
  • 19.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.4. South Korea
  • 19.2.3.4.1. Drug Insights
  • 19.2.3.4.2. Drug Estimates By Route of Administration
  • 19.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.4.3. Drug Estimates By Type
  • 19.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.5. Australia
  • 19.2.3.5.1. Drug Insights
  • 19.2.3.5.2. Drug Estimates By Route of Administration
  • 19.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.5.3. Drug Estimates By Type
  • 19.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.6. Thailand
  • 19.2.3.6.1. Drug Insights
  • 19.2.3.6.2. Drug Estimates By Route of Administration
  • 19.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.6.3. Drug Estimates By Type
  • 19.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.7. Rest of APAC
  • 19.2.3.7.1. Drug Insights
  • 19.2.3.7.2. Drug Estimates By Route of Administration
  • 19.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.7.3. Drug Estimates By Type
  • 19.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4. Latin America
  • 19.2.4.1. Brazil
  • 19.2.4.1.1. Drug Insights
  • 19.2.4.1.2. Drug Estimates By Route of Administration
  • 19.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.1.3. Drug Estimates By Type
  • 19.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.2. Argentina
  • 19.2.4.2.1. Drug Insights
  • 19.2.4.2.2. Drug Estimates By Route of Administration
  • 19.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.2.3. Drug Estimates By Type
  • 19.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.3. Rest of Latin America
  • 19.2.4.3.1. Drug Insights
  • 19.2.4.3.2. Drug Estimates By Route of Administration
  • 19.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.3.3. Drug Estimates By Type
  • 19.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5. Middle East & Africa
  • 19.2.5.1. Saudi Arabia
  • 19.2.5.1.1. Drug Insights
  • 19.2.5.1.2. Drug Estimates By Route of Administration
  • 19.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.1.3. Drug Estimates By Type
  • 19.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.2. UAE
  • 19.2.5.2.1. Drug Insights
  • 19.2.5.2.2. Drug Estimates By Route of Administration
  • 19.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.2.3. Drug Estimates By Type
  • 19.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.3. Kuwait
  • 19.2.5.3.1. Drug Insights
  • 19.2.5.3.2. Drug Estimates By Route of Administration
  • 19.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.3.3. Drug Estimates By Type
  • 19.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.4. Rest of Middle East & Africa
  • 19.2.5.4.1. Drug Insights
  • 19.2.5.4.2. Drug Estimates By Route of Administration
  • 19.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.4.3. Drug Estimates By Type
  • 19.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 19.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 20. Cannabidiol (Epidiolex / Epidyolex) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 20.1. Drug Information
  • 20.1.1. Drug Information
  • 20.1.2. Drug Patent Analysis
  • 20.2. Drug Estimates By Region
  • 20.2.1. North America
  • 20.2.1.1. Drug Insights
  • 20.2.1.2. Drug Estimates By Route of Administration
  • 20.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.3. Drug Estimates By Type
  • 20.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4. Drug Estimates By Country
  • 20.2.1.4.1. U.S.
  • 20.2.1.4.1.1. Drug Insight
  • 20.2.1.4.1.2. Drug Estimates By Route of Administration
  • 20.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.1.3. Drug Estimates By Type
  • 20.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.2. Canada
  • 20.2.1.4.2.1. Drug Insights
  • 20.2.1.4.2.2. Drug Estimates By Route of Administration
  • 20.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.2.3. Drug Estimates By Type
  • 20.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.3. Mexico
  • 20.2.1.4.3.1. Drug Insights
  • 20.2.1.4.3.2. Drug Estimates By Route of Administration
  • 20.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.3.3. Drug Estimates By Type
  • 20.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2. Europe
  • 20.2.2.1. UK
  • 20.2.2.1.1. Drug Insights
  • 20.2.2.1.2. Drug Estimates By Route of Administration
  • 20.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.1.3. Drug Estimates By Type
  • 20.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.2. Germany
  • 20.2.2.2.1. Drug Insights
  • 20.2.2.2.2. Drug Estimates By Route of Administration
  • 20.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.2.3. Drug Estimates By Type
  • 20.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.3. France
  • 20.2.2.3.1. Drug Insights
  • 20.2.2.3.2. Drug Estimates By Route of Administration
  • 20.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.3.3. Drug Estimates By Type
  • 20.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.4. Italy
  • 20.2.2.4.1. Drug Insights
  • 20.2.2.4.2. Drug Estimates By Route of Administration
  • 20.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.4.3. Drug Estimates By Type
  • 20.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.5. Spain
  • 20.2.2.5.1. Drug Insights
  • 20.2.2.5.2. Drug Estimates By Route of Administration
  • 20.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.5.3. Drug Estimates By Type
  • 20.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.6. Denmark
  • 20.2.2.6.1. Drug Insights
  • 20.2.2.6.2. Drug Estimates By Route of Administration
  • 20.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.6.3. Drug Estimates By Type
  • 20.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.7. Sweden
  • 20.2.2.7.1. Drug Insights
  • 20.2.2.7.2. Drug Estimates By Route of Administration
  • 20.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.7.3. Drug Estimates By Type
  • 20.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.8. Norway
  • 20.2.2.8.1. Drug Insights
  • 20.2.2.8.2. Drug Estimates By Route of Administration
  • 20.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.8.3. Drug Estimates By Type
  • 20.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.9. Rest of Europe
  • 20.2.2.9.1. Drug Insights
  • 20.2.2.9.2. Drug Estimates By Route of Administration
  • 20.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.9.3. Drug Estimates By Type
  • 20.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3. Asia Pacific
  • 20.2.3.1. Japan
  • 20.2.3.1.1. Drug Insights
  • 20.2.3.1.2. Drug Estimates By Route of Administration
  • 20.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.1.3. Drug Estimates By Type
  • 20.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.2. China
  • 20.2.3.2.1. Drug Insights
  • 20.2.3.2.2. Drug Estimates By Route of Administration
  • 20.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.2.3. Drug Estimates By Type
  • 20.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.3. India
  • 20.2.3.3.1. Drug Insights
  • 20.2.3.3.2. Drug Estimates By Route of Administration
  • 20.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.3.3. Drug Estimates By Type
  • 20.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.4. South Korea
  • 20.2.3.4.1. Drug Insights
  • 20.2.3.4.2. Drug Estimates By Route of Administration
  • 20.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.4.3. Drug Estimates By Type
  • 20.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.5. Australia
  • 20.2.3.5.1. Drug Insights
  • 20.2.3.5.2. Drug Estimates By Route of Administration
  • 20.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.5.3. Drug Estimates By Type
  • 20.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.6. Thailand
  • 20.2.3.6.1. Drug Insights
  • 20.2.3.6.2. Drug Estimates By Route of Administration
  • 20.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.6.3. Drug Estimates By Type
  • 20.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.7. Rest of APAC
  • 20.2.3.7.1. Drug Insights
  • 20.2.3.7.2. Drug Estimates By Route of Administration
  • 20.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.7.3. Drug Estimates By Type
  • 20.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4. Latin America
  • 20.2.4.1. Brazil
  • 20.2.4.1.1. Drug Insights
  • 20.2.4.1.2. Drug Estimates By Route of Administration
  • 20.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.1.3. Drug Estimates By Type
  • 20.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.2. Argentina
  • 20.2.4.2.1. Drug Insights
  • 20.2.4.2.2. Drug Estimates By Route of Administration
  • 20.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.2.3. Drug Estimates By Type
  • 20.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.3. Rest of Latin America
  • 20.2.4.3.1. Drug Insights
  • 20.2.4.3.2. Drug Estimates By Route of Administration
  • 20.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.3.3. Drug Estimates By Type
  • 20.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5. Middle East & Africa
  • 20.2.5.1. Saudi Arabia
  • 20.2.5.1.1. Drug Insights
  • 20.2.5.1.2. Drug Estimates By Route of Administration
  • 20.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.1.3. Drug Estimates By Type
  • 20.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.2. UAE
  • 20.2.5.2.1. Drug Insights
  • 20.2.5.2.2. Drug Estimates By Route of Administration
  • 20.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.2.3. Drug Estimates By Type
  • 20.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.3. Kuwait
  • 20.2.5.3.1. Drug Insights
  • 20.2.5.3.2. Drug Estimates By Route of Administration
  • 20.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.3.3. Drug Estimates By Type
  • 20.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.4. Rest of Middle East & Africa
  • 20.2.5.4.1. Drug Insights
  • 20.2.5.4.2. Drug Estimates By Route of Administration
  • 20.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.4.3. Drug Estimates By Type
  • 20.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 20.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 21. Pregabalin (Lyrica, Lyrica CR, Alzain) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 21.1. Drug Information
  • 21.1.1. Drug Information
  • 21.1.2. Drug Patent Analysis
  • 21.2. Drug Estimates By Region
  • 21.2.1. North America
  • 21.2.1.1. Drug Insights
  • 21.2.1.2. Drug Estimates By Route of Administration
  • 21.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.3. Drug Estimates By Type
  • 21.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4. Drug Estimates By Country
  • 21.2.1.4.1. U.S.
  • 21.2.1.4.1.1. Drug Insight
  • 21.2.1.4.1.2. Drug Estimates By Route of Administration
  • 21.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.1.3. Drug Estimates By Type
  • 21.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.2. Canada
  • 21.2.1.4.2.1. Drug Insights
  • 21.2.1.4.2.2. Drug Estimates By Route of Administration
  • 21.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.2.3. Drug Estimates By Type
  • 21.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.3. Mexico
  • 21.2.1.4.3.1. Drug Insights
  • 21.2.1.4.3.2. Drug Estimates By Route of Administration
  • 21.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.3.3. Drug Estimates By Type
  • 21.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2. Europe
  • 21.2.2.1. UK
  • 21.2.2.1.1. Drug Insights
  • 21.2.2.1.2. Drug Estimates By Route of Administration
  • 21.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.1.3. Drug Estimates By Type
  • 21.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.2. Germany
  • 21.2.2.2.1. Drug Insights
  • 21.2.2.2.2. Drug Estimates By Route of Administration
  • 21.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.2.3. Drug Estimates By Type
  • 21.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.3. France
  • 21.2.2.3.1. Drug Insights
  • 21.2.2.3.2. Drug Estimates By Route of Administration
  • 21.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.3.3. Drug Estimates By Type
  • 21.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.4. Italy
  • 21.2.2.4.1. Drug Insights
  • 21.2.2.4.2. Drug Estimates By Route of Administration
  • 21.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.4.3. Drug Estimates By Type
  • 21.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.5. Spain
  • 21.2.2.5.1. Drug Insights
  • 21.2.2.5.2. Drug Estimates By Route of Administration
  • 21.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.5.3. Drug Estimates By Type
  • 21.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.6. Denmark
  • 21.2.2.6.1. Drug Insights
  • 21.2.2.6.2. Drug Estimates By Route of Administration
  • 21.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.6.3. Drug Estimates By Type
  • 21.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.7. Sweden
  • 21.2.2.7.1. Drug Insights
  • 21.2.2.7.2. Drug Estimates By Route of Administration
  • 21.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.7.3. Drug Estimates By Type
  • 21.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.8. Norway
  • 21.2.2.8.1. Drug Insights
  • 21.2.2.8.2. Drug Estimates By Route of Administration
  • 21.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.8.3. Drug Estimates By Type
  • 21.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.9. Rest of Europe
  • 21.2.2.9.1. Drug Insights
  • 21.2.2.9.2. Drug Estimates By Route of Administration
  • 21.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.9.3. Drug Estimates By Type
  • 21.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3. Asia Pacific
  • 21.2.3.1. Japan
  • 21.2.3.1.1. Drug Insights
  • 21.2.3.1.2. Drug Estimates By Route of Administration
  • 21.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.1.3. Drug Estimates By Type
  • 21.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.2. China
  • 21.2.3.2.1. Drug Insights
  • 21.2.3.2.2. Drug Estimates By Route of Administration
  • 21.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.2.3. Drug Estimates By Type
  • 21.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.3. India
  • 21.2.3.3.1. Drug Insights
  • 21.2.3.3.2. Drug Estimates By Route of Administration
  • 21.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.3.3. Drug Estimates By Type
  • 21.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.4. South Korea
  • 21.2.3.4.1. Drug Insights
  • 21.2.3.4.2. Drug Estimates By Route of Administration
  • 21.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.4.3. Drug Estimates By Type
  • 21.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.5. Australia
  • 21.2.3.5.1. Drug Insights
  • 21.2.3.5.2. Drug Estimates By Route of Administration
  • 21.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.5.3. Drug Estimates By Type
  • 21.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.6. Thailand
  • 21.2.3.6.1. Drug Insights
  • 21.2.3.6.2. Drug Estimates By Route of Administration
  • 21.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.6.3. Drug Estimates By Type
  • 21.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.7. Rest of APAC
  • 21.2.3.7.1. Drug Insights
  • 21.2.3.7.2. Drug Estimates By Route of Administration
  • 21.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.7.3. Drug Estimates By Type
  • 21.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4. Latin America
  • 21.2.4.1. Brazil
  • 21.2.4.1.1. Drug Insights
  • 21.2.4.1.2. Drug Estimates By Route of Administration
  • 21.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.1.3. Drug Estimates By Type
  • 21.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.2. Argentina
  • 21.2.4.2.1. Drug Insights
  • 21.2.4.2.2. Drug Estimates By Route of Administration
  • 21.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.2.3. Drug Estimates By Type
  • 21.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.3. Rest of Latin America
  • 21.2.4.3.1. Drug Insights
  • 21.2.4.3.2. Drug Estimates By Route of Administration
  • 21.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.3.3. Drug Estimates By Type
  • 21.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5. Middle East & Africa
  • 21.2.5.1. Saudi Arabia
  • 21.2.5.1.1. Drug Insights
  • 21.2.5.1.2. Drug Estimates By Route of Administration
  • 21.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.1.3. Drug Estimates By Type
  • 21.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.2. UAE
  • 21.2.5.2.1. Drug Insights
  • 21.2.5.2.2. Drug Estimates By Route of Administration
  • 21.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.2.3. Drug Estimates By Type
  • 21.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.3. Kuwait
  • 21.2.5.3.1. Drug Insights
  • 21.2.5.3.2. Drug Estimates By Route of Administration
  • 21.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.3.3. Drug Estimates By Type
  • 21.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.4. Rest of Middle East & Africa
  • 21.2.5.4.1. Drug Insights
  • 21.2.5.4.2. Drug Estimates By Route of Administration
  • 21.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.4.3. Drug Estimates By Type
  • 21.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 21.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 22. Gabapentin (Neurontin) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 22.1. Drug Information
  • 22.1.1. Drug Information
  • 22.1.2. Drug Patent Analysis
  • 22.2. Drug Estimates By Region
  • 22.2.1. North America
  • 22.2.1.1. Drug Insights
  • 22.2.1.2. Drug Estimates By Route of Administration
  • 22.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.3. Drug Estimates By Type
  • 22.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4. Drug Estimates By Country
  • 22.2.1.4.1. U.S.
  • 22.2.1.4.1.1. Drug Insight
  • 22.2.1.4.1.2. Drug Estimates By Route of Administration
  • 22.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.1.3. Drug Estimates By Type
  • 22.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.2. Canada
  • 22.2.1.4.2.1. Drug Insights
  • 22.2.1.4.2.2. Drug Estimates By Route of Administration
  • 22.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.2.3. Drug Estimates By Type
  • 22.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.3. Mexico
  • 22.2.1.4.3.1. Drug Insights
  • 22.2.1.4.3.2. Drug Estimates By Route of Administration
  • 22.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.3.3. Drug Estimates By Type
  • 22.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2. Europe
  • 22.2.2.1. UK
  • 22.2.2.1.1. Drug Insights
  • 22.2.2.1.2. Drug Estimates By Route of Administration
  • 22.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.1.3. Drug Estimates By Type
  • 22.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.2. Germany
  • 22.2.2.2.1. Drug Insights
  • 22.2.2.2.2. Drug Estimates By Route of Administration
  • 22.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.2.3. Drug Estimates By Type
  • 22.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.3. France
  • 22.2.2.3.1. Drug Insights
  • 22.2.2.3.2. Drug Estimates By Route of Administration
  • 22.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.3.3. Drug Estimates By Type
  • 22.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.4. Italy
  • 22.2.2.4.1. Drug Insights
  • 22.2.2.4.2. Drug Estimates By Route of Administration
  • 22.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.4.3. Drug Estimates By Type
  • 22.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.5. Spain
  • 22.2.2.5.1. Drug Insights
  • 22.2.2.5.2. Drug Estimates By Route of Administration
  • 22.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.5.3. Drug Estimates By Type
  • 22.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.6. Denmark
  • 22.2.2.6.1. Drug Insights
  • 22.2.2.6.2. Drug Estimates By Route of Administration
  • 22.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.6.3. Drug Estimates By Type
  • 22.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.7. Sweden
  • 22.2.2.7.1. Drug Insights
  • 22.2.2.7.2. Drug Estimates By Route of Administration
  • 22.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.7.3. Drug Estimates By Type
  • 22.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.8. Norway
  • 22.2.2.8.1. Drug Insights
  • 22.2.2.8.2. Drug Estimates By Route of Administration
  • 22.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.8.3. Drug Estimates By Type
  • 22.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.9. Rest of Europe
  • 22.2.2.9.1. Drug Insights
  • 22.2.2.9.2. Drug Estimates By Route of Administration
  • 22.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.9.3. Drug Estimates By Type
  • 22.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3. Asia Pacific
  • 22.2.3.1. Japan
  • 22.2.3.1.1. Drug Insights
  • 22.2.3.1.2. Drug Estimates By Route of Administration
  • 22.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.1.3. Drug Estimates By Type
  • 22.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.2. China
  • 22.2.3.2.1. Drug Insights
  • 22.2.3.2.2. Drug Estimates By Route of Administration
  • 22.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.2.3. Drug Estimates By Type
  • 22.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.3. India
  • 22.2.3.3.1. Drug Insights
  • 22.2.3.3.2. Drug Estimates By Route of Administration
  • 22.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.3.3. Drug Estimates By Type
  • 22.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.4. South Korea
  • 22.2.3.4.1. Drug Insights
  • 22.2.3.4.2. Drug Estimates By Route of Administration
  • 22.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.4.3. Drug Estimates By Type
  • 22.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.5. Australia
  • 22.2.3.5.1. Drug Insights
  • 22.2.3.5.2. Drug Estimates By Route of Administration
  • 22.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.5.3. Drug Estimates By Type
  • 22.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.6. Thailand
  • 22.2.3.6.1. Drug Insights
  • 22.2.3.6.2. Drug Estimates By Route of Administration
  • 22.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.6.3. Drug Estimates By Type
  • 22.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.7. Rest of APAC
  • 22.2.3.7.1. Drug Insights
  • 22.2.3.7.2. Drug Estimates By Route of Administration
  • 22.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.7.3. Drug Estimates By Type
  • 22.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4. Latin America
  • 22.2.4.1. Brazil
  • 22.2.4.1.1. Drug Insights
  • 22.2.4.1.2. Drug Estimates By Route of Administration
  • 22.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.1.3. Drug Estimates By Type
  • 22.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.2. Argentina
  • 22.2.4.2.1. Drug Insights
  • 22.2.4.2.2. Drug Estimates By Route of Administration
  • 22.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.2.3. Drug Estimates By Type
  • 22.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.3. Rest of Latin America
  • 22.2.4.3.1. Drug Insights
  • 22.2.4.3.2. Drug Estimates By Route of Administration
  • 22.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.3.3. Drug Estimates By Type
  • 22.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5. Middle East & Africa
  • 22.2.5.1. Saudi Arabia
  • 22.2.5.1.1. Drug Insights
  • 22.2.5.1.2. Drug Estimates By Route of Administration
  • 22.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.1.3. Drug Estimates By Type
  • 22.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.2. UAE
  • 22.2.5.2.1. Drug Insights
  • 22.2.5.2.2. Drug Estimates By Route of Administration
  • 22.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.2.3. Drug Estimates By Type
  • 22.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.3. Kuwait
  • 22.2.5.3.1. Drug Insights
  • 22.2.5.3.2. Drug Estimates By Route of Administration
  • 22.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.3.3. Drug Estimates By Type
  • 22.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.4. Rest of Middle East & Africa
  • 22.2.5.4.1. Drug Insights
  • 22.2.5.4.2. Drug Estimates By Route of Administration
  • 22.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.4.3. Drug Estimates By Type
  • 22.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 22.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 23. Oxcarbazepine (Trileptal, Oxtellar XR) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 23.1. Drug Information
  • 23.1.1. Drug Information
  • 23.1.2. Drug Patent Analysis
  • 23.2. Drug Estimates By Region
  • 23.2.1. North America
  • 23.2.1.1. Drug Insights
  • 23.2.1.2. Drug Estimates By Route of Administration
  • 23.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.3. Drug Estimates By Type
  • 23.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4. Drug Estimates By Country
  • 23.2.1.4.1. U.S.
  • 23.2.1.4.1.1. Drug Insight
  • 23.2.1.4.1.2. Drug Estimates By Route of Administration
  • 23.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.1.3. Drug Estimates By Type
  • 23.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.2. Canada
  • 23.2.1.4.2.1. Drug Insights
  • 23.2.1.4.2.2. Drug Estimates By Route of Administration
  • 23.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.2.3. Drug Estimates By Type
  • 23.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.3. Mexico
  • 23.2.1.4.3.1. Drug Insights
  • 23.2.1.4.3.2. Drug Estimates By Route of Administration
  • 23.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.3.3. Drug Estimates By Type
  • 23.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2. Europe
  • 23.2.2.1. UK
  • 23.2.2.1.1. Drug Insights
  • 23.2.2.1.2. Drug Estimates By Route of Administration
  • 23.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.1.3. Drug Estimates By Type
  • 23.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.2. Germany
  • 23.2.2.2.1. Drug Insights
  • 23.2.2.2.2. Drug Estimates By Route of Administration
  • 23.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.2.3. Drug Estimates By Type
  • 23.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.3. France
  • 23.2.2.3.1. Drug Insights
  • 23.2.2.3.2. Drug Estimates By Route of Administration
  • 23.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.3.3. Drug Estimates By Type
  • 23.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.4. Italy
  • 23.2.2.4.1. Drug Insights
  • 23.2.2.4.2. Drug Estimates By Route of Administration
  • 23.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.4.3. Drug Estimates By Type
  • 23.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.5. Spain
  • 23.2.2.5.1. Drug Insights
  • 23.2.2.5.2. Drug Estimates By Route of Administration
  • 23.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.5.3. Drug Estimates By Type
  • 23.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.6. Denmark
  • 23.2.2.6.1. Drug Insights
  • 23.2.2.6.2. Drug Estimates By Route of Administration
  • 23.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.6.3. Drug Estimates By Type
  • 23.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.7. Sweden
  • 23.2.2.7.1. Drug Insights
  • 23.2.2.7.2. Drug Estimates By Route of Administration
  • 23.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.7.3. Drug Estimates By Type
  • 23.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.8. Norway
  • 23.2.2.8.1. Drug Insights
  • 23.2.2.8.2. Drug Estimates By Route of Administration
  • 23.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.8.3. Drug Estimates By Type
  • 23.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.9. Rest of Europe
  • 23.2.2.9.1. Drug Insights
  • 23.2.2.9.2. Drug Estimates By Route of Administration
  • 23.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.9.3. Drug Estimates By Type
  • 23.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3. Asia Pacific
  • 23.2.3.1. Japan
  • 23.2.3.1.1. Drug Insights
  • 23.2.3.1.2. Drug Estimates By Route of Administration
  • 23.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.1.3. Drug Estimates By Type
  • 23.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.2. China
  • 23.2.3.2.1. Drug Insights
  • 23.2.3.2.2. Drug Estimates By Route of Administration
  • 23.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.2.3. Drug Estimates By Type
  • 23.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.3. India
  • 23.2.3.3.1. Drug Insights
  • 23.2.3.3.2. Drug Estimates By Route of Administration
  • 23.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.3.3. Drug Estimates By Type
  • 23.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.4. South Korea
  • 23.2.3.4.1. Drug Insights
  • 23.2.3.4.2. Drug Estimates By Route of Administration
  • 23.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.4.3. Drug Estimates By Type
  • 23.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.5. Australia
  • 23.2.3.5.1. Drug Insights
  • 23.2.3.5.2. Drug Estimates By Route of Administration
  • 23.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.5.3. Drug Estimates By Type
  • 23.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.6. Thailand
  • 23.2.3.6.1. Drug Insights
  • 23.2.3.6.2. Drug Estimates By Route of Administration
  • 23.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.6.3. Drug Estimates By Type
  • 23.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.7. Rest of APAC
  • 23.2.3.7.1. Drug Insights
  • 23.2.3.7.2. Drug Estimates By Route of Administration
  • 23.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.7.3. Drug Estimates By Type
  • 23.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4. Latin America
  • 23.2.4.1. Brazil
  • 23.2.4.1.1. Drug Insights
  • 23.2.4.1.2. Drug Estimates By Route of Administration
  • 23.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.1.3. Drug Estimates By Type
  • 23.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.2. Argentina
  • 23.2.4.2.1. Drug Insights
  • 23.2.4.2.2. Drug Estimates By Route of Administration
  • 23.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.2.3. Drug Estimates By Type
  • 23.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.3. Rest of Latin America
  • 23.2.4.3.1. Drug Insights
  • 23.2.4.3.2. Drug Estimates By Route of Administration
  • 23.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.3.3. Drug Estimates By Type
  • 23.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5. Middle East & Africa
  • 23.2.5.1. Saudi Arabia
  • 23.2.5.1.1. Drug Insights
  • 23.2.5.1.2. Drug Estimates By Route of Administration
  • 23.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.1.3. Drug Estimates By Type
  • 23.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.2. UAE
  • 23.2.5.2.1. Drug Insights
  • 23.2.5.2.2. Drug Estimates By Route of Administration
  • 23.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.2.3. Drug Estimates By Type
  • 23.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.3. Kuwait
  • 23.2.5.3.1. Drug Insights
  • 23.2.5.3.2. Drug Estimates By Route of Administration
  • 23.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.3.3. Drug Estimates By Type
  • 23.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.4. Rest of Middle East & Africa
  • 23.2.5.4.1. Drug Insights
  • 23.2.5.4.2. Drug Estimates By Route of Administration
  • 23.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.4.3. Drug Estimates By Type
  • 23.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 23.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 24. Zonisamide (Zonegran, Desizon) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 24.1. Drug Information
  • 24.1.1. Drug Information
  • 24.1.2. Drug Patent Analysis
  • 24.2. Drug Estimates By Region
  • 24.2.1. North America
  • 24.2.1.1. Drug Insights
  • 24.2.1.2. Drug Estimates By Route of Administration
  • 24.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.3. Drug Estimates By Type
  • 24.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4. Drug Estimates By Country
  • 24.2.1.4.1. U.S.
  • 24.2.1.4.1.1. Drug Insight
  • 24.2.1.4.1.2. Drug Estimates By Route of Administration
  • 24.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.1.3. Drug Estimates By Type
  • 24.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.2. Canada
  • 24.2.1.4.2.1. Drug Insights
  • 24.2.1.4.2.2. Drug Estimates By Route of Administration
  • 24.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.2.3. Drug Estimates By Type
  • 24.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.3. Mexico
  • 24.2.1.4.3.1. Drug Insights
  • 24.2.1.4.3.2. Drug Estimates By Route of Administration
  • 24.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.3.3. Drug Estimates By Type
  • 24.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2. Europe
  • 24.2.2.1. UK
  • 24.2.2.1.1. Drug Insights
  • 24.2.2.1.2. Drug Estimates By Route of Administration
  • 24.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.1.3. Drug Estimates By Type
  • 24.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.2. Germany
  • 24.2.2.2.1. Drug Insights
  • 24.2.2.2.2. Drug Estimates By Route of Administration
  • 24.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.2.3. Drug Estimates By Type
  • 24.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.3. France
  • 24.2.2.3.1. Drug Insights
  • 24.2.2.3.2. Drug Estimates By Route of Administration
  • 24.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.3.3. Drug Estimates By Type
  • 24.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.4. Italy
  • 24.2.2.4.1. Drug Insights
  • 24.2.2.4.2. Drug Estimates By Route of Administration
  • 24.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.4.3. Drug Estimates By Type
  • 24.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.5. Spain
  • 24.2.2.5.1. Drug Insights
  • 24.2.2.5.2. Drug Estimates By Route of Administration
  • 24.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.5.3. Drug Estimates By Type
  • 24.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.6. Denmark
  • 24.2.2.6.1. Drug Insights
  • 24.2.2.6.2. Drug Estimates By Route of Administration
  • 24.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.6.3. Drug Estimates By Type
  • 24.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.7. Sweden
  • 24.2.2.7.1. Drug Insights
  • 24.2.2.7.2. Drug Estimates By Route of Administration
  • 24.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.7.3. Drug Estimates By Type
  • 24.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.8. Norway
  • 24.2.2.8.1. Drug Insights
  • 24.2.2.8.2. Drug Estimates By Route of Administration
  • 24.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.8.3. Drug Estimates By Type
  • 24.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.9. Rest of Europe
  • 24.2.2.9.1. Drug Insights
  • 24.2.2.9.2. Drug Estimates By Route of Administration
  • 24.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.9.3. Drug Estimates By Type
  • 24.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3. Asia Pacific
  • 24.2.3.1. Japan
  • 24.2.3.1.1. Drug Insights
  • 24.2.3.1.2. Drug Estimates By Route of Administration
  • 24.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.1.3. Drug Estimates By Type
  • 24.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.2. China
  • 24.2.3.2.1. Drug Insights
  • 24.2.3.2.2. Drug Estimates By Route of Administration
  • 24.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.2.3. Drug Estimates By Type
  • 24.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.3. India
  • 24.2.3.3.1. Drug Insights
  • 24.2.3.3.2. Drug Estimates By Route of Administration
  • 24.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.3.3. Drug Estimates By Type
  • 24.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.4. South Korea
  • 24.2.3.4.1. Drug Insights
  • 24.2.3.4.2. Drug Estimates By Route of Administration
  • 24.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.4.3. Drug Estimates By Type
  • 24.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.5. Australia
  • 24.2.3.5.1. Drug Insights
  • 24.2.3.5.2. Drug Estimates By Route of Administration
  • 24.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.5.3. Drug Estimates By Type
  • 24.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.6. Thailand
  • 24.2.3.6.1. Drug Insights
  • 24.2.3.6.2. Drug Estimates By Route of Administration
  • 24.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.6.3. Drug Estimates By Type
  • 24.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.7. Rest of APAC
  • 24.2.3.7.1. Drug Insights
  • 24.2.3.7.2. Drug Estimates By Route of Administration
  • 24.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.7.3. Drug Estimates By Type
  • 24.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4. Latin America
  • 24.2.4.1. Brazil
  • 24.2.4.1.1. Drug Insights
  • 24.2.4.1.2. Drug Estimates By Route of Administration
  • 24.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.1.3. Drug Estimates By Type
  • 24.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.2. Argentina
  • 24.2.4.2.1. Drug Insights
  • 24.2.4.2.2. Drug Estimates By Route of Administration
  • 24.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.2.3. Drug Estimates By Type
  • 24.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.3. Rest of Latin America
  • 24.2.4.3.1. Drug Insights
  • 24.2.4.3.2. Drug Estimates By Route of Administration
  • 24.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.3.3. Drug Estimates By Type
  • 24.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5. Middle East & Africa
  • 24.2.5.1. Saudi Arabia
  • 24.2.5.1.1. Drug Insights
  • 24.2.5.1.2. Drug Estimates By Route of Administration
  • 24.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.1.3. Drug Estimates By Type
  • 24.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.2. UAE
  • 24.2.5.2.1. Drug Insights
  • 24.2.5.2.2. Drug Estimates By Route of Administration
  • 24.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.2.3. Drug Estimates By Type
  • 24.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.3. Kuwait
  • 24.2.5.3.1. Drug Insights
  • 24.2.5.3.2. Drug Estimates By Route of Administration
  • 24.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.3.3. Drug Estimates By Type
  • 24.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.4. Rest of Middle East & Africa
  • 24.2.5.4.1. Drug Insights
  • 24.2.5.4.2. Drug Estimates By Route of Administration
  • 24.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.4.3. Drug Estimates By Type
  • 24.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 24.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 25. Clobazam (Onfi) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 25.1. Drug Information
  • 25.1.1. Drug Information
  • 25.1.2. Drug Patent Analysis
  • 25.2. Drug Estimates By Region
  • 25.2.1. North America
  • 25.2.1.1. Drug Insights
  • 25.2.1.2. Drug Estimates By Route of Administration
  • 25.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.3. Drug Estimates By Type
  • 25.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4. Drug Estimates By Country
  • 25.2.1.4.1. U.S.
  • 25.2.1.4.1.1. Drug Insight
  • 25.2.1.4.1.2. Drug Estimates By Route of Administration
  • 25.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.1.3. Drug Estimates By Type
  • 25.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.2. Canada
  • 25.2.1.4.2.1. Drug Insights
  • 25.2.1.4.2.2. Drug Estimates By Route of Administration
  • 25.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.2.3. Drug Estimates By Type
  • 25.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.3. Mexico
  • 25.2.1.4.3.1. Drug Insights
  • 25.2.1.4.3.2. Drug Estimates By Route of Administration
  • 25.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.3.3. Drug Estimates By Type
  • 25.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2. Europe
  • 25.2.2.1. UK
  • 25.2.2.1.1. Drug Insights
  • 25.2.2.1.2. Drug Estimates By Route of Administration
  • 25.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.1.3. Drug Estimates By Type
  • 25.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.2. Germany
  • 25.2.2.2.1. Drug Insights
  • 25.2.2.2.2. Drug Estimates By Route of Administration
  • 25.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.2.3. Drug Estimates By Type
  • 25.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.3. France
  • 25.2.2.3.1. Drug Insights
  • 25.2.2.3.2. Drug Estimates By Route of Administration
  • 25.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.3.3. Drug Estimates By Type
  • 25.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.4. Italy
  • 25.2.2.4.1. Drug Insights
  • 25.2.2.4.2. Drug Estimates By Route of Administration
  • 25.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.4.3. Drug Estimates By Type
  • 25.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.5. Spain
  • 25.2.2.5.1. Drug Insights
  • 25.2.2.5.2. Drug Estimates By Route of Administration
  • 25.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.5.3. Drug Estimates By Type
  • 25.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.6. Denmark
  • 25.2.2.6.1. Drug Insights
  • 25.2.2.6.2. Drug Estimates By Route of Administration
  • 25.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.6.3. Drug Estimates By Type
  • 25.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.7. Sweden
  • 25.2.2.7.1. Drug Insights
  • 25.2.2.7.2. Drug Estimates By Route of Administration
  • 25.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.7.3. Drug Estimates By Type
  • 25.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.8. Norway
  • 25.2.2.8.1. Drug Insights
  • 25.2.2.8.2. Drug Estimates By Route of Administration
  • 25.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.8.3. Drug Estimates By Type
  • 25.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.9. Rest of Europe
  • 25.2.2.9.1. Drug Insights
  • 25.2.2.9.2. Drug Estimates By Route of Administration
  • 25.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.9.3. Drug Estimates By Type
  • 25.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3. Asia Pacific
  • 25.2.3.1. Japan
  • 25.2.3.1.1. Drug Insights
  • 25.2.3.1.2. Drug Estimates By Route of Administration
  • 25.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.1.3. Drug Estimates By Type
  • 25.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.2. China
  • 25.2.3.2.1. Drug Insights
  • 25.2.3.2.2. Drug Estimates By Route of Administration
  • 25.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.2.3. Drug Estimates By Type
  • 25.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.3. India
  • 25.2.3.3.1. Drug Insights
  • 25.2.3.3.2. Drug Estimates By Route of Administration
  • 25.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.3.3. Drug Estimates By Type
  • 25.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.4. South Korea
  • 25.2.3.4.1. Drug Insights
  • 25.2.3.4.2. Drug Estimates By Route of Administration
  • 25.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.4.3. Drug Estimates By Type
  • 25.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.5. Australia
  • 25.2.3.5.1. Drug Insights
  • 25.2.3.5.2. Drug Estimates By Route of Administration
  • 25.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.5.3. Drug Estimates By Type
  • 25.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.6. Thailand
  • 25.2.3.6.1. Drug Insights
  • 25.2.3.6.2. Drug Estimates By Route of Administration
  • 25.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.6.3. Drug Estimates By Type
  • 25.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.7. Rest of APAC
  • 25.2.3.7.1. Drug Insights
  • 25.2.3.7.2. Drug Estimates By Route of Administration
  • 25.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.7.3. Drug Estimates By Type
  • 25.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4. Latin America
  • 25.2.4.1. Brazil
  • 25.2.4.1.1. Drug Insights
  • 25.2.4.1.2. Drug Estimates By Route of Administration
  • 25.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.1.3. Drug Estimates By Type
  • 25.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.2. Argentina
  • 25.2.4.2.1. Drug Insights
  • 25.2.4.2.2. Drug Estimates By Route of Administration
  • 25.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.2.3. Drug Estimates By Type
  • 25.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.3. Rest of Latin America
  • 25.2.4.3.1. Drug Insights
  • 25.2.4.3.2. Drug Estimates By Route of Administration
  • 25.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.3.3. Drug Estimates By Type
  • 25.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5. Middle East & Africa
  • 25.2.5.1. Saudi Arabia
  • 25.2.5.1.1. Drug Insights
  • 25.2.5.1.2. Drug Estimates By Route of Administration
  • 25.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.1.3. Drug Estimates By Type
  • 25.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.2. UAE
  • 25.2.5.2.1. Drug Insights
  • 25.2.5.2.2. Drug Estimates By Route of Administration
  • 25.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.2.3. Drug Estimates By Type
  • 25.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.3. Kuwait
  • 25.2.5.3.1. Drug Insights
  • 25.2.5.3.2. Drug Estimates By Route of Administration
  • 25.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.3.3. Drug Estimates By Type
  • 25.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.4. Rest of Middle East & Africa
  • 25.2.5.4.1. Drug Insights
  • 25.2.5.4.2. Drug Estimates By Route of Administration
  • 25.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.4.3. Drug Estimates By Type
  • 25.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 25.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 26. Vigabatrin (Sabril, Vigafyde, Vigpoder) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 26.1. Drug Information
  • 26.1.1. Drug Information
  • 26.1.2. Drug Patent Analysis
  • 26.2. Drug Estimates By Region
  • 26.2.1. North America
  • 26.2.1.1. Drug Insights
  • 26.2.1.2. Drug Estimates By Route of Administration
  • 26.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.3. Drug Estimates By Type
  • 26.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4. Drug Estimates By Country
  • 26.2.1.4.1. U.S.
  • 26.2.1.4.1.1. Drug Insight
  • 26.2.1.4.1.2. Drug Estimates By Route of Administration
  • 26.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.1.3. Drug Estimates By Type
  • 26.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.2. Canada
  • 26.2.1.4.2.1. Drug Insights
  • 26.2.1.4.2.2. Drug Estimates By Route of Administration
  • 26.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.2.3. Drug Estimates By Type
  • 26.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.3. Mexico
  • 26.2.1.4.3.1. Drug Insights
  • 26.2.1.4.3.2. Drug Estimates By Route of Administration
  • 26.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.3.3. Drug Estimates By Type
  • 26.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2. Europe
  • 26.2.2.1. UK
  • 26.2.2.1.1. Drug Insights
  • 26.2.2.1.2. Drug Estimates By Route of Administration
  • 26.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.1.3. Drug Estimates By Type
  • 26.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.2. Germany
  • 26.2.2.2.1. Drug Insights
  • 26.2.2.2.2. Drug Estimates By Route of Administration
  • 26.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.2.3. Drug Estimates By Type
  • 26.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.3. France
  • 26.2.2.3.1. Drug Insights
  • 26.2.2.3.2. Drug Estimates By Route of Administration
  • 26.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.3.3. Drug Estimates By Type
  • 26.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.4. Italy
  • 26.2.2.4.1. Drug Insights
  • 26.2.2.4.2. Drug Estimates By Route of Administration
  • 26.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.4.3. Drug Estimates By Type
  • 26.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.5. Spain
  • 26.2.2.5.1. Drug Insights
  • 26.2.2.5.2. Drug Estimates By Route of Administration
  • 26.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.5.3. Drug Estimates By Type
  • 26.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.6. Denmark
  • 26.2.2.6.1. Drug Insights
  • 26.2.2.6.2. Drug Estimates By Route of Administration
  • 26.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.6.3. Drug Estimates By Type
  • 26.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.7. Sweden
  • 26.2.2.7.1. Drug Insights
  • 26.2.2.7.2. Drug Estimates By Route of Administration
  • 26.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.7.3. Drug Estimates By Type
  • 26.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.8. Norway
  • 26.2.2.8.1. Drug Insights
  • 26.2.2.8.2. Drug Estimates By Route of Administration
  • 26.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.8.3. Drug Estimates By Type
  • 26.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.9. Rest of Europe
  • 26.2.2.9.1. Drug Insights
  • 26.2.2.9.2. Drug Estimates By Route of Administration
  • 26.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.9.3. Drug Estimates By Type
  • 26.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3. Asia Pacific
  • 26.2.3.1. Japan
  • 26.2.3.1.1. Drug Insights
  • 26.2.3.1.2. Drug Estimates By Route of Administration
  • 26.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.1.3. Drug Estimates By Type
  • 26.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.2. China
  • 26.2.3.2.1. Drug Insights
  • 26.2.3.2.2. Drug Estimates By Route of Administration
  • 26.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.2.3. Drug Estimates By Type
  • 26.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.3. India
  • 26.2.3.3.1. Drug Insights
  • 26.2.3.3.2. Drug Estimates By Route of Administration
  • 26.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.3.3. Drug Estimates By Type
  • 26.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.4. South Korea
  • 26.2.3.4.1. Drug Insights
  • 26.2.3.4.2. Drug Estimates By Route of Administration
  • 26.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.4.3. Drug Estimates By Type
  • 26.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.5. Australia
  • 26.2.3.5.1. Drug Insights
  • 26.2.3.5.2. Drug Estimates By Route of Administration
  • 26.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.5.3. Drug Estimates By Type
  • 26.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.6. Thailand
  • 26.2.3.6.1. Drug Insights
  • 26.2.3.6.2. Drug Estimates By Route of Administration
  • 26.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.6.3. Drug Estimates By Type
  • 26.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.7. Rest of APAC
  • 26.2.3.7.1. Drug Insights
  • 26.2.3.7.2. Drug Estimates By Route of Administration
  • 26.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.7.3. Drug Estimates By Type
  • 26.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4. Latin America
  • 26.2.4.1. Brazil
  • 26.2.4.1.1. Drug Insights
  • 26.2.4.1.2. Drug Estimates By Route of Administration
  • 26.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.1.3. Drug Estimates By Type
  • 26.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.2. Argentina
  • 26.2.4.2.1. Drug Insights
  • 26.2.4.2.2. Drug Estimates By Route of Administration
  • 26.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.2.3. Drug Estimates By Type
  • 26.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.3. Rest of Latin America
  • 26.2.4.3.1. Drug Insights
  • 26.2.4.3.2. Drug Estimates By Route of Administration
  • 26.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.3.3. Drug Estimates By Type
  • 26.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5. Middle East & Africa
  • 26.2.5.1. Saudi Arabia
  • 26.2.5.1.1. Drug Insights
  • 26.2.5.1.2. Drug Estimates By Route of Administration
  • 26.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.1.3. Drug Estimates By Type
  • 26.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.2. UAE
  • 26.2.5.2.1. Drug Insights
  • 26.2.5.2.2. Drug Estimates By Route of Administration
  • 26.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.2.3. Drug Estimates By Type
  • 26.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.3. Kuwait
  • 26.2.5.3.1. Drug Insights
  • 26.2.5.3.2. Drug Estimates By Route of Administration
  • 26.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.3.3. Drug Estimates By Type
  • 26.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.4. Rest of Middle East & Africa
  • 26.2.5.4.1. Drug Insights
  • 26.2.5.4.2. Drug Estimates By Route of Administration
  • 26.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.4.3. Drug Estimates By Type
  • 26.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 26.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 27. Phenytoin (Dilantin, Phenytek) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 27.1. Drug Information
  • 27.1.1. Drug Information
  • 27.1.2. Drug Patent Analysis
  • 27.2. Drug Estimates By Region
  • 27.2.1. North America
  • 27.2.1.1. Drug Insights
  • 27.2.1.2. Drug Estimates By Route of Administration
  • 27.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.3. Drug Estimates By Type
  • 27.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4. Drug Estimates By Country
  • 27.2.1.4.1. U.S.
  • 27.2.1.4.1.1. Drug Insight
  • 27.2.1.4.1.2. Drug Estimates By Route of Administration
  • 27.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.1.3. Drug Estimates By Type
  • 27.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.2. Canada
  • 27.2.1.4.2.1. Drug Insights
  • 27.2.1.4.2.2. Drug Estimates By Route of Administration
  • 27.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.2.3. Drug Estimates By Type
  • 27.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.3. Mexico
  • 27.2.1.4.3.1. Drug Insights
  • 27.2.1.4.3.2. Drug Estimates By Route of Administration
  • 27.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.3.3. Drug Estimates By Type
  • 27.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2. Europe
  • 27.2.2.1. UK
  • 27.2.2.1.1. Drug Insights
  • 27.2.2.1.2. Drug Estimates By Route of Administration
  • 27.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.1.3. Drug Estimates By Type
  • 27.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.2. Germany
  • 27.2.2.2.1. Drug Insights
  • 27.2.2.2.2. Drug Estimates By Route of Administration
  • 27.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.2.3. Drug Estimates By Type
  • 27.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.3. France
  • 27.2.2.3.1. Drug Insights
  • 27.2.2.3.2. Drug Estimates By Route of Administration
  • 27.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.3.3. Drug Estimates By Type
  • 27.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.4. Italy
  • 27.2.2.4.1. Drug Insights
  • 27.2.2.4.2. Drug Estimates By Route of Administration
  • 27.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.4.3. Drug Estimates By Type
  • 27.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.5. Spain
  • 27.2.2.5.1. Drug Insights
  • 27.2.2.5.2. Drug Estimates By Route of Administration
  • 27.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.5.3. Drug Estimates By Type
  • 27.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.6. Denmark
  • 27.2.2.6.1. Drug Insights
  • 27.2.2.6.2. Drug Estimates By Route of Administration
  • 27.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.6.3. Drug Estimates By Type
  • 27.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.7. Sweden
  • 27.2.2.7.1. Drug Insights
  • 27.2.2.7.2. Drug Estimates By Route of Administration
  • 27.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.7.3. Drug Estimates By Type
  • 27.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.8. Norway
  • 27.2.2.8.1. Drug Insights
  • 27.2.2.8.2. Drug Estimates By Route of Administration
  • 27.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.8.3. Drug Estimates By Type
  • 27.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.9. Rest of Europe
  • 27.2.2.9.1. Drug Insights
  • 27.2.2.9.2. Drug Estimates By Route of Administration
  • 27.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.9.3. Drug Estimates By Type
  • 27.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3. Asia Pacific
  • 27.2.3.1. Japan
  • 27.2.3.1.1. Drug Insights
  • 27.2.3.1.2. Drug Estimates By Route of Administration
  • 27.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.1.3. Drug Estimates By Type
  • 27.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.2. China
  • 27.2.3.2.1. Drug Insights
  • 27.2.3.2.2. Drug Estimates By Route of Administration
  • 27.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.2.3. Drug Estimates By Type
  • 27.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.3. India
  • 27.2.3.3.1. Drug Insights
  • 27.2.3.3.2. Drug Estimates By Route of Administration
  • 27.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.3.3. Drug Estimates By Type
  • 27.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.4. South Korea
  • 27.2.3.4.1. Drug Insights
  • 27.2.3.4.2. Drug Estimates By Route of Administration
  • 27.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.4.3. Drug Estimates By Type
  • 27.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.5. Australia
  • 27.2.3.5.1. Drug Insights
  • 27.2.3.5.2. Drug Estimates By Route of Administration
  • 27.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.5.3. Drug Estimates By Type
  • 27.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.6. Thailand
  • 27.2.3.6.1. Drug Insights
  • 27.2.3.6.2. Drug Estimates By Route of Administration
  • 27.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.6.3. Drug Estimates By Type
  • 27.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.7. Rest of APAC
  • 27.2.3.7.1. Drug Insights
  • 27.2.3.7.2. Drug Estimates By Route of Administration
  • 27.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.7.3. Drug Estimates By Type
  • 27.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4. Latin America
  • 27.2.4.1. Brazil
  • 27.2.4.1.1. Drug Insights
  • 27.2.4.1.2. Drug Estimates By Route of Administration
  • 27.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.1.3. Drug Estimates By Type
  • 27.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.2. Argentina
  • 27.2.4.2.1. Drug Insights
  • 27.2.4.2.2. Drug Estimates By Route of Administration
  • 27.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.2.3. Drug Estimates By Type
  • 27.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.3. Rest of Latin America
  • 27.2.4.3.1. Drug Insights
  • 27.2.4.3.2. Drug Estimates By Route of Administration
  • 27.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.3.3. Drug Estimates By Type
  • 27.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5. Middle East & Africa
  • 27.2.5.1. Saudi Arabia
  • 27.2.5.1.1. Drug Insights
  • 27.2.5.1.2. Drug Estimates By Route of Administration
  • 27.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.1.3. Drug Estimates By Type
  • 27.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.2. UAE
  • 27.2.5.2.1. Drug Insights
  • 27.2.5.2.2. Drug Estimates By Route of Administration
  • 27.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.2.3. Drug Estimates By Type
  • 27.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.3. Kuwait
  • 27.2.5.3.1. Drug Insights
  • 27.2.5.3.2. Drug Estimates By Route of Administration
  • 27.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.3.3. Drug Estimates By Type
  • 27.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.4. Rest of Middle East & Africa
  • 27.2.5.4.1. Drug Insights
  • 27.2.5.4.2. Drug Estimates By Route of Administration
  • 27.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.4.3. Drug Estimates By Type
  • 27.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 27.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 28. Ethosuximide (Zarontin) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 28.1. Drug Information
  • 28.1.1. Drug Information
  • 28.1.2. Drug Patent Analysis
  • 28.2. Drug Estimates By Region
  • 28.2.1. North America
  • 28.2.1.1. Drug Insights
  • 28.2.1.2. Drug Estimates By Route of Administration
  • 28.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.3. Drug Estimates By Type
  • 28.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4. Drug Estimates By Country
  • 28.2.1.4.1. U.S.
  • 28.2.1.4.1.1. Drug Insight
  • 28.2.1.4.1.2. Drug Estimates By Route of Administration
  • 28.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.1.3. Drug Estimates By Type
  • 28.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.2. Canada
  • 28.2.1.4.2.1. Drug Insights
  • 28.2.1.4.2.2. Drug Estimates By Route of Administration
  • 28.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.2.3. Drug Estimates By Type
  • 28.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.3. Mexico
  • 28.2.1.4.3.1. Drug Insights
  • 28.2.1.4.3.2. Drug Estimates By Route of Administration
  • 28.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.3.3. Drug Estimates By Type
  • 28.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2. Europe
  • 28.2.2.1. UK
  • 28.2.2.1.1. Drug Insights
  • 28.2.2.1.2. Drug Estimates By Route of Administration
  • 28.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.1.3. Drug Estimates By Type
  • 28.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.2. Germany
  • 28.2.2.2.1. Drug Insights
  • 28.2.2.2.2. Drug Estimates By Route of Administration
  • 28.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.2.3. Drug Estimates By Type
  • 28.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.3. France
  • 28.2.2.3.1. Drug Insights
  • 28.2.2.3.2. Drug Estimates By Route of Administration
  • 28.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.3.3. Drug Estimates By Type
  • 28.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.4. Italy
  • 28.2.2.4.1. Drug Insights
  • 28.2.2.4.2. Drug Estimates By Route of Administration
  • 28.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.4.3. Drug Estimates By Type
  • 28.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.5. Spain
  • 28.2.2.5.1. Drug Insights
  • 28.2.2.5.2. Drug Estimates By Route of Administration
  • 28.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.5.3. Drug Estimates By Type
  • 28.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.6. Denmark
  • 28.2.2.6.1. Drug Insights
  • 28.2.2.6.2. Drug Estimates By Route of Administration
  • 28.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.6.3. Drug Estimates By Type
  • 28.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.7. Sweden
  • 28.2.2.7.1. Drug Insights
  • 28.2.2.7.2. Drug Estimates By Route of Administration
  • 28.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.7.3. Drug Estimates By Type
  • 28.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.8. Norway
  • 28.2.2.8.1. Drug Insights
  • 28.2.2.8.2. Drug Estimates By Route of Administration
  • 28.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.8.3. Drug Estimates By Type
  • 28.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.9. Rest of Europe
  • 28.2.2.9.1. Drug Insights
  • 28.2.2.9.2. Drug Estimates By Route of Administration
  • 28.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.9.3. Drug Estimates By Type
  • 28.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3. Asia Pacific
  • 28.2.3.1. Japan
  • 28.2.3.1.1. Drug Insights
  • 28.2.3.1.2. Drug Estimates By Route of Administration
  • 28.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.1.3. Drug Estimates By Type
  • 28.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.2. China
  • 28.2.3.2.1. Drug Insights
  • 28.2.3.2.2. Drug Estimates By Route of Administration
  • 28.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.2.3. Drug Estimates By Type
  • 28.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.3. India
  • 28.2.3.3.1. Drug Insights
  • 28.2.3.3.2. Drug Estimates By Route of Administration
  • 28.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.3.3. Drug Estimates By Type
  • 28.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.4. South Korea
  • 28.2.3.4.1. Drug Insights
  • 28.2.3.4.2. Drug Estimates By Route of Administration
  • 28.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.4.3. Drug Estimates By Type
  • 28.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.5. Australia
  • 28.2.3.5.1. Drug Insights
  • 28.2.3.5.2. Drug Estimates By Route of Administration
  • 28.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.5.3. Drug Estimates By Type
  • 28.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.6. Thailand
  • 28.2.3.6.1. Drug Insights
  • 28.2.3.6.2. Drug Estimates By Route of Administration
  • 28.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.6.3. Drug Estimates By Type
  • 28.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.7. Rest of APAC
  • 28.2.3.7.1. Drug Insights
  • 28.2.3.7.2. Drug Estimates By Route of Administration
  • 28.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.7.3. Drug Estimates By Type
  • 28.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4. Latin America
  • 28.2.4.1. Brazil
  • 28.2.4.1.1. Drug Insights
  • 28.2.4.1.2. Drug Estimates By Route of Administration
  • 28.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.1.3. Drug Estimates By Type
  • 28.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.2. Argentina
  • 28.2.4.2.1. Drug Insights
  • 28.2.4.2.2. Drug Estimates By Route of Administration
  • 28.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.2.3. Drug Estimates By Type
  • 28.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.3. Rest of Latin America
  • 28.2.4.3.1. Drug Insights
  • 28.2.4.3.2. Drug Estimates By Route of Administration
  • 28.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.3.3. Drug Estimates By Type
  • 28.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5. Middle East & Africa
  • 28.2.5.1. Saudi Arabia
  • 28.2.5.1.1. Drug Insights
  • 28.2.5.1.2. Drug Estimates By Route of Administration
  • 28.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.1.3. Drug Estimates By Type
  • 28.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.2. UAE
  • 28.2.5.2.1. Drug Insights
  • 28.2.5.2.2. Drug Estimates By Route of Administration
  • 28.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.2.3. Drug Estimates By Type
  • 28.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.3. Kuwait
  • 28.2.5.3.1. Drug Insights
  • 28.2.5.3.2. Drug Estimates By Route of Administration
  • 28.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.3.3. Drug Estimates By Type
  • 28.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.4. Rest of Middle East & Africa
  • 28.2.5.4.1. Drug Insights
  • 28.2.5.4.2. Drug Estimates By Route of Administration
  • 28.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.4.3. Drug Estimates By Type
  • 28.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 28.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 29. Diazepam (Valium, Diastat Acudial) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 29.1. Drug Information
  • 29.1.1. Drug Information
  • 29.1.2. Drug Patent Analysis
  • 29.2. Drug Estimates By Region
  • 29.2.1. North America
  • 29.2.1.1. Drug Insights
  • 29.2.1.2. Drug Estimates By Route of Administration
  • 29.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.3. Drug Estimates By Type
  • 29.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4. Drug Estimates By Country
  • 29.2.1.4.1. U.S.
  • 29.2.1.4.1.1. Drug Insight
  • 29.2.1.4.1.2. Drug Estimates By Route of Administration
  • 29.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.1.3. Drug Estimates By Type
  • 29.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.2. Canada
  • 29.2.1.4.2.1. Drug Insights
  • 29.2.1.4.2.2. Drug Estimates By Route of Administration
  • 29.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.2.3. Drug Estimates By Type
  • 29.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.3. Mexico
  • 29.2.1.4.3.1. Drug Insights
  • 29.2.1.4.3.2. Drug Estimates By Route of Administration
  • 29.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.3.3. Drug Estimates By Type
  • 29.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2. Europe
  • 29.2.2.1. UK
  • 29.2.2.1.1. Drug Insights
  • 29.2.2.1.2. Drug Estimates By Route of Administration
  • 29.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.1.3. Drug Estimates By Type
  • 29.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.2. Germany
  • 29.2.2.2.1. Drug Insights
  • 29.2.2.2.2. Drug Estimates By Route of Administration
  • 29.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.2.3. Drug Estimates By Type
  • 29.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.3. France
  • 29.2.2.3.1. Drug Insights
  • 29.2.2.3.2. Drug Estimates By Route of Administration
  • 29.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.3.3. Drug Estimates By Type
  • 29.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.4. Italy
  • 29.2.2.4.1. Drug Insights
  • 29.2.2.4.2. Drug Estimates By Route of Administration
  • 29.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.4.3. Drug Estimates By Type
  • 29.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.5. Spain
  • 29.2.2.5.1. Drug Insights
  • 29.2.2.5.2. Drug Estimates By Route of Administration
  • 29.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.5.3. Drug Estimates By Type
  • 29.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.6. Denmark
  • 29.2.2.6.1. Drug Insights
  • 29.2.2.6.2. Drug Estimates By Route of Administration
  • 29.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.6.3. Drug Estimates By Type
  • 29.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.7. Sweden
  • 29.2.2.7.1. Drug Insights
  • 29.2.2.7.2. Drug Estimates By Route of Administration
  • 29.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.7.3. Drug Estimates By Type
  • 29.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.8. Norway
  • 29.2.2.8.1. Drug Insights
  • 29.2.2.8.2. Drug Estimates By Route of Administration
  • 29.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.8.3. Drug Estimates By Type
  • 29.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.9. Rest of Europe
  • 29.2.2.9.1. Drug Insights
  • 29.2.2.9.2. Drug Estimates By Route of Administration
  • 29.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.9.3. Drug Estimates By Type
  • 29.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3. Asia Pacific
  • 29.2.3.1. Japan
  • 29.2.3.1.1. Drug Insights
  • 29.2.3.1.2. Drug Estimates By Route of Administration
  • 29.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.1.3. Drug Estimates By Type
  • 29.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.2. China
  • 29.2.3.2.1. Drug Insights
  • 29.2.3.2.2. Drug Estimates By Route of Administration
  • 29.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.2.3. Drug Estimates By Type
  • 29.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.3. India
  • 29.2.3.3.1. Drug Insights
  • 29.2.3.3.2. Drug Estimates By Route of Administration
  • 29.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.3.3. Drug Estimates By Type
  • 29.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.4. South Korea
  • 29.2.3.4.1. Drug Insights
  • 29.2.3.4.2. Drug Estimates By Route of Administration
  • 29.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.4.3. Drug Estimates By Type
  • 29.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.5. Australia
  • 29.2.3.5.1. Drug Insights
  • 29.2.3.5.2. Drug Estimates By Route of Administration
  • 29.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.5.3. Drug Estimates By Type
  • 29.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.6. Thailand
  • 29.2.3.6.1. Drug Insights
  • 29.2.3.6.2. Drug Estimates By Route of Administration
  • 29.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.6.3. Drug Estimates By Type
  • 29.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.7. Rest of APAC
  • 29.2.3.7.1. Drug Insights
  • 29.2.3.7.2. Drug Estimates By Route of Administration
  • 29.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.7.3. Drug Estimates By Type
  • 29.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4. Latin America
  • 29.2.4.1. Brazil
  • 29.2.4.1.1. Drug Insights
  • 29.2.4.1.2. Drug Estimates By Route of Administration
  • 29.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.1.3. Drug Estimates By Type
  • 29.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.2. Argentina
  • 29.2.4.2.1. Drug Insights
  • 29.2.4.2.2. Drug Estimates By Route of Administration
  • 29.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.2.3. Drug Estimates By Type
  • 29.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.3. Rest of Latin America
  • 29.2.4.3.1. Drug Insights
  • 29.2.4.3.2. Drug Estimates By Route of Administration
  • 29.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.3.3. Drug Estimates By Type
  • 29.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5. Middle East & Africa
  • 29.2.5.1. Saudi Arabia
  • 29.2.5.1.1. Drug Insights
  • 29.2.5.1.2. Drug Estimates By Route of Administration
  • 29.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.1.3. Drug Estimates By Type
  • 29.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.2. UAE
  • 29.2.5.2.1. Drug Insights
  • 29.2.5.2.2. Drug Estimates By Route of Administration
  • 29.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.2.3. Drug Estimates By Type
  • 29.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.3. Kuwait
  • 29.2.5.3.1. Drug Insights
  • 29.2.5.3.2. Drug Estimates By Route of Administration
  • 29.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.3.3. Drug Estimates By Type
  • 29.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.4. Rest of Middle East & Africa
  • 29.2.5.4.1. Drug Insights
  • 29.2.5.4.2. Drug Estimates By Route of Administration
  • 29.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.4.3. Drug Estimates By Type
  • 29.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 29.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 30. Tiagabine (Gabitril) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 30.1. Drug Information
  • 30.1.1. Drug Information
  • 30.1.2. Drug Patent Analysis
  • 30.2. Drug Estimates By Region
  • 30.2.1. North America
  • 30.2.1.1. Drug Insights
  • 30.2.1.2. Drug Estimates By Route of Administration
  • 30.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.3. Drug Estimates By Type
  • 30.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4. Drug Estimates By Country
  • 30.2.1.4.1. U.S.
  • 30.2.1.4.1.1. Drug Insight
  • 30.2.1.4.1.2. Drug Estimates By Route of Administration
  • 30.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.1.3. Drug Estimates By Type
  • 30.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.2. Canada
  • 30.2.1.4.2.1. Drug Insights
  • 30.2.1.4.2.2. Drug Estimates By Route of Administration
  • 30.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.2.3. Drug Estimates By Type
  • 30.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.3. Mexico
  • 30.2.1.4.3.1. Drug Insights
  • 30.2.1.4.3.2. Drug Estimates By Route of Administration
  • 30.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.3.3. Drug Estimates By Type
  • 30.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2. Europe
  • 30.2.2.1. UK
  • 30.2.2.1.1. Drug Insights
  • 30.2.2.1.2. Drug Estimates By Route of Administration
  • 30.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.1.3. Drug Estimates By Type
  • 30.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.2. Germany
  • 30.2.2.2.1. Drug Insights
  • 30.2.2.2.2. Drug Estimates By Route of Administration
  • 30.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.2.3. Drug Estimates By Type
  • 30.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.3. France
  • 30.2.2.3.1. Drug Insights
  • 30.2.2.3.2. Drug Estimates By Route of Administration
  • 30.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.3.3. Drug Estimates By Type
  • 30.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.4. Italy
  • 30.2.2.4.1. Drug Insights
  • 30.2.2.4.2. Drug Estimates By Route of Administration
  • 30.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.4.3. Drug Estimates By Type
  • 30.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.5. Spain
  • 30.2.2.5.1. Drug Insights
  • 30.2.2.5.2. Drug Estimates By Route of Administration
  • 30.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.5.3. Drug Estimates By Type
  • 30.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.6. Denmark
  • 30.2.2.6.1. Drug Insights
  • 30.2.2.6.2. Drug Estimates By Route of Administration
  • 30.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.6.3. Drug Estimates By Type
  • 30.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.7. Sweden
  • 30.2.2.7.1. Drug Insights
  • 30.2.2.7.2. Drug Estimates By Route of Administration
  • 30.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.7.3. Drug Estimates By Type
  • 30.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.8. Norway
  • 30.2.2.8.1. Drug Insights
  • 30.2.2.8.2. Drug Estimates By Route of Administration
  • 30.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.8.3. Drug Estimates By Type
  • 30.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.9. Rest of Europe
  • 30.2.2.9.1. Drug Insights
  • 30.2.2.9.2. Drug Estimates By Route of Administration
  • 30.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.9.3. Drug Estimates By Type
  • 30.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3. Asia Pacific
  • 30.2.3.1. Japan
  • 30.2.3.1.1. Drug Insights
  • 30.2.3.1.2. Drug Estimates By Route of Administration
  • 30.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.1.3. Drug Estimates By Type
  • 30.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.2. China
  • 30.2.3.2.1. Drug Insights
  • 30.2.3.2.2. Drug Estimates By Route of Administration
  • 30.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.2.3. Drug Estimates By Type
  • 30.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.3. India
  • 30.2.3.3.1. Drug Insights
  • 30.2.3.3.2. Drug Estimates By Route of Administration
  • 30.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.3.3. Drug Estimates By Type
  • 30.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.4. South Korea
  • 30.2.3.4.1. Drug Insights
  • 30.2.3.4.2. Drug Estimates By Route of Administration
  • 30.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.4.3. Drug Estimates By Type
  • 30.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.5. Australia
  • 30.2.3.5.1. Drug Insights
  • 30.2.3.5.2. Drug Estimates By Route of Administration
  • 30.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.5.3. Drug Estimates By Type
  • 30.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.6. Thailand
  • 30.2.3.6.1. Drug Insights
  • 30.2.3.6.2. Drug Estimates By Route of Administration
  • 30.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.6.3. Drug Estimates By Type
  • 30.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.7. Rest of APAC
  • 30.2.3.7.1. Drug Insights
  • 30.2.3.7.2. Drug Estimates By Route of Administration
  • 30.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.7.3. Drug Estimates By Type
  • 30.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4. Latin America
  • 30.2.4.1. Brazil
  • 30.2.4.1.1. Drug Insights
  • 30.2.4.1.2. Drug Estimates By Route of Administration
  • 30.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.1.3. Drug Estimates By Type
  • 30.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.2. Argentina
  • 30.2.4.2.1. Drug Insights
  • 30.2.4.2.2. Drug Estimates By Route of Administration
  • 30.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.2.3. Drug Estimates By Type
  • 30.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.3. Rest of Latin America
  • 30.2.4.3.1. Drug Insights
  • 30.2.4.3.2. Drug Estimates By Route of Administration
  • 30.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.3.3. Drug Estimates By Type
  • 30.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5. Middle East & Africa
  • 30.2.5.1. Saudi Arabia
  • 30.2.5.1.1. Drug Insights
  • 30.2.5.1.2. Drug Estimates By Route of Administration
  • 30.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.1.3. Drug Estimates By Type
  • 30.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.2. UAE
  • 30.2.5.2.1. Drug Insights
  • 30.2.5.2.2. Drug Estimates By Route of Administration
  • 30.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.2.3. Drug Estimates By Type
  • 30.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.3. Kuwait
  • 30.2.5.3.1. Drug Insights
  • 30.2.5.3.2. Drug Estimates By Route of Administration
  • 30.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.3.3. Drug Estimates By Type
  • 30.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.4. Rest of Middle East & Africa
  • 30.2.5.4.1. Drug Insights
  • 30.2.5.4.2. Drug Estimates By Route of Administration
  • 30.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.4.3. Drug Estimates By Type
  • 30.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 30.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 31. Clonazepam (Klonopin) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 31.1. Drug Information
  • 31.1.1. Drug Information
  • 31.1.2. Drug Patent Analysis
  • 31.2. Drug Estimates By Region
  • 31.2.1. North America
  • 31.2.1.1. Drug Insights
  • 31.2.1.2. Drug Estimates By Route of Administration
  • 31.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.3. Drug Estimates By Type
  • 31.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4. Drug Estimates By Country
  • 31.2.1.4.1. U.S.
  • 31.2.1.4.1.1. Drug Insight
  • 31.2.1.4.1.2. Drug Estimates By Route of Administration
  • 31.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.1.3. Drug Estimates By Type
  • 31.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.2. Canada
  • 31.2.1.4.2.1. Drug Insights
  • 31.2.1.4.2.2. Drug Estimates By Route of Administration
  • 31.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.2.3. Drug Estimates By Type
  • 31.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.3. Mexico
  • 31.2.1.4.3.1. Drug Insights
  • 31.2.1.4.3.2. Drug Estimates By Route of Administration
  • 31.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.3.3. Drug Estimates By Type
  • 31.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2. Europe
  • 31.2.2.1. UK
  • 31.2.2.1.1. Drug Insights
  • 31.2.2.1.2. Drug Estimates By Route of Administration
  • 31.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.1.3. Drug Estimates By Type
  • 31.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.2. Germany
  • 31.2.2.2.1. Drug Insights
  • 31.2.2.2.2. Drug Estimates By Route of Administration
  • 31.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.2.3. Drug Estimates By Type
  • 31.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.3. France
  • 31.2.2.3.1. Drug Insights
  • 31.2.2.3.2. Drug Estimates By Route of Administration
  • 31.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.3.3. Drug Estimates By Type
  • 31.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.4. Italy
  • 31.2.2.4.1. Drug Insights
  • 31.2.2.4.2. Drug Estimates By Route of Administration
  • 31.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.4.3. Drug Estimates By Type
  • 31.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.5. Spain
  • 31.2.2.5.1. Drug Insights
  • 31.2.2.5.2. Drug Estimates By Route of Administration
  • 31.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.5.3. Drug Estimates By Type
  • 31.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.6. Denmark
  • 31.2.2.6.1. Drug Insights
  • 31.2.2.6.2. Drug Estimates By Route of Administration
  • 31.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.6.3. Drug Estimates By Type
  • 31.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.7. Sweden
  • 31.2.2.7.1. Drug Insights
  • 31.2.2.7.2. Drug Estimates By Route of Administration
  • 31.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.7.3. Drug Estimates By Type
  • 31.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.8. Norway
  • 31.2.2.8.1. Drug Insights
  • 31.2.2.8.2. Drug Estimates By Route of Administration
  • 31.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.8.3. Drug Estimates By Type
  • 31.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.9. Rest of Europe
  • 31.2.2.9.1. Drug Insights
  • 31.2.2.9.2. Drug Estimates By Route of Administration
  • 31.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.9.3. Drug Estimates By Type
  • 31.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3. Asia Pacific
  • 31.2.3.1. Japan
  • 31.2.3.1.1. Drug Insights
  • 31.2.3.1.2. Drug Estimates By Route of Administration
  • 31.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.1.3. Drug Estimates By Type
  • 31.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.2. China
  • 31.2.3.2.1. Drug Insights
  • 31.2.3.2.2. Drug Estimates By Route of Administration
  • 31.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.2.3. Drug Estimates By Type
  • 31.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.3. India
  • 31.2.3.3.1. Drug Insights
  • 31.2.3.3.2. Drug Estimates By Route of Administration
  • 31.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.3.3. Drug Estimates By Type
  • 31.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.4. South Korea
  • 31.2.3.4.1. Drug Insights
  • 31.2.3.4.2. Drug Estimates By Route of Administration
  • 31.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.4.3. Drug Estimates By Type
  • 31.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.5. Australia
  • 31.2.3.5.1. Drug Insights
  • 31.2.3.5.2. Drug Estimates By Route of Administration
  • 31.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.5.3. Drug Estimates By Type
  • 31.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.6. Thailand
  • 31.2.3.6.1. Drug Insights
  • 31.2.3.6.2. Drug Estimates By Route of Administration
  • 31.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.6.3. Drug Estimates By Type
  • 31.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.7. Rest of APAC
  • 31.2.3.7.1. Drug Insights
  • 31.2.3.7.2. Drug Estimates By Route of Administration
  • 31.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.7.3. Drug Estimates By Type
  • 31.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4. Latin America
  • 31.2.4.1. Brazil
  • 31.2.4.1.1. Drug Insights
  • 31.2.4.1.2. Drug Estimates By Route of Administration
  • 31.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.1.3. Drug Estimates By Type
  • 31.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.2. Argentina
  • 31.2.4.2.1. Drug Insights
  • 31.2.4.2.2. Drug Estimates By Route of Administration
  • 31.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.2.3. Drug Estimates By Type
  • 31.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.3. Rest of Latin America
  • 31.2.4.3.1. Drug Insights
  • 31.2.4.3.2. Drug Estimates By Route of Administration
  • 31.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.3.3. Drug Estimates By Type
  • 31.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5. Middle East & Africa
  • 31.2.5.1. Saudi Arabia
  • 31.2.5.1.1. Drug Insights
  • 31.2.5.1.2. Drug Estimates By Route of Administration
  • 31.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.1.3. Drug Estimates By Type
  • 31.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.2. UAE
  • 31.2.5.2.1. Drug Insights
  • 31.2.5.2.2. Drug Estimates By Route of Administration
  • 31.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.2.3. Drug Estimates By Type
  • 31.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.3. Kuwait
  • 31.2.5.3.1. Drug Insights
  • 31.2.5.3.2. Drug Estimates By Route of Administration
  • 31.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.3.3. Drug Estimates By Type
  • 31.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.4. Rest of Middle East & Africa
  • 31.2.5.4.1. Drug Insights
  • 31.2.5.4.2. Drug Estimates By Route of Administration
  • 31.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.4.3. Drug Estimates By Type
  • 31.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 31.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 32. Stiripentol (Diacomit) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 32.1. Drug Information
  • 32.1.1. Drug Information
  • 32.1.2. Drug Patent Analysis
  • 32.2. Drug Estimates By Region
  • 32.2.1. North America
  • 32.2.1.1. Drug Insights
  • 32.2.1.2. Drug Estimates By Route of Administration
  • 32.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.3. Drug Estimates By Type
  • 32.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4. Drug Estimates By Country
  • 32.2.1.4.1. U.S.
  • 32.2.1.4.1.1. Drug Insight
  • 32.2.1.4.1.2. Drug Estimates By Route of Administration
  • 32.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.1.3. Drug Estimates By Type
  • 32.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.2. Canada
  • 32.2.1.4.2.1. Drug Insights
  • 32.2.1.4.2.2. Drug Estimates By Route of Administration
  • 32.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.2.3. Drug Estimates By Type
  • 32.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.3. Mexico
  • 32.2.1.4.3.1. Drug Insights
  • 32.2.1.4.3.2. Drug Estimates By Route of Administration
  • 32.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.3.3. Drug Estimates By Type
  • 32.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2. Europe
  • 32.2.2.1. UK
  • 32.2.2.1.1. Drug Insights
  • 32.2.2.1.2. Drug Estimates By Route of Administration
  • 32.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.1.3. Drug Estimates By Type
  • 32.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.2. Germany
  • 32.2.2.2.1. Drug Insights
  • 32.2.2.2.2. Drug Estimates By Route of Administration
  • 32.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.2.3. Drug Estimates By Type
  • 32.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.3. France
  • 32.2.2.3.1. Drug Insights
  • 32.2.2.3.2. Drug Estimates By Route of Administration
  • 32.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.3.3. Drug Estimates By Type
  • 32.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.4. Italy
  • 32.2.2.4.1. Drug Insights
  • 32.2.2.4.2. Drug Estimates By Route of Administration
  • 32.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.4.3. Drug Estimates By Type
  • 32.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.5. Spain
  • 32.2.2.5.1. Drug Insights
  • 32.2.2.5.2. Drug Estimates By Route of Administration
  • 32.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.5.3. Drug Estimates By Type
  • 32.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.6. Denmark
  • 32.2.2.6.1. Drug Insights
  • 32.2.2.6.2. Drug Estimates By Route of Administration
  • 32.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.6.3. Drug Estimates By Type
  • 32.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.7. Sweden
  • 32.2.2.7.1. Drug Insights
  • 32.2.2.7.2. Drug Estimates By Route of Administration
  • 32.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.7.3. Drug Estimates By Type
  • 32.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.8. Norway
  • 32.2.2.8.1. Drug Insights
  • 32.2.2.8.2. Drug Estimates By Route of Administration
  • 32.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.8.3. Drug Estimates By Type
  • 32.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.9. Rest of Europe
  • 32.2.2.9.1. Drug Insights
  • 32.2.2.9.2. Drug Estimates By Route of Administration
  • 32.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.9.3. Drug Estimates By Type
  • 32.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3. Asia Pacific
  • 32.2.3.1. Japan
  • 32.2.3.1.1. Drug Insights
  • 32.2.3.1.2. Drug Estimates By Route of Administration
  • 32.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.1.3. Drug Estimates By Type
  • 32.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.2. China
  • 32.2.3.2.1. Drug Insights
  • 32.2.3.2.2. Drug Estimates By Route of Administration
  • 32.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.2.3. Drug Estimates By Type
  • 32.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.3. India
  • 32.2.3.3.1. Drug Insights
  • 32.2.3.3.2. Drug Estimates By Route of Administration
  • 32.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.3.3. Drug Estimates By Type
  • 32.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.4. South Korea
  • 32.2.3.4.1. Drug Insights
  • 32.2.3.4.2. Drug Estimates By Route of Administration
  • 32.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.4.3. Drug Estimates By Type
  • 32.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.5. Australia
  • 32.2.3.5.1. Drug Insights
  • 32.2.3.5.2. Drug Estimates By Route of Administration
  • 32.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.5.3. Drug Estimates By Type
  • 32.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.6. Thailand
  • 32.2.3.6.1. Drug Insights
  • 32.2.3.6.2. Drug Estimates By Route of Administration
  • 32.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.6.3. Drug Estimates By Type
  • 32.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.7. Rest of APAC
  • 32.2.3.7.1. Drug Insights
  • 32.2.3.7.2. Drug Estimates By Route of Administration
  • 32.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.7.3. Drug Estimates By Type
  • 32.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4. Latin America
  • 32.2.4.1. Brazil
  • 32.2.4.1.1. Drug Insights
  • 32.2.4.1.2. Drug Estimates By Route of Administration
  • 32.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.1.3. Drug Estimates By Type
  • 32.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.2. Argentina
  • 32.2.4.2.1. Drug Insights
  • 32.2.4.2.2. Drug Estimates By Route of Administration
  • 32.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.2.3. Drug Estimates By Type
  • 32.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.3. Rest of Latin America
  • 32.2.4.3.1. Drug Insights
  • 32.2.4.3.2. Drug Estimates By Route of Administration
  • 32.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.3.3. Drug Estimates By Type
  • 32.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5. Middle East & Africa
  • 32.2.5.1. Saudi Arabia
  • 32.2.5.1.1. Drug Insights
  • 32.2.5.1.2. Drug Estimates By Route of Administration
  • 32.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.1.3. Drug Estimates By Type
  • 32.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.2. UAE
  • 32.2.5.2.1. Drug Insights
  • 32.2.5.2.2. Drug Estimates By Route of Administration
  • 32.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.2.3. Drug Estimates By Type
  • 32.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.3. Kuwait
  • 32.2.5.3.1. Drug Insights
  • 32.2.5.3.2. Drug Estimates By Route of Administration
  • 32.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.3.3. Drug Estimates By Type
  • 32.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.4. Rest of Middle East & Africa
  • 32.2.5.4.1. Drug Insights
  • 32.2.5.4.2. Drug Estimates By Route of Administration
  • 32.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.4.3. Drug Estimates By Type
  • 32.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 32.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 33. Felbamate (Felbatol) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 33.1. Drug Information
  • 33.1.1. Drug Information
  • 33.1.2. Drug Patent Analysis
  • 33.2. Drug Estimates By Region
  • 33.2.1. North America
  • 33.2.1.1. Drug Insights
  • 33.2.1.2. Drug Estimates By Route of Administration
  • 33.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.3. Drug Estimates By Type
  • 33.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4. Drug Estimates By Country
  • 33.2.1.4.1. U.S.
  • 33.2.1.4.1.1. Drug Insight
  • 33.2.1.4.1.2. Drug Estimates By Route of Administration
  • 33.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.1.3. Drug Estimates By Type
  • 33.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.2. Canada
  • 33.2.1.4.2.1. Drug Insights
  • 33.2.1.4.2.2. Drug Estimates By Route of Administration
  • 33.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.2.3. Drug Estimates By Type
  • 33.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.3. Mexico
  • 33.2.1.4.3.1. Drug Insights
  • 33.2.1.4.3.2. Drug Estimates By Route of Administration
  • 33.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.3.3. Drug Estimates By Type
  • 33.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2. Europe
  • 33.2.2.1. UK
  • 33.2.2.1.1. Drug Insights
  • 33.2.2.1.2. Drug Estimates By Route of Administration
  • 33.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.1.3. Drug Estimates By Type
  • 33.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.2. Germany
  • 33.2.2.2.1. Drug Insights
  • 33.2.2.2.2. Drug Estimates By Route of Administration
  • 33.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.2.3. Drug Estimates By Type
  • 33.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.3. France
  • 33.2.2.3.1. Drug Insights
  • 33.2.2.3.2. Drug Estimates By Route of Administration
  • 33.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.3.3. Drug Estimates By Type
  • 33.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.4. Italy
  • 33.2.2.4.1. Drug Insights
  • 33.2.2.4.2. Drug Estimates By Route of Administration
  • 33.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.4.3. Drug Estimates By Type
  • 33.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.5. Spain
  • 33.2.2.5.1. Drug Insights
  • 33.2.2.5.2. Drug Estimates By Route of Administration
  • 33.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.5.3. Drug Estimates By Type
  • 33.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.6. Denmark
  • 33.2.2.6.1. Drug Insights
  • 33.2.2.6.2. Drug Estimates By Route of Administration
  • 33.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.6.3. Drug Estimates By Type
  • 33.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.7. Sweden
  • 33.2.2.7.1. Drug Insights
  • 33.2.2.7.2. Drug Estimates By Route of Administration
  • 33.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.7.3. Drug Estimates By Type
  • 33.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.8. Norway
  • 33.2.2.8.1. Drug Insights
  • 33.2.2.8.2. Drug Estimates By Route of Administration
  • 33.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.8.3. Drug Estimates By Type
  • 33.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.9. Rest of Europe
  • 33.2.2.9.1. Drug Insights
  • 33.2.2.9.2. Drug Estimates By Route of Administration
  • 33.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.9.3. Drug Estimates By Type
  • 33.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3. Asia Pacific
  • 33.2.3.1. Japan
  • 33.2.3.1.1. Drug Insights
  • 33.2.3.1.2. Drug Estimates By Route of Administration
  • 33.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.1.3. Drug Estimates By Type
  • 33.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.2. China
  • 33.2.3.2.1. Drug Insights
  • 33.2.3.2.2. Drug Estimates By Route of Administration
  • 33.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.2.3. Drug Estimates By Type
  • 33.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.3. India
  • 33.2.3.3.1. Drug Insights
  • 33.2.3.3.2. Drug Estimates By Route of Administration
  • 33.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.3.3. Drug Estimates By Type
  • 33.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.4. South Korea
  • 33.2.3.4.1. Drug Insights
  • 33.2.3.4.2. Drug Estimates By Route of Administration
  • 33.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.4.3. Drug Estimates By Type
  • 33.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.5. Australia
  • 33.2.3.5.1. Drug Insights
  • 33.2.3.5.2. Drug Estimates By Route of Administration
  • 33.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.5.3. Drug Estimates By Type
  • 33.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.6. Thailand
  • 33.2.3.6.1. Drug Insights
  • 33.2.3.6.2. Drug Estimates By Route of Administration
  • 33.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.6.3. Drug Estimates By Type
  • 33.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.7. Rest of APAC
  • 33.2.3.7.1. Drug Insights
  • 33.2.3.7.2. Drug Estimates By Route of Administration
  • 33.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.7.3. Drug Estimates By Type
  • 33.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4. Latin America
  • 33.2.4.1. Brazil
  • 33.2.4.1.1. Drug Insights
  • 33.2.4.1.2. Drug Estimates By Route of Administration
  • 33.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.1.3. Drug Estimates By Type
  • 33.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.2. Argentina
  • 33.2.4.2.1. Drug Insights
  • 33.2.4.2.2. Drug Estimates By Route of Administration
  • 33.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.2.3. Drug Estimates By Type
  • 33.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.3. Rest of Latin America
  • 33.2.4.3.1. Drug Insights
  • 33.2.4.3.2. Drug Estimates By Route of Administration
  • 33.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.3.3. Drug Estimates By Type
  • 33.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5. Middle East & Africa
  • 33.2.5.1. Saudi Arabia
  • 33.2.5.1.1. Drug Insights
  • 33.2.5.1.2. Drug Estimates By Route of Administration
  • 33.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.1.3. Drug Estimates By Type
  • 33.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.2. UAE
  • 33.2.5.2.1. Drug Insights
  • 33.2.5.2.2. Drug Estimates By Route of Administration
  • 33.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.2.3. Drug Estimates By Type
  • 33.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.3. Kuwait
  • 33.2.5.3.1. Drug Insights
  • 33.2.5.3.2. Drug Estimates By Route of Administration
  • 33.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.3.3. Drug Estimates By Type
  • 33.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.4. Rest of Middle East & Africa
  • 33.2.5.4.1. Drug Insights
  • 33.2.5.4.2. Drug Estimates By Route of Administration
  • 33.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.4.3. Drug Estimates By Type
  • 33.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 33.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 34. Primidone (Mysoline) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 34.1. Drug Information
  • 34.1.1. Drug Information
  • 34.1.2. Drug Patent Analysis
  • 34.2. Drug Estimates By Region
  • 34.2.1. North America
  • 34.2.1.1. Drug Insights
  • 34.2.1.2. Drug Estimates By Route of Administration
  • 34.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.3. Drug Estimates By Type
  • 34.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4. Drug Estimates By Country
  • 34.2.1.4.1. U.S.
  • 34.2.1.4.1.1. Drug Insight
  • 34.2.1.4.1.2. Drug Estimates By Route of Administration
  • 34.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.1.3. Drug Estimates By Type
  • 34.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.2. Canada
  • 34.2.1.4.2.1. Drug Insights
  • 34.2.1.4.2.2. Drug Estimates By Route of Administration
  • 34.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.2.3. Drug Estimates By Type
  • 34.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.3. Mexico
  • 34.2.1.4.3.1. Drug Insights
  • 34.2.1.4.3.2. Drug Estimates By Route of Administration
  • 34.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.3.3. Drug Estimates By Type
  • 34.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2. Europe
  • 34.2.2.1. UK
  • 34.2.2.1.1. Drug Insights
  • 34.2.2.1.2. Drug Estimates By Route of Administration
  • 34.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.1.3. Drug Estimates By Type
  • 34.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.2. Germany
  • 34.2.2.2.1. Drug Insights
  • 34.2.2.2.2. Drug Estimates By Route of Administration
  • 34.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.2.3. Drug Estimates By Type
  • 34.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.3. France
  • 34.2.2.3.1. Drug Insights
  • 34.2.2.3.2. Drug Estimates By Route of Administration
  • 34.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.3.3. Drug Estimates By Type
  • 34.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.4. Italy
  • 34.2.2.4.1. Drug Insights
  • 34.2.2.4.2. Drug Estimates By Route of Administration
  • 34.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.4.3. Drug Estimates By Type
  • 34.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.5. Spain
  • 34.2.2.5.1. Drug Insights
  • 34.2.2.5.2. Drug Estimates By Route of Administration
  • 34.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.5.3. Drug Estimates By Type
  • 34.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.6. Denmark
  • 34.2.2.6.1. Drug Insights
  • 34.2.2.6.2. Drug Estimates By Route of Administration
  • 34.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.6.3. Drug Estimates By Type
  • 34.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.7. Sweden
  • 34.2.2.7.1. Drug Insights
  • 34.2.2.7.2. Drug Estimates By Route of Administration
  • 34.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.7.3. Drug Estimates By Type
  • 34.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.8. Norway
  • 34.2.2.8.1. Drug Insights
  • 34.2.2.8.2. Drug Estimates By Route of Administration
  • 34.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.8.3. Drug Estimates By Type
  • 34.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.9. Rest of Europe
  • 34.2.2.9.1. Drug Insights
  • 34.2.2.9.2. Drug Estimates By Route of Administration
  • 34.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.9.3. Drug Estimates By Type
  • 34.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3. Asia Pacific
  • 34.2.3.1. Japan
  • 34.2.3.1.1. Drug Insights
  • 34.2.3.1.2. Drug Estimates By Route of Administration
  • 34.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.1.3. Drug Estimates By Type
  • 34.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.2. China
  • 34.2.3.2.1. Drug Insights
  • 34.2.3.2.2. Drug Estimates By Route of Administration
  • 34.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.2.3. Drug Estimates By Type
  • 34.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.3. India
  • 34.2.3.3.1. Drug Insights
  • 34.2.3.3.2. Drug Estimates By Route of Administration
  • 34.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.3.3. Drug Estimates By Type
  • 34.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.4. South Korea
  • 34.2.3.4.1. Drug Insights
  • 34.2.3.4.2. Drug Estimates By Route of Administration
  • 34.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.4.3. Drug Estimates By Type
  • 34.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.5. Australia
  • 34.2.3.5.1. Drug Insights
  • 34.2.3.5.2. Drug Estimates By Route of Administration
  • 34.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.5.3. Drug Estimates By Type
  • 34.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.6. Thailand
  • 34.2.3.6.1. Drug Insights
  • 34.2.3.6.2. Drug Estimates By Route of Administration
  • 34.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.6.3. Drug Estimates By Type
  • 34.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.7. Rest of APAC
  • 34.2.3.7.1. Drug Insights
  • 34.2.3.7.2. Drug Estimates By Route of Administration
  • 34.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.7.3. Drug Estimates By Type
  • 34.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4. Latin America
  • 34.2.4.1. Brazil
  • 34.2.4.1.1. Drug Insights
  • 34.2.4.1.2. Drug Estimates By Route of Administration
  • 34.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.1.3. Drug Estimates By Type
  • 34.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.2. Argentina
  • 34.2.4.2.1. Drug Insights
  • 34.2.4.2.2. Drug Estimates By Route of Administration
  • 34.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.2.3. Drug Estimates By Type
  • 34.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.3. Rest of Latin America
  • 34.2.4.3.1. Drug Insights
  • 34.2.4.3.2. Drug Estimates By Route of Administration
  • 34.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.3.3. Drug Estimates By Type
  • 34.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5. Middle East & Africa
  • 34.2.5.1. Saudi Arabia
  • 34.2.5.1.1. Drug Insights
  • 34.2.5.1.2. Drug Estimates By Route of Administration
  • 34.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.1.3. Drug Estimates By Type
  • 34.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.2. UAE
  • 34.2.5.2.1. Drug Insights
  • 34.2.5.2.2. Drug Estimates By Route of Administration
  • 34.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.2.3. Drug Estimates By Type
  • 34.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.3. Kuwait
  • 34.2.5.3.1. Drug Insights
  • 34.2.5.3.2. Drug Estimates By Route of Administration
  • 34.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.3.3. Drug Estimates By Type
  • 34.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.4. Rest of Middle East & Africa
  • 34.2.5.4.1. Drug Insights
  • 34.2.5.4.2. Drug Estimates By Route of Administration
  • 34.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.4.3. Drug Estimates By Type
  • 34.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 34.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 35. Acetazolamide (Diamox) Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 35.1. Drug Information
  • 35.1.1. Drug Information
  • 35.1.2. Drug Patent Analysis
  • 35.2. Drug Estimates By Region
  • 35.2.1. North America
  • 35.2.1.1. Drug Insights
  • 35.2.1.2. Drug Estimates By Route of Administration
  • 35.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.3. Drug Estimates By Type
  • 35.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4. Drug Estimates By Country
  • 35.2.1.4.1. U.S.
  • 35.2.1.4.1.1. Drug Insight
  • 35.2.1.4.1.2. Drug Estimates By Route of Administration
  • 35.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.1.3. Drug Estimates By Type
  • 35.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.2. Canada
  • 35.2.1.4.2.1. Drug Insights
  • 35.2.1.4.2.2. Drug Estimates By Route of Administration
  • 35.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.2.3. Drug Estimates By Type
  • 35.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.3. Mexico
  • 35.2.1.4.3.1. Drug Insights
  • 35.2.1.4.3.2. Drug Estimates By Route of Administration
  • 35.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.3.3. Drug Estimates By Type
  • 35.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2. Europe
  • 35.2.2.1. UK
  • 35.2.2.1.1. Drug Insights
  • 35.2.2.1.2. Drug Estimates By Route of Administration
  • 35.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.1.3. Drug Estimates By Type
  • 35.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.2. Germany
  • 35.2.2.2.1. Drug Insights
  • 35.2.2.2.2. Drug Estimates By Route of Administration
  • 35.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.2.3. Drug Estimates By Type
  • 35.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.3. France
  • 35.2.2.3.1. Drug Insights
  • 35.2.2.3.2. Drug Estimates By Route of Administration
  • 35.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.3.3. Drug Estimates By Type
  • 35.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.4. Italy
  • 35.2.2.4.1. Drug Insights
  • 35.2.2.4.2. Drug Estimates By Route of Administration
  • 35.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.4.3. Drug Estimates By Type
  • 35.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.5. Spain
  • 35.2.2.5.1. Drug Insights
  • 35.2.2.5.2. Drug Estimates By Route of Administration
  • 35.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.5.3. Drug Estimates By Type
  • 35.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.6. Denmark
  • 35.2.2.6.1. Drug Insights
  • 35.2.2.6.2. Drug Estimates By Route of Administration
  • 35.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.6.3. Drug Estimates By Type
  • 35.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.7. Sweden
  • 35.2.2.7.1. Drug Insights
  • 35.2.2.7.2. Drug Estimates By Route of Administration
  • 35.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.7.3. Drug Estimates By Type
  • 35.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.8. Norway
  • 35.2.2.8.1. Drug Insights
  • 35.2.2.8.2. Drug Estimates By Route of Administration
  • 35.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.8.3. Drug Estimates By Type
  • 35.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.9. Rest of Europe
  • 35.2.2.9.1. Drug Insights
  • 35.2.2.9.2. Drug Estimates By Route of Administration
  • 35.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.9.3. Drug Estimates By Type
  • 35.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3. Asia Pacific
  • 35.2.3.1. Japan
  • 35.2.3.1.1. Drug Insights
  • 35.2.3.1.2. Drug Estimates By Route of Administration
  • 35.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.1.3. Drug Estimates By Type
  • 35.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.2. China
  • 35.2.3.2.1. Drug Insights
  • 35.2.3.2.2. Drug Estimates By Route of Administration
  • 35.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.2.3. Drug Estimates By Type
  • 35.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.3. India
  • 35.2.3.3.1. Drug Insights
  • 35.2.3.3.2. Drug Estimates By Route of Administration
  • 35.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.3.3. Drug Estimates By Type
  • 35.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.4. South Korea
  • 35.2.3.4.1. Drug Insights
  • 35.2.3.4.2. Drug Estimates By Route of Administration
  • 35.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.4.3. Drug Estimates By Type
  • 35.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.5. Australia
  • 35.2.3.5.1. Drug Insights
  • 35.2.3.5.2. Drug Estimates By Route of Administration
  • 35.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.5.3. Drug Estimates By Type
  • 35.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.6. Thailand
  • 35.2.3.6.1. Drug Insights
  • 35.2.3.6.2. Drug Estimates By Route of Administration
  • 35.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.6.3. Drug Estimates By Type
  • 35.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.7. Rest of APAC
  • 35.2.3.7.1. Drug Insights
  • 35.2.3.7.2. Drug Estimates By Route of Administration
  • 35.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.7.3. Drug Estimates By Type
  • 35.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4. Latin America
  • 35.2.4.1. Brazil
  • 35.2.4.1.1. Drug Insights
  • 35.2.4.1.2. Drug Estimates By Route of Administration
  • 35.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.1.3. Drug Estimates By Type
  • 35.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.2. Argentina
  • 35.2.4.2.1. Drug Insights
  • 35.2.4.2.2. Drug Estimates By Route of Administration
  • 35.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.2.3. Drug Estimates By Type
  • 35.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.3. Rest of Latin America
  • 35.2.4.3.1. Drug Insights
  • 35.2.4.3.2. Drug Estimates By Route of Administration
  • 35.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.3.3. Drug Estimates By Type
  • 35.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5. Middle East & Africa
  • 35.2.5.1. Saudi Arabia
  • 35.2.5.1.1. Drug Insights
  • 35.2.5.1.2. Drug Estimates By Route of Administration
  • 35.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.1.3. Drug Estimates By Type
  • 35.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.2. UAE
  • 35.2.5.2.1. Drug Insights
  • 35.2.5.2.2. Drug Estimates By Route of Administration
  • 35.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.2.3. Drug Estimates By Type
  • 35.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.3. Kuwait
  • 35.2.5.3.1. Drug Insights
  • 35.2.5.3.2. Drug Estimates By Route of Administration
  • 35.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.3.3. Drug Estimates By Type
  • 35.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.4. Rest of Middle East & Africa
  • 35.2.5.4.1. Drug Insights
  • 35.2.5.4.2. Drug Estimates By Route of Administration
  • 35.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.4.3. Drug Estimates By Type
  • 35.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 35.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 36. Other Drugs Market Estimates & Forecast 2021 - 2033 (USD Mn)

  • 36.1. Drug Information
  • 36.1.1. Drug Information
  • 36.1.2. Drug Patent Analysis
  • 36.2. Drug Estimates By Region
  • 36.2.1. North America
  • 36.2.1.1. Drug Insights
  • 36.2.1.2. Drug Estimates By Route of Administration
  • 36.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.3. Drug Estimates By Type
  • 36.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4. Drug Estimates By Country
  • 36.2.1.4.1. U.S.
  • 36.2.1.4.1.1. Drug Insight
  • 36.2.1.4.1.2. Drug Estimates By Route of Administration
  • 36.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.1.3. Drug Estimates By Type
  • 36.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.2. Canada
  • 36.2.1.4.2.1. Drug Insights
  • 36.2.1.4.2.2. Drug Estimates By Route of Administration
  • 36.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.2.3. Drug Estimates By Type
  • 36.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.3. Mexico
  • 36.2.1.4.3.1. Drug Insights
  • 36.2.1.4.3.2. Drug Estimates By Route of Administration
  • 36.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.3.3. Drug Estimates By Type
  • 36.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2. Europe
  • 36.2.2.1. UK
  • 36.2.2.1.1. Drug Insights
  • 36.2.2.1.2. Drug Estimates By Route of Administration
  • 36.2.2.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.1.3. Drug Estimates By Type
  • 36.2.2.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.2. Germany
  • 36.2.2.2.1. Drug Insights
  • 36.2.2.2.2. Drug Estimates By Route of Administration
  • 36.2.2.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.2.3. Drug Estimates By Type
  • 36.2.2.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.3. France
  • 36.2.2.3.1. Drug Insights
  • 36.2.2.3.2. Drug Estimates By Route of Administration
  • 36.2.2.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.3.3. Drug Estimates By Type
  • 36.2.2.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.4. Italy
  • 36.2.2.4.1. Drug Insights
  • 36.2.2.4.2. Drug Estimates By Route of Administration
  • 36.2.2.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.4.3. Drug Estimates By Type
  • 36.2.2.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.5. Spain
  • 36.2.2.5.1. Drug Insights
  • 36.2.2.5.2. Drug Estimates By Route of Administration
  • 36.2.2.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.5.3. Drug Estimates By Type
  • 36.2.2.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.6. Denmark
  • 36.2.2.6.1. Drug Insights
  • 36.2.2.6.2. Drug Estimates By Route of Administration
  • 36.2.2.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.6.3. Drug Estimates By Type
  • 36.2.2.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.7. Sweden
  • 36.2.2.7.1. Drug Insights
  • 36.2.2.7.2. Drug Estimates By Route of Administration
  • 36.2.2.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.7.3. Drug Estimates By Type
  • 36.2.2.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.8. Norway
  • 36.2.2.8.1. Drug Insights
  • 36.2.2.8.2. Drug Estimates By Route of Administration
  • 36.2.2.8.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.8.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.8.3. Drug Estimates By Type
  • 36.2.2.8.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.8.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.9. Rest of Europe
  • 36.2.2.9.1. Drug Insights
  • 36.2.2.9.2. Drug Estimates By Route of Administration
  • 36.2.2.9.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.9.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.9.3. Drug Estimates By Type
  • 36.2.2.9.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.2.9.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3. Asia Pacific
  • 36.2.3.1. Japan
  • 36.2.3.1.1. Drug Insights
  • 36.2.3.1.2. Drug Estimates By Route of Administration
  • 36.2.3.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.1.3. Drug Estimates By Type
  • 36.2.3.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.2. China
  • 36.2.3.2.1. Drug Insights
  • 36.2.3.2.2. Drug Estimates By Route of Administration
  • 36.2.3.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.2.3. Drug Estimates By Type
  • 36.2.3.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.3. India
  • 36.2.3.3.1. Drug Insights
  • 36.2.3.3.2. Drug Estimates By Route of Administration
  • 36.2.3.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.3.3. Drug Estimates By Type
  • 36.2.3.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.4. South Korea
  • 36.2.3.4.1. Drug Insights
  • 36.2.3.4.2. Drug Estimates By Route of Administration
  • 36.2.3.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.4.3. Drug Estimates By Type
  • 36.2.3.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.5. Australia
  • 36.2.3.5.1. Drug Insights
  • 36.2.3.5.2. Drug Estimates By Route of Administration
  • 36.2.3.5.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.5.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.5.3. Drug Estimates By Type
  • 36.2.3.5.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.5.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.6. Thailand
  • 36.2.3.6.1. Drug Insights
  • 36.2.3.6.2. Drug Estimates By Route of Administration
  • 36.2.3.6.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.6.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.6.3. Drug Estimates By Type
  • 36.2.3.6.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.6.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.7. Rest of APAC
  • 36.2.3.7.1. Drug Insights
  • 36.2.3.7.2. Drug Estimates By Route of Administration
  • 36.2.3.7.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.7.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.7.3. Drug Estimates By Type
  • 36.2.3.7.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.3.7.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4. Latin America
  • 36.2.4.1. Brazil
  • 36.2.4.1.1. Drug Insights
  • 36.2.4.1.2. Drug Estimates By Route of Administration
  • 36.2.4.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.1.3. Drug Estimates By Type
  • 36.2.4.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.2. Argentina
  • 36.2.4.2.1. Drug Insights
  • 36.2.4.2.2. Drug Estimates By Route of Administration
  • 36.2.4.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.2.3. Drug Estimates By Type
  • 36.2.4.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.3. Rest of Latin America
  • 36.2.4.3.1. Drug Insights
  • 36.2.4.3.2. Drug Estimates By Route of Administration
  • 36.2.4.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.3.3. Drug Estimates By Type
  • 36.2.4.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.4.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5. Middle East & Africa
  • 36.2.5.1. Saudi Arabia
  • 36.2.5.1.1. Drug Insights
  • 36.2.5.1.2. Drug Estimates By Route of Administration
  • 36.2.5.1.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.1.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.1.3. Drug Estimates By Type
  • 36.2.5.1.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.1.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.2. UAE
  • 36.2.5.2.1. Drug Insights
  • 36.2.5.2.2. Drug Estimates By Route of Administration
  • 36.2.5.2.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.2.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.2.3. Drug Estimates By Type
  • 36.2.5.2.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.2.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.3. Kuwait
  • 36.2.5.3.1. Drug Insights
  • 36.2.5.3.2. Drug Estimates By Route of Administration
  • 36.2.5.3.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.3.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.3.3. Drug Estimates By Type
  • 36.2.5.3.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.3.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.4. Rest of Middle East & Africa
  • 36.2.5.4.1. Drug Insights
  • 36.2.5.4.2. Drug Estimates By Route of Administration
  • 36.2.5.4.2.1. Oral Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.4.2.3. Others Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.4.3. Drug Estimates By Type
  • 36.2.5.4.3.1. Branded Drug Estimates & Forecast 2021 - 2033 (USD Mn)
  • 36.2.5.4.3.2. Generic Drug Estimates & Forecast 2021 - 2033 (USD Mn)

Chapter 37. Innovations & Pipeline Scenario

Chapter 38. Competition Mapping

  • 38.1. Company Market Share (2025)
  • 38.2. Drug Revenue share (2025 & 2033)

Chapter 39. Epilepsy & Seizure Drugs Market Share, By Region 2025 & 2033

Chapter 40. Conclusion



What questions do you have? Get quick response from our industry experts. Request a Free Consultation
ISO 9001:2015 & 27001:2022 Certified

ISO 9001:2015 & 27001:2022 Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

Customize This Report
logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo